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Phosphoinositides (PIs) are negatively charged glycerol-based phospholipids. Their 
inositol head can be phosphorylated at three positions generating seven differently 
phosphorylated species. Cytoplasmic phosphoinositides regulate membrane and 
cytoskeletal dynamics, vesicular trafficking, ion channels and transporters and generate 
second messengers. In the nucleus, PIs are implicated in pre-mRNA processing, DNA 
transcription and chromatin remodelling. However, their nuclear functions are still poorly 
understood. Here we focus on nuclear phosphatidylinositol 4-phosphate (PI(4)P) and 
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2). We describe their localization and 
interaction with proteins involved in regulation of DNA transcription. 
PI(4)P localizes to the nuclear membrane, nuclear speckles and nucleoplasm.  The 
majority of nuclear PI(4)P is associated with chromatin and colocalizes with H3K4me2. 
PI(4,5)P2 localizes to nucleoli and nuclear speckles. Besides, 30 % of nuclear PI(4,5)P2 forms 
small nucleoplasmic PI(4,5)P2 islets. They have carbon rich core, which is probably formed 
by lipids, and are surrounded by proteins and nucleic acids. The active form of RNA 
polymerase II associates with PI(4,5)P2 islets and DNA is actively transcribed in the vicinity of 
PI(4,5)P2 islets. Moreover, nuclear myosin 1 (NM1) binds PI(4,5)P2 in the nucleus. This 
interaction targets NM1 to PI(4,5)P2 islets and is essential for NM1 interaction with 
transcription machinery and active DNA transcription. Therefore, we suggest that PI(4,5)P2 
islets facilitate a spatial-temporal arrangement of transcription complexes assembly. 
Moreover, we demonstrate that lysine-specific histone demethylase 1 (LSD1), 
enzyme that demethylates H3K4me2, interacts with both PI(4)P and PI(4,5)P2. While the 
interaction with PI(4)P leads to an inhibition of LSD1, the interaction with PI(4,5)P2 
stimulates LSD1 H3K4me2 demethylase activity in vitro. Thus, PI(4)P and PI(4,5)P2 could 
regulate transcription at the epigenetic level also in vivo. 
Another PI(4,5)P2 binding protein, actin, exists in the cytoplasm in monomeric form 
that can polymerize to filaments. However, in which form is actin present in the nucleus is 
still not sufficiently understood. After actin overexpression, we observed formation of actin 
filaments in the nucleus. These filaments resemble cytoplasmic F-actin and recruit cofilin and 
Arp3 actin binding proteins. The formation of actin filaments in the nucleus results in an 




Fosfoinositidy jsou negativně nabité fosfolipidy. Jejich inositolová hlavička může být 
fosforylována na třech pozicích, a tak mohou tvořit sedm různě fosforylovaných forem. 
Cytoplasmatické fosfoinositidy regulují dynamiku buněčných membrán a cytoskeletu, 
transport membránových váčků, funkci iontových kanálů a transportérů a produkci druhých 
poslů. Jaderné fosfoinositidy ovlivňují postranskripční úpravy pre-mRNA, DNA transkripci a 
remodelování chromatinu. Jejich jaderné funkce jsou nicméně nedostatečně prozkoumány. 
Tato práce se zaměřuje na jaderný fosfatidylinositol 4-fosfát (PI(4)P) a fosfatidylinositol 4,5-
bisfosfát (PI(4,5)P2), jejich lokalizaci a interakce s proteiny regulujícími transkripci. 
PI(4)P je součástí jaderné membrány, nachází se v jaderných speckles a 
v nukleoplasmě. Většina jaderného PI(4)P je navázána na chromatin a kolokalizuje 
s H3K4me2 histonovou značkou. PI(4,5)P2 lokalizuje do jadérka a jaderných speckles. 
Přibližně 30 % jaderného PI(4,5)P2 tvoří malé ostrůvky v nukleoplasmě. Nitro těchto 
ostrůvků je bohaté na uhlík a je pravděpodobně tvořeno lipidy. Ostrůvky jsou obklopeny 
proteiny a nukleovými kyselinami. Aktivní forma RNA polymerázy II lokalizuje k PI(4,5)P2 
ostrůvkům a v blízkosti ostrůvků dochází k aktivní transkripci. Jaderný myosin 1 (NM1) váže 
PI(4,5)P2. Tato interakce je zásadní pro vazbu NM1 na transkripční komplex a probíhající 
transkripci. Předpokládáme proto, že PI(4,5)P2 ostrůvky zprostředkovávají časově-
prostorovou koordinaci tvorby aktivních transckripčních komplexů. 
Lyzín-specifická histon demetyláza 1 (LSD1) interaguje s PI(4)P i PI(4,5)P2. Interakce 
s PI(4)P inhibuje, zatímco interakce s PI(4,5)P2 stimuluje LSD1 demetylační aktivitu a 
ovlivňuje tak hladinu H3K4me2 in vitro. Tímto způsobem by PI(4)P a PI(4,5)P2 mohly 
regulovat transkripční aktivitu na epigenetické úrovni i in vivo. 
Dalším PI(4,5)P2 vazebným proteinem, který jsme studovali, je aktin. Aktin existuje 
v cytoplasmě ve formě monomerů, které mohou polymerizovat a vytvářet vlákna. Zatím není 
dostatečně objasněno, v jaké formě se aktin vyskytuje v buněčném jádře. Po exogenní 
overexpresi aktinu jsme pozorovali tvorbu jaderných aktinových vláken. Tato vlákna 
připomínala svými vlastnostmi cytoplasmatická aktinová vlákna. Aktin vazebné proteiny 
cofilin a Arp3 lokalizovaly k těmto jaderným vláknům. Následkem tvorby jaderných 
aktinových vláken byla zvýšená transkripce během S fáze buněčného cyklu, snížená buněčná 




Phosphatidylinositol (PI) is a negatively charged glycerol-based phospholipid. As an 
amphipathic molecule, PI is formed by hydrophobic acyl tail and hydrophilic inositol head. 
The inositol head can be phosphorylated at three different positions generating 7 
phosphorylated species – phosphoinositides (PIs) – phosphatidylinositol 3-phosphate 
(PI(3)P), phosphatidylinositol  4-phosphate (PI(4)P), phosphatidylinositol 5-phosphate 
(PI(5)P), phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2), phosphatidylinositol 3,5-
bisphosphate (PI(3,5)P2), phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) and 
phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3; Fig. 1). Their metabolism is very 
dynamic, regulated by numerous PIs kinases, phosphatases and phospholipases. Although 
PIs represent only about 2 % of cellular phospholipids, they are very important signalling 
molecules (reviewed in Viaud et al. 2015; Tan et al. 2015). 
  
 
Fig. 1 Schematic representation of PI and seven differently phosphorylated PIs. PI 
can be phosphorylated at 3’, 4’ and 5’ positions yielding three phosphatidylinositol 
monophosphates (PI(3)P, PI(4)P, PI(5)P), three phosphatidylinositol bisphosphates (PI(3,4)P2, 
PI(3,5)P2, PI(4,5)P2) and one phosphatidylinositol trisphosphate (PI(3,4,5)P3). Red circles 
depict sites of inositol ring phosphorylation. 
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1.1 Phosphoinositides in the cytoplasm 
As phospholipids, cytoplasmic PIs are components of cellular membranes. Their 
localization can be visualized by specific PIs-binding protein domains coupled to GFP and can 
also be concluded from the localization of their metabolizing enzymes. There are many PIs 
metabolizing enzymes, which differ in their specificity, activity and localization. Therefore, 
several pools of particular PIs are produced in different membranes and organelles (Fig. 2). 
PIs then recruit their binding partners to these sites, which results in unique functions of 




Fig. 2. PIs distribution in the cellular membranes. MBV- multivesicular body; TGN – trans-






PI(3)P is predominantly present in endosomes (Ivetac et al. 2005; Slessareva et al. 
2006) but localizes also to the plasma membrane (Ivetac et al. 2005), smooth endoplasmic 
reticulum and the Golgi apparatus (Sarkes and Rameh 2010). It can be produced also in 
autophagosome (Kihara 2001). PI(3)P binds to Fab1/YOTB/Vac1/EEA1 (FYVE) domain 
(Gaullier et al. 1998; Patki et al. 1998) and phox homology (PX) domain protein modules (Xu 
et al. 2001; Ellson et al. 2001; Kanai et al. 2001; Cheever et al. 2001) and tethers proteins 
containing these domains to PI(3)P enriched membranes. PI(3)P regulates vesicular 
trafficking from early endosomes to recycling endosomes and to the lysosomes (Xu et al. 
2001), as well as autophagosome formation, exocytosis or cytokinesis (reviewed in Schink et 
al. 2013). PI(3)P interacts with nicotinamide adenine dinucleotide phosphate-oxidase 
(NADPH) through a p40-PX domain, targets NADPH oxidase to endosomes and stimulates 
formation of reactive oxygen species (ROS) in neutrophils (Ellson et al. 2001; Ellson et al. 
2006). 
Moreover, PI(3)P in endosomes can regulate transcription in a response to 
transforming growth factor- β (TGF-β). After TGF-β stimuli, FYVE domain of Smad anchor for 
receptor activation (SARA) targets SARA to early endosomes. SARA then triggers a formation 
of Smad2 and Smad3 transcriptional complex and Smad-dependent transcription (Tsukazaki 
et al. 1998; Itoh et al. 2002).  
1.1.2 PI(4)P 
PI(4)P is together with PI(4,5)P2 the most abundant PIs species. PI(4)P is mostly 
present in the Golgi apparatus, the plasma membrane and  endosomes (reviewed in (Viaud 
et al. 2015) and regulates vesicular transport between these compartments (Mills et al. 
2003; Wang et al. 2003; Godi et al. 2004). PI(4)P promotes formation of secretory vesicles  in 
the Golgi apparatus and regulates their association with the plasma membrane (Mizuno-
Yamasaki et al. 2010) in growth factor-dependent manner (Blagoveshchenskaya et al. 2008). 
Moreover, PI(4)P recruits lipid transfer proteins to the Golgi apparatus and thus enables 
import of ceramide and synthesis of sphingomyelin in the Golgi apparatus (Tóth et al. 2006; 
Yamaji et al. 2008). 
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Interestingly, PI(4)P itself can be transported between the endoplasmic reticulum and 
trans-Golgi membranes. Oxysterol-binding protein 4 (Osh4p) transports sterol from the 
endoplasmic reticulum to trans-Golgi. In Golgi, sterol is released and PI(4)P is loaded and 
retrogradely transported to endoplasmic reticulum. In the endoplasmic reticulum, PI(4)P is 
released and the Osh4p transport cycle can be repeated (de Saint-Jean et al. 2011). PI(4)P 
restores the level of sterol also at the plasma membrane (Beh and Rine 2004) probably by 
the same mechanism.  
1.1.3 PI(5)P 
Cellular level of PI(5)P is more than 50 times lower than the level of PI(4)P. The 
majority of PI(5)P localizes to  the plasma membrane but it is present also in the smooth 
endoplasmic reticulum and the Golgi apparatus (Sarkes and Rameh 2010). PI(5)P is a key 
regulator of endosome to lysosome trafficking (reviewed in Viaud et al. 2014). Particularly 
interesting is the production of PI(5)P after an infection by bacterium Shigella flexneri.  
Bacteria injects ipgD, a phosphatase dephosphorylating PI(4,5)P2 to PI(5)P, into the host cell 
(Niebuhr 2002). Subsequently, the upregulation of PI(5)P in early endosomes of the host cell 
impairs the endosomes-lysosomes trafficking and protects bacteria from degradation (Ramel 
et al. 2011).  
Although the basal level of PI(5)P is low, it is upregulated in response to various 
stimuli, such as insulin (Sbrissa et al. 2004; Sarkes and Rameh 2010), thrombin (Morris et al. 
2000), specific oncogenes (Dupuis-Coronas et al. 2011), H2O2 treatment (Wilcox and 
Hinchliffe 2008; Sarkes and Rameh 2010; Jones et al. 2013), T-cell receptor activation 
(Guittard et al. 2009; Guittard et al. 2010), or bacterial infection (Niebuhr et al. 2002; Mason 
et al. 2007). 
1.1.4 PI(3,4)P2 
PI(3,4)P2  localizes mostly to the plasma membrane, where it regulates endocytosis 
(Posor et al. 2013; Boucrot et al. 2015), recruits lamellopodin to the plasma membrane and 
stimulates formation of lamellipodia (Krause et al. 2004; Boucrot et al. 2015) or podosomes 
(Oikawa et al. 2008). It negatively regulates insulin signalling through its interaction with 
tandem pleckstrin homology (PH) domain containing protein 1 and 2 (TAPP1 and TAPP2) and 




PI(3,5)P2 is mainly synthesized from PI(3)P by FYVE finger-containing 
phosphoinositide kinase (PIKfyve) and localizes to endosomes and lysosomes  (reviewed in 
McCartney et al. 2014). It is involved in the regulation of retrograde endosome to trans-Golgi 
trafficking as well as fission or fusion of late endosomes (Rutherford et al. 2006; Zhang et al. 
2007; de Lartigue et al. 2009). Downregulation of PI(3,5)P2 causes vacuolation of neurons 
and thus leads to neurodegeneration in mice (Zhang et al. 2007). The levels of PI(3,5)P2 
increase upon UV radiation (Jones et al. 1999) and under an osmotic shock both in yeast 
(Dove et al. 1997; Duex et al. 2006) and mammalian cells (Dove et al. 1997). 
Interestingly, lysosomal PI(3,5)P2 is implicated in the regulation of DNA transcription 
in S. cerevisiae. PI(3,5)P2 interacts with the general transcription factor Tup1. PI(3,5)P2 
further mediates assembly of a Tup1 transcriptional coactivator complex and facilitates Tup1 
switch from corepressor to coactivator function. Moreover, Cti6, which is required for Tup1 
activation, also binds PI(3,5)P2. The nuclear localization of Cti6 and Cti6-Tup1 association 
with target promoters is PI(3,5)P2 dependent (Han and Emr 2011). 
1.1.7 PI(4,5)P2 
PI(4,5)P2 is one of the most abundant cellular PIs. It is predominantly present in the 
inner leaflet of the plasma membrane but localize also to other cellular membranes, such as 
the Golgi apparatus, endosomes and endoplasmatic reticulum. PI(4,5)P2 is recognized by 
several protein binding modules, such as PH, epsin N-terminal homology (ENTH), 
4.1/ezrin/radixin/moesin (FERM) or Tubby domains. PI(4,5)P2 regulates actin dynamics, 
epithelial cell polarity and morphology, cell migration, endocytosis and exocytosis, 
phagocytosis, function of distinct ion channels and transporters. PI(4,5)P2 has also a very 
important signalling role, as it can be cleaved by phospholipases C to generate inositol 1,4,5-
trisphosphate (Ins(1,4,5)P3) and diacylglycerol (DAG), second messengers. 
Moreover, PI(4,5)P2 regulates β-catenin transcriptional activity. β-catenin interacts 
with phosphatidylinositol 4-phosphate 5-kinase I γ (PIP5KIγ). The activity of PIPKIγ and thus 
the production of PI(4,5)P2 promotes transclocation of  β-catenin to the nucleus and 





PI(3,4,5)P3 localizes mainly to the inner leaflet of the plasma membrane. It is present 
in a small amount in quiescent cells and it is produced in response to the activation of 
receptor tyrosine kinases or G-protein coupled receptors. PI(3,4,5)P3 is recognized by many 
PH domain-containing proteins and therefore it is a very important molecule involved in the 
formation of intracellular signalling complexes. It regulates the cell proliferation and survival, 
glucose homeostasis, cell polarization and motility (reviewed in Salamon and Backer 2013; 
Viaud et al. 2015). 
1.2 Phosphoinositides in the nucleus 
Beside their cytoplasmic functions, PIs play an important role also in the cell nucleus 
(reviewed in Shah et al. 2013). It is still unclear whether or how PIs are transported from the 
sites of their synthesis to the nucleus. However, two isoforms of PI transfer proteins (PIPTs) 
are able to translocate to the nucleus (De Vries et al. 1996). As many PIs metabolizing 
enzymes also localize to the nucleus (Fig. 3), it is plausible that PI is transported to the 
nucleus, where it is further metabolized. Indeed, several studies have confirmed an active 
intranuclear PIs metabolism. Smith and Wells (1983) showed that after an incubation of 
isolated nuclear membranes with [γ32P]-ATP the radioactive phosphate is incorporated into 
PI(4,5)P2 and PI(4)P (Smith and Wells 1983). Cocco et al. (1987) showed that even nuclei 
deprived of the nuclear membrane can incorporate the radioactive phosphate into 
phosphatidylinositol monophosphates and PI(4,5)P2. They also observed that the 
intranuclear synthesis of PI(4,5)P2 is stimulated during cell differentiation (Cocco et al. 
1987). In agreement, Deleris at al. (2006) demonstrated that PI(3,4,5)P3 and PI(3,4)P2 can be 
dephosphorylated in vascular smooth muscle cells nuclei regardless of the nuclear 
membrane (Déléris et al. 2003). In addition, we have shown that nuclear PI(4,5)P2 is 
synthesized co-transcriptionally at RNA polymerase I promoters (RNA Pol I; Yildirim et al. 
2013). These results point towards the existence of an intranuclear PIs cycle, which is 




1.3 Metabolism of nuclear PIs 
1.3.1 Nuclear PIs kinases 
Nuclear PI can be phosphorylated at 3’ position by class II phosphatidylinositol 3-
kinases PI3KC2α (Didichenko and Thelen 2001) and PI3KC2β (Sindić et al. 2001) and at 4’ by 
phosphatidylinositol 4-kinases PI4Kα and PI4Kβ (de Graaf et al. 2002; Strahl et al. 2005; 
Kakuk et al. 2006; Kakuk et al. 2008) generating PI(3)P and PI(4)P, respectively. PI3KC2α and 
PI3KC2β can further phosphorylate PI(4)P to PI(3,4)P2 (Didichenko and Thelen 2001; Sindić 
et al. 2001). PI4Kα is targeted to the nucleolus (Kakuk et al. 2006; Kakuk et al. 2008) while 
PI4Kβ (Szivak et al. 2006) and PI3KC2α (Didichenko and Thelen 2001) localize to the nuclear 
speckles. Moreover, PI4Kβ accumulates in the nuclear speckles after inhibition of RNA 
polymerase II (RNA Pol II; Szivak et al. 2006). 
Fig. 3 PIs metabolism in the nucleus. Enzymes involved in PIs metabolism that localize to the 
nucleus are depicted. PIs kinases (black), phosphatases (green), and phospholipases (blue) 
form a metabolic network that most likely facilitates a formation of different PIs species 
(red) in the nucleus. Pathways catalysed by enzymes confirmed to be present in the nucleus 
(solid black arrows) and also possible pathways without known nuclear enzyme (dashed grey 
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arrows) are illustrated. A specific case is phosphatase and tensin homolog (PTEN), which 
localizes to the nucleus but has been shown to be unable to dephosphorylate nuclear 
PI(3,4,5)P3 (Lindsay 2006). 
 
The major precursor for nuclear PI(4,5)P2 is PI(4)P (Vann et al. 1997). PI(4)P is 
phosphorylated at 5’ position by type I phosphatidylinositol 4-phosphate 5-kinases PIP5KIα 
and PIP5Kγ_i4. Both, PIP5KIα and PIP5Kγ_i4 localize to nuclear speckles (Boronenkov et al. 
1998; Mellman et al. 2008; Schill and Anderson 2009). 
Yet, PI(4,5)P2 can be formed also from PI(5)P. PI(5)P is phosphorylated at 4’ position 
by type II phosphatidylinositol 5-phosphate 4-kinases PIP4KIIα, PIP4KIIβ (Boronenkov et al. 
1998; Richardson et al. 2007; Wang et al. 2010; Clarke and Irvine 2012), and PIP4KIIγ (Clarke 
et al. 2009; Clarke and Irvine 2012). PIP4KIIβ kinase is inhibited upon cellular stress as UV 
irradiation, oxidative stress or etoposide treatment (Jones et al. 2006). 
PI(3,4,5)P3 can be formed from PI(3,4)P2 by nuclear type I phosphatidylinositol 4-
phosphate 5-kinases. Alternatively, PI(3,4,5)P3 can be synthesized from PI(4,5)P2 by class I 
phosphatidylinositol 3-kinases PI3Kβ and PI3Kγ (Neri et al. 1994; Zini et al. 1996; Metjian et 
al. 1999; Bacqueville et al. 2001) and inositol multiphosphate kinase (IPMK) (Nalaskowski et 
al. 2002; Resnick et al. 2005; Maag et al. 2011). The activity of class I PI3K increases during 
the granulocytic differentiation (Bertagnolo et al. 1999) or after growth factors stimulation 
(Tanaka et al. 1999; Ahn et al. 2004).  
1.3.2. Nuclear PIs phosphatases 
Four different PIs phosphatases localize to the nucleus. Two Src-homology 2-
containing inositol 5-phosphatases (SHIP-1, SHIP-2) hydrolyse phosphate group at 5' position 
of PI(3,4,5)P3 and PI(4,5)P2 and generate PI(3,4)P2 and PI(4)P, respectively (Damen et al. 
1996; Lioubin et al. 1996). Both SHIP phosphatases localize to the nucleus (Déléris et al. 
2003; Elong Edimo et al. 2011; Nalaskowski et al. 2012; Ehm et al. 2015). Moreover, SHIP-2 
localizes to the nuclear speckles (Déléris et al. 2003; Elong Edimo et al. 2011) and when it is 
phosphorylated at S132, it acts only on PI(4,5)P2 generating PI(4)P (Elong Edimo et al. 2011). 
Phosphatidylinositol (4,5)-bisphosphate 4-phosphatase (PI(4,5)P2 4-Ptase I) 
dephosphorylates PI(4,5)P2 at 4’ position and generates PI(5)P (Ungewickell et al. 2005). 
PI(4,5)P2 4-Ptase I translocates to the nucleus in a response to DNA damage (Zou et al. 
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2007). Moreover, phosphatase and tensin homolog phosphatase (PTEN) localizes to the 
nucleus (Lachyankar et al. 2000; Gimm et al. 2000; Déléris et al. 2003). PTEN acts at 3' 
position of PI(3,4,5)P3 and PI(3,4)P2 (reviewed in Vanhaesebroeck et al. 2001) however it 
has been shown that nuclear PTEN dephosphorylate mostly PI(3,4)P2 generating PI(4)P 
(Déléris et al. 2003; Lindsay et al. 2006).  
1.3.3 Nuclear PIs-specific phospholipases 
Phosphoinositide-specific phospholipase C (PI-PLC) cleaves PI(4,5)P2 and generates 
second messengers - Ins(1,4,5)P3 and DAG. Eight isoforms of PI-PLC were detected within 
the nucleus. 
The most studied PI-PLCβ1 contains the nuclear localization signal (NLS) in its C-
terminus (Kim et al. 1996) and localizes in the nuclear speckles (Zini et al. 1993; Tabellini et 
al. 2003). Also other subtypes of PI-PLCβ (PI-PLCβ2, β3 and β4) and other isozymes such as PI-
PLCγ1, PI-PLCδ1, PI-PLCδ4 and PI-PLCζ have been confirmed to localize to the nucleus 
(Bertagnolo et al. 1995; Liu et al. 1996; Kim et al. 1996; Bertagnolo et al. 1997; Yamaga et al. 
1999; Yoda et al. 2004; Larman et al. 2004; Klein et al. 2008; Cooney et al. 2010; Fiume et al. 
2012). 
1.4 Functions of nuclear PIs 
Approximately 15 % of cellular PIs reside in the nucleus (York and Majerus 1994). 
Recent high-throughput studies identified more than 120 nuclear PIs-interacting proteins 
involved in different nuclear functions including DNA repair, chromatin remodelling and 
rRNA or mRNA processing (Lewis et al. 2011; Jungmichel et al. 2014). In the following 
section, data about nuclear PIs and their roles in these processes will be summarized. 
1.4.1 Pre-rRNA and pre-mRNA processing 
We have recently shown that PI(4,5)P2 binds to nucleolar protein fibrillarin (Yildirim 
et al. 2013). Fibrillarin functions in pre-rRNA processing, modification, and ribosomal 
assembly (Tollervey et al. 1993). PI(4,5)P2 binds to fibrillarin in the transcriptionally active 
regions of the nucleolus, alters its conformation and modulates the binding of fibrillarin to 
pre-rRNA (Yildirim et al. 2013). 
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Depletion of PI(4,5)P2 from HeLa nuclear extract by anti-PI(4,5)P2 antibody inhibits 
pre-mRNA splicing in vitro. However, addition of PI(4,5)P2 itself into depleted extract does 
not restore splicing reaction indicating that not only PI(4,5)P2 but also its binding partners 
are necessary to restore splicing activity. Indeed, the same antibody against PI(4,5)P2 
immunoprecipitates both small nuclear RNAs and the active form of RNA Pol II (Osborne et 
al. 2001). These results indicate that PI(4,5)P2 interacts with nuclear proteins and small 
nuclear RNAs and forms RNA-protein-lipid complexes which are directly involved in pre-
mRNA splicing. However, the exact molecular mechanism behind this phenomenon remains 
unknown. 
PI(4,5)P2 acts also as a regulatory molecule in mRNA polyadenylation. PI(4,5)P2 
synthesized by PIP5KIα stimulates processivity of a non-canonical Speckles targeted PIP5KIα 
regulated poly(A) polymerase (Star-PAP) resulting in a longer poly(A) tail of targeted mRNAs 
and their stabilization. PIP5KIα and Star-PAP enzymes interact directly in nuclear speckles, 
and their knock-down downregulates polyadenylation of mRNA coding proteins involved 
mostly in detoxification and oxidative stress response (Mellman et al. 2008).  
Once mRNA is maturated, it is exported to the cytoplasm upon an association with 
RNA-interacting protein complexes (Nojima et al. 2007; Fuke and Ohno 2008). PI(4,5)P2 and 
PI(3,4,5)P3 directly interact with the N-terminal part of export factor Aly/REF. The disruption 
of phosphoinositide binding displaces Aly from nuclear speckles and mRNA export is 
attenuated (Okada et al. 2008). Recently, Wickramasinghe et al. (2013) showed that the PI3K 
activity of IPMK and nuclear PI(3,4,5)P3 formation is essential for Aly binding to target 
mRNA. The downregulation of IPMK activity inhibits the export of mRNA coding proteins 
implicated in DNA repair and homologous recombination (Wickramasinghe et al. 2013). 
1.4.2 DNA damage response and apoptosis 
Nuclear PI(3,4,5)P3 is an important molecule in the cell differentiation and anti-
apoptotic signalling (Bertagnolo et al. 1999; Ahn et al. 2004; Ahn et al. 2005). The activity of 
class I PI3K is increased upon induction of granulocytic differentiation (Bertagnolo et al. 
1999) and also after growth factors stimulation of various cell lines (Tanaka et al. 1999) or 
isolated nuclei (Ahn et al. 2004). PI(3,4,5)P3 binds directly to nuclephosmin (B23) in the 
nucleus, their interaction is induced by nerve growth factor (NGF) treatment (Ahn et al. 
2005). Moreover, Akt, a PI(3,4,5)P3 effector protein, translocates to the nucleus after NGF 
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stimulation in PI3K dependent manner (Borgatti et al. 2003; Xuan Nguyen et al. 2006). In the 
nucleus, Akt interacts directly with B23 and protects B23 from degradation (Lee et al. 2008). 
The PI(3,4,5)P3-B23 complex then mediates anti-apoptotic signalization, inhibits caspase-
activated DNAse and therefore protects DNA against fragmentation (Ahn et al. 2005). The 
action of both SHIP-2 and phosphatase and tensin homolog (PTEN) phosphatases (Ahn et al. 
2004; Ahn et al. 2005) as well as overexpression of B23 PI(3,4,5)P3-binding mutant (Ahn et 
al. 2005) can inhibit NGF induced anti-apoptotic actions. Because it was reported that PTEN 
does not dephosphorylate PI(3,4,5)P3 in the nucleus (Déléris et al. 2003; Lindsay et al. 2006), 
it is unclear whether PTEN can antagonize NGF pathway through the decrease of PI(3,4,5)P3 
level or through a different mechanism. 
Besides its role in the stabilization of particular mRNAs, Star-PAP-PIP5KIα complex 
takes part in DNA damage response and apoptosis. Via PIP5KIα, Star-PAP interacts with PKCδ 
(Li et al. 2012), which is a key regulator of apoptosis (reviewed in Brodie and Blumberg 
2003). Following DNA damage, PI(4,5)P2 generated by PIP5KIα stimulates PKCδ activity. 
PKCδ then phosphorylates Star-PAP, leading to Star-PAP activation and stabilization of a pro-
apoptotic protein Bcl2-interacting killer (BIK) mRNA (Li et al. 2012). 
PI(5)P is an important player in DNA damage response through its interaction with 
inhibitor of growth protein 2 (ING2; Gozani et al. 2003). Following DNA damage, ING2 
expression is induced. ING2 then stimulates acetylation of the cellular tumour antigen p53 
leading to enhancement of p53-dependent transcription, G1-phase cycle arrest, and 
apoptosis (Nagashima et al. 2001). PI(5)P binds to ING2 through the plant homeodomain 
(PHD) finger domain (Gozani et al. 2003) and stabilizes it at the promoters of target genes 
(Bua et al. 2013). The ING2 mutant, which is unable to bind PI(5)P, fails to regulate p53 
acetylation and apoptosis (Bua et al. 2013). Therefore, Jones et al. (2006) studied the 
alteration of PI(5)P levels in response to cellular stress induced by UV irradiation, oxidative 
stress, and etoposide treatment in murine erythroleukaemia cells. They showed that the 
PIP4KIIβ kinase, which phosphorylates PI(5)P to PI(4,5)P2, is inhibited upon cellular stress 
resulting in accumulation of PI(5)P within the nucleus (Jones et al. 2006). Similarly, PI(4,5)P2 
4-Ptase I, which dephosphorylates PI(4,5)P2 to PI(5)P, translocates into the nucleus upon 
DNA damage (Zou et al. 2007). Elevated PI(5)P levels result in increased ING2 association 
with chromatin (Jones et al. 2006) and induction of apoptosis through ING2-p53 pathway 
(Zou et al. 2007). 
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1.4.3 Chromatin remodeling and modifications 
The accessibility of DNA is crucial for gene expression regulation. There are data 
demonstrating that PI(4,5)P2 plays an important role in DNA topological change and 
chromatin remodelling, since it interacts with proteins involved in these processes (Yu et al. 
1998; Zhao et al. 1998; Rando et al. 2002; Lewis et al. 2011; Toska et al. 2012). 
Histone acetylation reduces a positive charge of histones and loosens their 
association with negatively charged DNA. As a result, DNA is more accessible for 
transcription factors that can facilitate DNA transcription (Lee et al. 1993; Garcia-Ramirez et 
al. 1995). A recent study showed that chromatin acetylation is repressed by a process which 
requires a myristoylation of transcriptional co-repressor brain acid soluble protein 1 (BASP1) 
and PI(4,5)P2. Myristoylation of BASP1 is essential for its function as a transcriptional co-
repressor. It was shown that nuclear PI(4,5)P2 interacts with BASP1 through its myristoyl 
moiety and facilitates BASP1 interaction with histone deacetylase 1 (HDAC1). BASP1-
PI(4,5)P2-HDAC1 complex is then recruited to the promoter of target genes, where HDAC1 
deacetylates histones and reduces promoter accessibility for RNA Pol II transcription 
machinery (Toska et al. 2012). Moreover, DNA topoisomerase IIα associates with RNA pol II 
transcription machinery and relaxes the superhelical tension of DNA during transcription 
(Mondal and Parvin 2001). PI(4,5)P2 interacts directly with DNA topoisomerase IIα and 
inhibits its activity in vitro (Lewis et al. 2011). 
On the contrary, PI(4,5)P2 may stimulate RNA Pol II through a direct interaction with 
histones H1 and H3 (Yu et al. 1998). In vitro, RNA Pol II transcription is inhibited by H1 
(Croston et al. 1991; Levine et al. 1993; Johnson et al. 1995). This inhibition can be partially 
restored by addition of PI(4,5)P2. Another mechanism of PI(4,5)P2 action in chromatin 
remodelling is through its direct interaction with SWI/SNF-like BAF chromatin remodelling 
complex (Rando et al. 2002). PI(4,5)P2 binds BAF complex, targets it to the chromatin, and 
facilitates changes in chromatin structure during T-lymphocyte activation (Zhao et al. 1998). 
Gelato et al. (2014) described the regulation of ubiquitin-like PHD and really 
interesting new gene (RING) finger domain- containing protein 1 (UHRF1) by PI(5)P (Gelato 
et al. 2014). UHRF1 is a multidomain protein that binds unmodified histone H3 and recruits 
histone methyltransferases to methylate H3K9 and establish transcription repressive marks. 
Moreover, UHRF1 is able to bind H3K9me3 modification and in a complex with histone 
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methyltransferases maintains heterochromatin state (reviewed in (Bronner et al. 2013). 
PI(5)P binds directly to the polybasic region in the C-terminal part of UHRF1, changes the 
conformation of UHRF1, and allosterically regulates its histone binding specificity. When not 
bound to PI(5)P, UHRF1 recognizes unmodified histone H3 tail, while PI(5)P-UHRF1 complex 
binds histone H3K9me3 (Gelato et al. 2014). Therefore, PI(5)P levels could regulate UHFR1 
association with chromatin and heterochromatic state of the genome. 
1.4.4 DNA transcription 
Recent findings show that PI(4,5)P2 and PI(3,4,5)P3 can interact with steroidogenic 
factor 1 (SF-1; Blind et al. 2012; Blind et al. 2014). As a transcription factor, SF-1 regulates 
transcription of genes involved a lipid and steroid metabolism, cytoskeleton dynamics, cell 
cycle, or apoptosis (reviewed in Lalli et al. 2013). PI(4,5)P2 or PI(3,4,5)P3 bind to SF-1 sterol 
binding pocket through their acyl chains (Blind et al. 2012; Blind et al. 2014) and stabilize the 
tertiary structure of SF-1. SF-1 in a complex with PI(3,4,5)P3 displays significantly higher 
affinity for a coactivator peptide than in a complex with PI(4,5)P2 (Blind et al. 2014). 
Therefore, the action of IMPK kinase or PTEN phosphatase can regulate SF-1 activity and SF-
1 target genes expression (Blind et al. 2012). 
Furthermore, PI(4,5)P2 plays a role in gene regulation through the interaction with 
RNA Pol II and RNA Pol I transcription machinery (Osborne et al. 2001; Toska et al. 2012; 
Sobol et al. 2013; Yildirim et al. 2013). PI(4,5)P2 forms a complex with the active form of RNA 
Pol II (Osborne et al. 2001; Toska et al. 2012). Yet, there is no evidence of a direct interaction 
between PI(4,5)P2 and RNA Pol II. 
In comparison to RNA Pol II, the mode of PI(4,5)P2 action in RNA Pol I transcription is 
more understood. The upstream binding factor (UBF) and the promoter selectivity factor 1 
form a complex, which is recruited to the rDNA promoter and facilitates the initiation of RNA 
Pol I transcription (Bell et al. 1988). Recently, we have shown that PI(4,5)P2 binds to UBF and 
enhances the binding of UBF to the rDNA promoter. Moreover, the depletion of PI(4,5)P2 
from HeLa nuclear extract decreases the level of RNA Pol I transcription in vitro. The 
decrease can be partially restored by addition of PI(4,5)P2 into the transcription reaction 
(Yildirim et al. 2013). These data suggest that PI(4,5)P2-UBF interaction might be required 





PIs and PIs-interacting proteins are important cellular regulators. Although it 
becomes apparent that PIs have important roles also in the cell nucleus, still only a little is 
known about their nuclear localization and functions. Therefore we addressed these 
questions: 
 
1) Which PIs localize to the cell nucleus? 
2) In which subnuclear domains are they localized? 
3) What are the binding partners of PIs in the nucleus? 
 
 
Actin is a well-known PI(4,5)P2 interacting protein. In the cytoplasm, monomeric 
actin can polymerize and form filaments. The state of actin in the nucleus (monomeric, 
filamentous, alternative polymeric) is unclear. We will address these questions: 
 
4) Can actin form filaments in the nucleus? Does the filament formation 
affect nuclear functions? 




3. RESEARCH PAPERS 
 
Tools for visualization of phosphoinositides in the cell nucleus 
Kalasova I, Fáberová V, Kalendová A, Yildirim S, Uličná L, Venit T and Hozák P 
Histochem Cell Biol. 2016 Feb 4 [Epub ahead of print]. doi: 10.1007/s00418-016-1409-8.  
IF: 3.054 (2014) 
I. K. designed and performed experiments (DNA cloning, DNA mutagenesis, fluorescence 
microscopy, protein expression and purification) and wrote the manuscript. 
 
Nuclear phosphatidylinositol 4,5-bisphosphate islets contribute to efficient DNA 
transcription 
Sobol M, Kalendová A, Yildirim S, Philimonenko V, Marášek P, Kalasová I, Pastorek, Hozák P 
Manuscript. 
I.K. performed experiments (pull-down assay and western blotting). 
 
Chromatin associated PI(4)P regulates lysine-specific histone demethylase 1 
Kalasova I, Kalendová A, Fáberová V, Marášek P, Uličná L, Vacík T and Hozák P 
Manuscript. 
I.K. designed and performed most of the experiments (DNA cloning, DNA mutagenesis, 
protein expression and purification, cellular fractionations, pull-down assays, fluorescence 
microscopy, western blotting, demethylation assays, qPCR) and wrote the manuscript. 
 
Nuclear actin filaments recruit cofilin and Arp3 and their formation is connected 
with a mitotic block 
Kalendová A, Kalasová I, Yamazaki S, Uličná L, Harata M and Hozák P 
Histochem Cell Biol. 2014 Aug;142(2):139-52. doi: 10.1007/s00418-014-1243-9. Epub 2014 
Jul 8. 
IF: 3.054 (2014) 





3.1 Tools for visualization of phosphoinositides in the cell nucleus 
 
Kalasova I, Fáberová V, Kalendová A, Yildirim S, Uličná L, Venit T and Hozák P 
 
Histochem Cell Biol. 2016 Feb 4 [Epub ahead of print]. doi: 10.1007/s00418-016-1409-8.  
 
IF: 3.054 (2014) 
 
 
I. K. designed and performed experiments (DNA cloning, DNA mutagenesis, fluorescence 






Tools for visualization of phosphoinositides in the cell nucleus
Ilona Kalasova1,2 · Veronika Fáberová1 · Alžběta Kalendová1 · Sukriye Yildirim1 · 
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Introduction
Phosphoinositides (PIs) are glycerol-based phospholipids. 
As amphipathic molecules, they consist of hydrophobic tail 
and hydrophilic head. Their head is formed by the inosi-
tol ring that can be phosphorylated at three different posi-
tions yielding seven mono-, bis-, or tris-phosphorylated PIs 
species. PIs are important signalling molecules involved in 
membrane and cytoskeletal dynamics, modulation of ion 
channels and transporters, or generation of second mes-
sengers (reviewed in Balla 2013; Tan et al. 2015). These 
functions are related to PIs present in the cytoplasm and 
the plasma membrane. Approximately 15 % of cellular 
PIs are nuclear (York and Majerus 1994). It is, however, 
not well understood whether nuclear PIs originate in the 
cytoplasm or whether they are synthesized in the nucleus 
de novo. Many PIs metabolizing enzymes—kinases, phos-
phatases, and phospholipases (reviewed in Keune et al. 
2011; Martelli et al. 2011; Shah et al. 2013)—as well as 
phosphatidylinositol (PI) transfer proteins (De Vries et al. 
1996) localize to the nucleus. Besides, several in vitro stud-
ies reported intranuclear synthesis of PIs (Smith and Wells 
1983; Cocco et al. 1987; Yildirim et al. 2013). These data 
suggest that PIs are in the nucleus metabolized indepen-
dently of the cytoplasm and do not require the presence 
of membranes. However, spatiotemporal visualization of 
such events in the nucleus is still missing. Since a large 
fraction of PIs does not associate with nuclear membrane 
(Vann et al. 1997), it is currently unclear where the syn-
thesis and metabolism of nuclear PIs occur. Several studies 
suggested that PIs are retained in the nucleus in the form of 
protein–lipid complexes, where proteins shield the hydro-
phobic tails of PIs (Blind et al. 2014; Sablin et al. 2015) 
and thus could prevent their extraction by detergents. Using 
various approaches, more than 300 nuclear PIs-interacting 
Abstract Phosphoinositides (PIs) are glycerol-based 
phospholipids containing hydrophilic inositol ring. The 
inositol ring is mono-, bis-, or tris-phosphorylated yield-
ing seven PIs members. Ample evidence shows that PIs 
localize both to the cytoplasm and to the nucleus. How-
ever, tools for direct visualization of nuclear PIs are limited 
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and mobility of PIs differ from their metabolic enzymes, 
these approaches may result in incomplete data. In this 
paper, we tested commercially available PIs antibodies 
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proteins were identified. These proteins are involved in 
essential nuclear processes, and therefore, nuclear PIs are 
probably important regulators of these events (Lewis et al. 
2011; Jungmichel et al. 2014). And indeed, nuclear phos-
phatidylinositol 4,5-bisphosphate (PI(4,5)P2) modulates 
protein functions and thus plays a role in chromatin remod-
elling (Zhao et al. 1998), transcription by RNA polymer-
ase I and II (Osborne et al. 2001; Toska et al. 2012; Yildi-
rim et al. 2013), or pre-mRNA processing (Osborne et al. 
2001; Mellman et al. 2008). Nuclear phosphatidylinositol 
3,4,5-trisphosphate (PI(3,4,5)P3) was linked to mRNA 
export (Okada et al. 2008; Wickramasinghe et al. 2013) 
and anti-apoptotic signalling (Ahn et al. 2004, 2005), while 
nuclear phosphatidylinositol 5-phosphate (PI(5)P) is impli-
cated in DNA damage response (Gozani et al. 2003; Jones 
et al. 2006; Zou et al. 2007). Despite the fact that there are 
no data on functions of other nuclear PIs, their presence in 
the nucleus has been confirmed (Vann et al. 1997; Gillo-
oly et al. 2000; Yokogawa et al. 2000; Clarke et al. 2001; 
Višnjić et al. 2003; Watt et al. 2004).
To better understand functions of individuals PIs, it 
is important to have information about their localization 
within the nucleus. So far, two fundamental approaches 
of PIs visualization have been employed. First, commer-
cially available antibodies against PI(4,5)P2 (Mazzotti 
et al. 1995; Boronenkov et al. 1998; Osborne et al. 2001) 
and phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2; 
Yokogawa et al. 2000) have been used. Second, PIs-binding 
domains from PLCδ1 (Watt et al. 2002; Hammond et al. 
2009; Yildirim et al. 2013), Tapp1 (Watt et al. 2004), Hrs 
(Gillooly et al. 2000), and Grp1 (Lindsay et al. 2006) pro-
teins specifically recognizing PI(4,5)P2, PI(3,4)P2, phos-
phatidylinositol 3-phosphate (PI(3)P), and PI(3,4,5)P3, 
respectively, were generated. The use of anti-PI(4,5)P2 
and PLCδ1-PH domain provided similar results and made 
it possible to address functions of PI(4,5)P2 as well as its 
localization in the nucleus, nuclear speckles, and hetero-
chromatin regions (Mazzotti et al. 1995; Boronenkov et al. 
1998; Osborne et al. 2001; Watt et al. 2002; Hammond 
et al. 2009; Yildirim et al. 2013). Similarly, both antibodies 
and domains demonstrated localization of PI(3,4)P2 in the 
nuclear membrane. FYVE domain of tyrosine kinase Hrs 
detected PI(3)P signal in nucleoli of BHK cells (Gillooly 
et al. 2000). PH domain of Grp1 showed an increased level 
of nuclear PI(3,4,5)P3 after stimulation of Swiss 3T3 cells 
with PDGF (Lindsay et al. 2006).
In this paper, we explored localization of nuclear PI(4,5)
P2, PI(3,4)P2, and phosphatidylinositol 4-phosphate (PI(4)
P) in greater detail. First, we tested commercial antibod-
ies against PI(4,5)P2, PI(3,4)P2, and PI(4)P. Since tools 
for visualization of nuclear PIs in live cells are miss-
ing, we next inspected nuclear patterns of different PIs-
binding protein domains (Table 1) after overexpression in 
U2OS cells. Given that most domains did not specifically 
label nuclear PIs in live cells, we purified eGFP-fused 
PLCδ1-PH, OSH1-PH, and Tubby domains and used them 
in analogy to antibodies for labelling in fixed cells. Using 
these approaches, we identified anti-PI4P antibody, OSH1-
PH, EEA1-FYVE, and PLCδ1-PH, and Tubby domains 
as a potential tools for visualization of PI(4)P, PI(3)P, and 
PI(4,5)P2 in live or fixed cells.
Materials and methods
Cell cultures and transfections
U2OS were cultured in D-MEM supplemented with 10 % 
FBS in 5 % CO2/air, 37 °C, and humidified atmosphere. 
Cells were transfected with Lipofectamine (Life Technolo-
gies) according to manufacturer’s instructions.
Constructs used in this study
For overexpression in U2OS cells, PLCδ1-PH, EEA1-
FYVE, Grp1-PH, OSH1-PH, Akt-PH, and Tubby domains 
in pEGFP (Clontech, kind gifts from Dr Tamas Balla, 
National Institutes of Health, Bethesda, MD) were used. 
PLCδ1-PH with nuclear localization signal (NLS) was 
Table 1  Summary of PIs-binding domains used for overexpression in U2OS cells
Domains were mutated according to Yagisawa et al. (1998), Levine and Munro (2001), Santagata et al. (2001), Lee et al. (2005), Guillou et al. 
(2007), Jo et al. (2012)
Domain Specificity Protein Size (kDa) Mutant
EEA1-FYVE PI(3)P Early endosome antigen 1 ~18 RRHH126-129AANN
OSH1-PH PI(4)P Oxysterol-binding protein homolog 1 ~15 KR37,39EE
Akt-PH PI(3,4)P2, PI(3,4,5)P3 Protein kinase B ~21 KR14,15AA
Tubby PI(4,5)P2 Tubby-like protein ~31 KR300,302AA
PLCδ1-PH PI(4,5)P2 Phosphoinositide phospholipase C δ1 ~20 R40A
Grp1-PH PI(3,4,5)P3 General receptor for phosphoinositides 1 ~15 K273A
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prepared by insertion of SV40 NLS into PLCδ1-PH 
pEGFP-N1 by BsrGI and AFlII restriction sites. Mutant 
domains (PLCδ1-PH R40A, EEA1-FYVE RRHH123-
129AANN, Grp1-PH K273A, OSH1-PH KR37,39EE, Akt-
PH KR14,15AA, Tubby domain KR330,332AA) were pre-
pared by site-directed mutagenesis by Q5® Site-Directed 
Mutagenesis Kit (New England Biolabs, E0552S) accord-
ing to the manufacturer’s instructions. For expression in E. 
Coli, eGFP fusions of wild-type as well as mutant forms 
of PLCδ1-PH, OSH1-PH domains were amplified by PCR 
and ligated to pET-15b (Merck Millipore). Tubby domain 
in pET-23a (Merck Millipore, a kind gift from Dr Tamas 
Balla, National Institutes of Health, Bethesda, MD) was 
used, and mutant Tubby domain was prepared as described 
above.
Antibodies
Following primary antibodies were used: anti-PI(4)P 
(Echelon, Z-P004; 10 µg/ml), anti-PI(3,4)P2 (Echelon, 
Z-P034b; 20 µg/ml), anti-PI(4,5)P2 (Echelon, Z-A045; 
4.9 µg/ml).
For immunofluorescence, secondary antibodies were 
used: goat anti-mouse IgG conjugated with Alexa Fluor 
555 and goat anti-mouse IgM conjugated with Alexa 
Fluor 555 all purchased from Life Sciences. For protein–
lipid overlay assay, the following secondary antibod-
ies were used: donkey anti-mouse IgG IRDye®680RD 
and goat anti-mouse IgM IRDye®680RD (LI-COR 
Biosciences).
Expression and purification of recombinant proteins
Recombinant PLCδ1-PH, OSH1-PH, and Tubby domains 
were expressed in E. coli BL21-Gold(DE3). Bacte-
ria transformed with PLCδ1-PH and Tubby domains 
were grown up to OD(600) = 0.6. The expression of 
PLCδ1-PH was induced with 0.6 mM IPTG for 4 h at 
37 °C. The expression of Tubby domain was induced with 
0.3 mM IPTG for 8 h at 18 °C. Bacteria transformed with 
OSH1-PH domain were grown up to OD(600) = 0.4. The 
expression of OSH1-PH was induced with 0.1 mM IPTG 
for 16 h at 25 °C. Cells were lysed in lysis buffer (10 mM 
Tris, pH 7.4, 150 mM NaCl, 0.5 % Triton X-100, AEBSF) 
and sonicated. The purification was carried on HIS-Select 
Nickel Affinity Gel (Sigma, P6611). The beads were 
equilibrated with lysis buffer and incubated with protein 
lysates for 1 h at 4 °C. Then the beads were washed three 
times (10 m M Tris, pH 7.4, 150 mM NaCl, AEBSF). 
Bound proteins were eluted (10 mM Tris, pH 8, 150 mM 
NaCl, 250 mM imidazole, pH 8, 20 % glycerol, AEBSF). 
Subsequently, imidazole was removed by dialysis (10 mM 
Tris, pH 8, 150 mM NaCl, 20 % glycerol, AEBSF). Puri-
fied PIs-binding domains were used for immunofluores-
cence (1 µg/µl).
Indirect immunofluorescence and confocal fluorescence 
microscopy
Cells seeded on glass coverslips were washed with PBS, 
fixed with 3 % paraformaldehyde in PBS, and permeabi-
lized with 0.1 % Triton X-100 in PBS for 20 min. Cover-
slips were blocked with 5 % normal goat serum (Invitro-
gen) in PBS for 30 min. Coverslips were incubated with 
primary antibodies diluted in PBS for 1 h at room tem-
perature (RT) and then washed with PBS or with purified 
domains diluted in PBS with 0.05 % Tween 20 (PBS-T) for 
1 h at RT and then washed with PBS-T. In case of antibod-
ies, coverslips were incubated with corresponding second-
ary antibodies diluted in PBS-T for 1 h at RT. After final 
washes in PBS-T, coverslips were mounted in ProLong 
Gold anti-fade reagent with DAPI (Life Technologies). 
Images were acquired using confocal microscope Leica 
TCS SP8 with 63× (NA 1.4) immersion oil objective lens 
with 405 and 561 laser excitations, Leica advanced fluores-
cence software (LAS AF).
Antibody blocking assay
Antibodies were incubated with phosphatidylino-
sitol diC8 (P-0008), PI(3)P diC8 (P-3008), PI(4)P 
diC8 (P-4008), PI(5)P diC8 (P-5008), PI(3,4)P2 diC8 
(P-3408), phosphatidylinositol 3,5-bisphosphate diC8 
(P-3508), PI(4,5)P2 diC8 (P-4508), PI(3,4,5)P3 diC8 
(P-3908), all purchased from Echelon Biosciences 
Inc. Antibodies were incubated with PIs in molar ratio 
1:1000. Concentrations of antibodies were as described 
above. Concentrations of PIs were 5, 10, and 130 nM to 
block anti-PI(4,5)P2, anti-PI(4)P, and anti-PI(3,4)P2 anti-
body, respectively. Incubations were performed in 1 % 
BSA, PBS for 30 min. Pre-blocked antibodies were used 
for immunostaining.
Protein–lipid overlay assay
PIP Strips (P-6001, Echelon Biosciences Inc.) were 
blocked with 3 % BSA in PBS-T for 1 h at RT and then 
incubated with antibodies (1 ug/ml) in 3 % BSA, PBS-T 
for 1 h at RT. Membranes were washed three times with 
PBS-T for 1 h at RT. Membranes were incubated with 
goat/donkey anti-mouse IgG or anti-mouse IgM sec-
ondary antibodies conjugated to IRDye. The signal was 
detected by Odyssey Infrared Imaging System (LI-COR 
Biosciences).
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Results
Antibodies show nuclear localization of PI(4,5)P2, 
PI(3,4)P2, and PI(4)P
To describe the localization of particular nuclear PIs, we 
used antibodies against PI(4,5)P2, PI(3,4)P2, and PI(4)P, 
which are all commercially available (Echelon).
As it has been reported before, the antibody against 
PI(4,5)P2 detects nuclear PI(4,5)P2 in nuclear speckles 
and nucleoplasmic foci. Moreover, weak nucleolar PI(4,5)
P2 pool can be also detected (Osborne et al. 2001; Yildirim 
et al. 2013; Fig. 1a, inset). To test the specificity of PI(4,5)
P2 antibody, we used protein–lipid overlay assay, where the 
antibody is incubated with different phospholipids spotted 
on a nitrocellulose membrane. Protein–lipid overlay assay 
shows that PI(4,5)P2 antibody detects not only PI(4,5)
P2 but also PI(3,4,5)P3 (Fig. 2a). Therefore, we used lipid 
blocking assay to further investigate the antibody specific-
ity. In this approach, the antibody was preincubated with 
an excess amount of each PI (1:1000) and then used for 
immunofluorescence (Fig. 2b). Although preincubation 
with PI(3,4,5)P3 decreased the detected signal to 15 % of 
the original value, preincubation with PI(4,5)P2 abolished 
the signal completely (Fig. 2c). The results of protein–lipid 
overlay assay suggest that PI(4,5)P2 antibody has higher 
affinity to PI(3,4,5)P3 (Fig. 2a). However, the lipid blocking 
assay shows that PI(4,5)P2 antibody detects mostly PI(4,5)
P2 in fixed cells, as shown in Fig. 2c. As the total amount 
of cellular PI(3,4,5)P3 is more than 20-fold lower than the 
amount of cellular PI(4,5)P2 (Stephens et al. 1993; Nasuho-
glu et al. 2002), we believe that the antibody predominantly 
but not exclusively recognizes PI(4,5)P2 in the cells.
The antibody against PI(3,4)P2 shows nuclear pattern 
similar to PI(4,5)P2 with nuclear speckles and smaller 
nucleoplasmic foci (Fig. 1b). The antibody recognizes 
mainly PI(3,4)P2 on protein–lipid overlay assay, but binds 
also to PI(4,5)P2 and PI(3,4,5)P3 (Fig. 2d). Lipid blocking 
assay shows that the fluorescence signal is not abolished 
after preincubation of anti-PI(3,4)P2 antibody with PI(3,4)
P2; however, the signal decreases after preincubations with 
PI(3)P, PI(4)P, PI(5)P, PI(3,4)P2, PI(3,5)P2, and PI(3,4,5)
P3 (Fig. 2e). Our results therefore suggest that although the 
PI(3,4)P2 antibody can be used to detect PI(3,4)P2 spotted 
on a membrane, it is not suitable for immunofluorescence 
studies under experimental conditions we tested.
The antibody against PI(4)P detects nuclear PI(4)P sig-
nal, which resembles the signal of PI(4,5)P2 in nuclear 
speckles and small foci in nucleoplasm and nucleoli 
(Fig. 1c). The antibody detects specifically PI(4)P on pro-
tein–lipid overlay assay with a weak signal coming from 
PI(4,5)P2 and PI(3)P (Fig. 2f). Moreover, the lipid block-
ing assay shows that the fluorescence signal diminishes 
only after preincubation with PI(4)P (Fig. 2g). Therefore, 
we concluded that the PI(4)P antibody can be used for 
PI(4)P detection by immunofluorescence in fixed cells.
Fig. 1  Antibodies detect nuclear PI(4,5)P2, PI(3,4)P2, and PI(4)
P. Anti-PI(4,5)P2 detects PI(4,5)P2 in the nucleoplasm and nuclear 
speckles (a) and weak foci in nucleoli (inset, arrowheads). Anti-
PI(3,4)P2 antibody detects nuclear pattern similar to anti-PI(4,5)
P2 antibody (b) Anti-PI(4)P antibody detects both cytoplasmic and 
nuclear signal (c, optical sections focused on the cytoplasm and on 
the nucleus). In the nucleus, anti-PI(4)P antibody gives similar pat-
tern to anti-PI(4,5)P2 antibody (inset). Scale bars 5 µm
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Fig. 2  Antibody against PI(4,5)
P2 binds to PI(4,5)P2 and 
PI(3,4,5)P3 on protein–lipid 
overlay assay (a). On immu-
nofluorescence, the antibody 
is blocked by preincubation 
with PI(4,5)P2 and PI(3,4,5)
P3 (b). The graph shows signal 
intensities from images of the 
cell without treatment and after 
pre-blocking with PI(4,5)P2 
and PI(3,4,5)P3. The blocking 
is only partial (up to 85 %) after 
preincubation with PI(3,4,5)
P3, while preincubation 
with PI(4,5)P2 blocks signal 
completely (c). The antibody 
against PI(3,4)P2 detects mostly 
PI(3,4)P2 and weakly also 
PI(4,5)P2 and PI(3,4,5)P3 on 
protein–lipid overlay (d). The 
immunofluorescence signal 
from anti-PI(3,4)P2 antibody is 
decreased after preincubation of 
the antibody with PI(3)P, PI(4)
P, PI(5)P, PI(3,4)P2, PI(3,5)P2, 
and PI(3,4,5)P3 (e). Anti-PI(4)
P antibody detects PI(4)P and 
very weakly binds to PI(3)P and 
PI(4,5)P2 on protein–lipid over-
lay assay (f). Immunofluores-
cence signal of anti-PI(4)P anti-
body is completely abolished 
after preincubation with PI(4)P 
only (g). LPA, lysophosphatidic 




PA, phosphatidic acid, PS, 
phosphatidylserine, Scale bars 
5 µm
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Overexpressed PIs‑binding domains show nuclear 
staining in U2OS cells
In addition to commercially available antibodies, we 
tested several PIs-binding domains (Table 1). These pro-
tein modules have been used before for PIs detection in 
cellular membranes (reviewed in Balla and Várnai 2009). 
We transfected PLCδ1-PH, EEA1-FYVE, Akt-PH, Grp1-
PH, OSH1-PH, and Tubby domains coupled to eGFP 
into U2OS cells and inspected their nuclear patterns. 
As a control, we prepared mutant form of each domain, 
which prevents binding of the domain to the respective 
PIs. As published before, PLCδ1-PH binds PI(4,5)P2 in 
the plasma membrane (Stauffer et al. 1998; Varnai and 
Balla 1998; Kavran et al. 1998). Indeed, overexpressed 
PLCδ1-PH localizes mainly to the plasma membrane 
and is diffused throughout the cytoplasm (Fig. 3a), while 
mutant PLCδ1-PH loses the plasma membrane localiza-
tion (Fig. 3b). Both wild-type and mutant PLCδ1-PH show 
diffused nuclear signal. The nuclear signal is enriched in 
mutant probably due to relocalization of the domain from 
the plasma membrane. To target PLCδ1-PH to the nucleus, 
we cloned NLS sequence downstream of GFP. Even though 
this construct was efficiently imported into the nucleus, we 
did not observe any difference between localization pat-
terns of wild-type and mutant domains (Fig. 3c, d). Since 
the overexpressed PLCδ1-PH does not seem to be a suit-
able tool for nuclear PI(4,5)P2 detection, we tested also 
another PI(4,5)P2 binding domain, a Tubby domain (Santa-
gata et al. 2001; Quinn et al. 2008; Szentpetery et al. 2009). 
Similarly to PLCδ1-PH, wild-type Tubby domain localizes 
to the plasma membrane (Fig. 3e). Moreover, we detected 
signal in the nucleus and small foci in nucleoli. Mutant 
Tubby domain loses the plasma membrane localization and 
relocalizes to the nucleus, where the pattern resembles the 
signal of wild-type Tubby domain (Fig. 3f). In conclusion, 
both PLCδ1-PH and Tubby fail to specifically recognize 
nuclear PI(4,5)P2.
EEA1-FYVE has been previously used for visualiza-
tion of PI(3)P in endosomes (Burd and Emr 1998; Gaullier 
et al. 1998). We observed the same pattern, which is lost 
after mutation in EEA1-FYVE confirming its specificity 
(Fig. 3g, h). Both wild-type and mutant EEA1-FYVE enter 
nucleus, where they show the same diffused nuclear sig-
nal. In addition, wild-type also recognizes foci in nucleoli, 
which are absent in mutant (Fig. 3h, inset). This suggests 
that EEA1-FYVE domain recognizes nucleolar specific 
pool of PI(3)P.
Akt-PH binds PI(3,4,5)P3 and PI(3,4)P2 (Kavran et al. 
1998; Watton and Downward 1999; Rowland et al. 2012). 
After overexpression, Akt-PH localizes to the plasma mem-
brane and intracellular membranes (Fig. 3i), while mutant 
Akt-PH is diffused throughout the cytoplasm (Fig. 3j). 
Both wild-type and mutant Akt-PH localize to the nucleus, 
where they display a similar pattern suggesting their ina-
bility to recognize nuclear PI(3,4,5)P3 or PI(3,4)P2. An 
alternative tool for visualization of PI(3,4,5)P3 is Grp1-PH 
domain (Venkateswarlu et al. 1998; Kavran et al. 1998; 
Gray et al. 1999; Manna et al. 2007). Using Grp1-PH, we 
detected only a weak signal in the cytoplasm (Fig. 3k, l). 
It is therefore possible that Akt-PH detects mostly PI(3,4)
P2 in the plasma membrane. Both, wild-type and mutant 
Grp1-PH domains localized mostly to the nucleus, where 
they display a similar pattern suggesting the inability of 
Grp1 to detect nuclear PI(3,4,5)P3 specifically (Fig. 3k, l).
It has been reported that overexpressed OSH1-PH binds 
to PI(4)P present in the plasma membrane and Golgi appa-
ratus (Roy and Levine 2004; Yu et al. 2004; Balla et al. 
2008). In agreement with this, we show OSH1-PH localiza-
tion to the plasma membrane and other cellular membranes 
(Fig. 3m), while mutant OSH1-PH is diffused throughout 
the cytoplasm (Fig. 3n). Both wild-type and mutant OSH1-
PH localize to the nucleus, where they display a similar 
pattern.
Taken together, our results are consistent with previously 
published data and show that overexpressed PIs-binding 
domains localize to the nucleus. Careful comparison with 
mutant domains, however, revealed that in the nucleus, 
these domains do not specifically interact with PIs. Among 
Fig. 3  Comparison of PIs-binding domains after overexpression 
in U2OS cells. Images are taken at optical sections focused on the 
plasma membrane (Cytopl.) and on the nucleus (Nucleus). Wild-
type PLCδ1-PH (a) but not mutant PLCδ1-PH (b) is accumulated 
at the plasma membrane. Both domains are diffused throughout the 
cytoplasm and the nucleus (a, b inset). With NLS, both wild-type 
PLCδ1-PH (c) and mutant PLCδ1-PH (d) are accumulated in the 
nucleus and display the same nuclear pattern (c, d inset). Wild-type 
Tubby domain localizes to the plasma membrane and weakly also 
to the nucleus (e), where it forms small foci in the nucleoli (inset, 
arrowheads). Mutant Tubby domain is absent from the plasma 
membrane and accumulates in the nucleus (f), where it displays pat-
tern similar to the wild-type domain (inset, arrowheads). Wild-type 
EEA1-FYVE localizes to endosomes and also to the nucleus (g), 
where it localizes to the nucleoplasm and forms foci in the nucleoli 
(inset, arrowheads). Mutant EEA1-FYVE is diffused throughout 
the cytoplasm and the nucleus (h), whereas nucleoli foci are absent 
(inset). Wild-type Akt-PH localizes to the plasma membrane and 
other cellular membranes (i) and to the nucleus (inset). While mutant 
Akt-PH is absent from the membranes (j), it displays similar nuclear 
pattern as the wild-type domain (inset). Both wild-type Grp1-PH (k) 
and mutant Grp1-PH (l) are almost absent from the cytoplasm and 
are accumulated in the nucleus, where they display similar pattern 
(k, l inset). Wild-type OSH1-PH localizes to the plasma membrane 
and other cellular membranes, probably Golgi apparatus (m), while 
the mutant OSH1-PH is diffused throughout the cytoplasm (n). Both 
wild-type and mutant OSH1-PH domains localize to the nucleus (m, 
n inset). Scale bars 5 µm
▸
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the domains tested, the only exception was the EEA1-
FYVE. It displays nucleolar localization, which is lost after 
mutation of PIs-binding site. Therefore, we believe that 
overexpressed EEA1-FYVE can be used for imaging of 
PI(3)P in nucleoli.
Purified PIs‑binding domains conjugated with eGFP 
show nuclear pattern
Since overexpressed PIs-binding domains do not follow 
PIs to the nucleus, we looked for an alternative approach. 
Fig. 4  Purified PLCδ1-PH, Tubby, and OSH1-PH domains recog-
nize nuclear PIs. The images are taken at optical sections focused on 
the plasma membrane (Cytopl.) and on the nucleus (Nucleus). Puri-
fied PLCδ1-PH detects PI(4,5)P2 in intracellular membranes and 
in a lesser extent also in the plasma membrane (a). Moreover, wild-
type PLCδ1-PH detects nuclear PI(4,5)P2 in the nucleus (a inset), 
where it accumulates in nucleoli (arrowheads) and nuclear speckles 
(empty arrowheads). The signal is completely abolished when mutant 
PLCδ1-PH is used (b). Wild-type Tubby domain detects PI(4,5)
P2 only in the nucleus (c), where it localizes to nucleolar foci (inset, 
arrowheads). Mutant Tubby shows very weak nuclear signal (d). 
Wild-type OSH1-PH detects PI(4)P in the plasma membrane and 
other cellular membranes (e). Moreover, it has strong nuclear signal 
with larger bright foci, probably nuclear speckles (inset, empty arrow-
heads). Mutant OSH1-PH detects very weak cytoplasmic signal (f), 
while nuclear signal is completely abolished (inset). Scale bars 5 µm
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Fused with GST, PIs-binding domains have been success-
fully used for imaging of nuclear PIs in fixed cells (Gillo-
oly et al. 2000; Watt et al. 2002, 2004; Lindsay et al. 2006; 
Yildirim et al. 2013). In this system, the purified domain 
was incubated with fixed and permeabilized cells and sub-
sequently detected by anti-GST antibody. To omit the use 
of an additional antibody, we fused PLCd1-PH, OSH1-PH, 
and Tubby domains with eGFP, cloned them into bacterial 
expression vector, and purified them from bacteria. The 
purified domains were tested for specificity in protein–
lipid overlay assay and then used in an analogy to anti-
bodies for immunofluorescence staining (Fig. 4). Mutant 
domains which are not able to bind PIs were used as nega-
tive controls.
It has been reported that GST tagged PLCδ1-PH recog-
nizes PI(4,5)P2 in nuclear speckles and nucleoli (Watt et al. 
2002; Hammond et al. 2009; Yildirim et al. 2013). There-
fore, we selected PI(4,5)P2 binding domains—PLCδ1-PH 
and Tubby—to test their eGFP fusions on immunofluores-
cence. In addition, we purified eGFP tagged OSH1-PH that 
recognizes PI(4)P, whose nuclear signal is unknown. Since 
antibodies against both PI(4,5)P2 and PI(4)P are available 
and specific, we were able to compare results obtained by 
immunofluorescence.
Purified PLCδ1-PH detects PI(4,5)P2 foci in nucleoli 
and nuclear speckles (Fig. 4a). The signal is diminished in 
mutant PLCδ1-PH (Fig. 4b). In comparison with overex-
pressed wild-type PLCδ1-PH (Fig. 3a), purified PLCδ1-PH 
stains the plasma membrane to a lesser extent but detects 
signal from other cellular membranes. On the other hand, 
the nuclear pattern of purified PLCδ1-PH resembles PI(4,5)
P2 labelling obtained by anti-PI(4,5)P2 antibody. In con-
trast, purified Tubby domain shows PI(4,5)P2 signal only in 
nucleoli of U2OS cells (Fig. 4c). We still detected a weak 
signal from mutant Tubby domain (Fig. 4d); however, the 
signal from wild-type domain was stronger, and therefore, 
we believe that it is specific. Similarly to PLCδ1-PH, Tubby 
is also absent from the plasma membrane. These results 
suggest that purified PLCδ1-PH is specific and detects 
similar pool of PI(4,5)P2 as anti-PI(4,5)P2 antibody. Tubby 
domain probably specifically recognizes nucleolar PI(4,5)
P2 only.
Purified wild-type OSH1-PH detects PI(4)P in the 
plasma membrane and other cellular membranes, in the 
nucleoplasm and larger nuclear foci, and probably in 
nuclear speckles (Fig. 4e). The signal is lost when the cells 
are incubated with mutant OSH1-PH (Fig. 4f). The nuclear 
pattern of purified OSH1-PH resembles anti-PI(4)P label-
ling. We conclude that purified OSH1-PH can be used for 
visualization of PI(4)P in the nucleus. Importantly, we 
noted that nuclear patterns of all domains used for stain-
ing on fixed cells are similar to antibody-based labelling; 
however, they differ significantly from the patterns of over-
expressed domains.
Discussion
Nuclear PIs have been identified as important regula-
tors of various nuclear functions (reviewed in Shah et al. 
2013). To better understand their role in the nucleus, tools 
for nuclear PIs visualization both in vivo and in vitro are 
needed. Here we performed a screen in which we aimed 
to identify an approach to track nuclear PIs in space and 
time. We compared labelling patterns of antibodies and 
protein domains that can be used for detection of nuclear 
PIs (summarized in Table 2). We showed that PI(4,5)P2 
antibody recognizes PI(4,5)P2 and PI(3,4,5)P3 on pro-
tein–lipid overlay. However, according to the results of 
the blocking assay, the antibody is blocked by PI(3,4,5)P3 
only partially while the incubation with PI(4,5)P2 abolishes 
the antibody signal completely (Fig. 2a–c). Because the 
cellular level of PI(3,4,5)P3 is more than 20-fold smaller 
in comparison with PI(4,5)P2 (Stephens et al. 1993; Nas-
uhoglu et al. 2002), we believe that the signal detected by 
anti-PI(4,5)P2 antibody comes from the nuclear PI(4,5)
P2. Although antibody against PI(3,4)P2, the second anti-
body we tested, is specific on protein–lipid overlay assay, 
we show that it is not suitable for immunofluorescence 
Table 2  Summary and specificity of tools used for PIs detection in 
the cytoplasm and in the nucleus
Based on our results, antibodies and domains were rated as unsuitable 
(−), good (+), or very good (+++)
Tools Target Suitable for detection in
Cytoplasm Nucleus
Antibodies
αPI(4,5)P2 PI(4,5)P2 − +++
αPI(3,4)P2 PI(3,4)P2 − −
αPI(4)P PI(4)P − +++
Overexpressed domains
EEA1-FYVE PI(3)P +++ + (nucleoli)
OSH1-PH PI(4)P +++ −
Akt-PH PI(3,4)P2, PI(3,4,5)P3 +++ −
Tubby PI(4,5)P2 +++ −
PLCδ1-PH PI(4,5)P2 +++ −
PLCδ1-PH NLS PI(4,5)P2 − −
Grp1-PH PI(3,4,5)P3 − −
Purified domains
Tubby PI(4,5)P2 − + (nucleoli)
PLCδ1-PH PI(4,5)P2 + +++
OSH1-PH PI(4)P + +++
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under our experimental conditions since it can be partially 
blocked by preincubation with most PIs tested (Fig. 2a, 
b). We suspect that these discrepancies are caused by high 
concentration of PIs spotted on the membrane, which do 
not resemble well enough the physiological conditions. On 
the other hand, the antibody against PI(4)P, the third anti-
body we tested, recognizes mainly PI(4)P as shown on both 
protein–lipid overlay and blocking assay (Fig. 2a, b). Using 
this antibody, we demonstrated for the first time that PI(4)
P can be detected in the cell nucleus and that its pattern 
resembles the localization of PI(4,5)P2 in nuclear speckles. 
This antibody also detects small foci in the nucleoplasm 
and nucleoli (Fig. 1c). These results are in agreement with 
published data, which repeatedly reported localization of 
PI(4)P metabolizing enzymes in nuclear speckles (Boro-
nenkov et al. 1998; Szivak et al. 2006; Mellman et al. 2008; 
Schill and Anderson 2009; Elong Edimo et al. 2011) and 
nucleoli (Kakuk et al. 2008). Regarding the nucleolar PI(4)
P signal, we have shown previously that nucleolar PI(4,5)
P2 forms foci in fibrillar centres and in the dense fibrillar 
component where it regulates rDNA synthesis and process-
ing (Sobol et al. 2013; Yildirim et al. 2013). It is possible 
that the nucleolar PI(4)P serves as a precursor for PI(4,5)P2 
in these compartments.
To track PIs in live cells, we overexpressed PIs-binding 
domains fused with eGFP in U2OS cells (Table 1; Fig. 3). 
We confirm that these domains are suitable for PIs monitor-
ing in the plasma membrane and other cellular membranes. 
The localization of overexpressed PIs-binding domains 
in the nucleus has been described earlier, and it was con-
sidered as a consequence of overexpression. Since the 
domains are relatively small, they could diffuse passively 
through the nuclear pore (reviewed in Hammond and Balla 
2015). We decided to inspect carefully the nuclear signal of 
several overexpressed domains. Mostly, we observed simi-
lar nuclear patter of wild-type and mutant domains. How-
ever, we show that wild-type but not mutant EEA1-FYVE 
domain localizes to foci in nucleoli. Therefore, the overex-
pressed EEA-1 FYVE domain can be used for visualization 
of PI(3)P in nucleoli.
Since most of the overexpressed PIs-binding domains 
were not suitable for PIs detection in the nucleus, we pre-
pared purified PLCδ1-PH, Tubby, and OSH1-PH domains 
fused with eGFP. In contrast to the results obtained after 
overexpression, purified PLCδ1-PH and Tubby domains 
specifically detect PI(4,5)P2 in nucleoli. Moreover, 
PLCδ1-PH shows PI(4,5)P2 localization also in nuclear 
speckles. OSH1-PH detects nuclear PI(4)P in the nucleo-
plasm and concentrated in bigger nucleoplasmic foci, prob-
ably nuclear speckles. It is known that the concentration and 
type of detergent used for permeabilization affect the detec-
tion of PIs in the cell (Mazzotti et al. 1995; Hammond et al. 
2009). Therefore, we think that different conditions used for 
PIs detection are the reason for diversities between overex-
pressed and purified domains staining. After overexpression, 
PIs-binding domains are targeted to the site of their ligand, 
where they are fixed, and therefore, stronger signal from 
cellular membranes can be detected. In case of purified PIs-
binding domains and antibodies, cell membranes are first 
permeabilized, and then, PIs detection tools are applied. We 
believe that these differences in sample preparation result in 
reduction in the PIs signal from cellular membranes while 
the signal from the nucleus, where PIs form complexes with 
nuclear proteins, is more prominent. Therefore, purified 
domains are more suitable tools for nuclear PIs detection.
We also report differences in the nuclear signal detected 
by purified domains and antibodies in fixed cells. We 
show that anti-PI(4,5)P2 detects signal mostly in nuclear 
speckles and the nucleoplasm while purified PLCδ1-PH 
detects strong signal also in nucleolar foci. Tubby domain 
detects PI(4,5)P2 predominantly in nucleoli (Figs. 1a, 4). 
We believe that domains and antibodies recognize differ-
ent pools of nuclear PIs with different affinities. It might be 
caused by different mechanism of PIs recognition. More-
over, anti-PI(4,5)P2 is IgM isotype and is therefore more 
than tenfold larger than both purified domains. Therefore, 
the antibody might not be able to access the nucleolar pool 
of PI(4,5)P2.
Here we identified some useful tools for PIs detection 
in the nucleus (Table 2). Unfortunately, the tools which 
would enable the visualization of nuclear PIs in vivo 
are still missing. One possibility is the use of labelled 
PIs. However, their use is problematic since they can be 
modified or cleaved in the cell. The future goal is thus to 
engineer such modifications of PIs which would enable 
their delivery to the nucleus and subsequently study their 
involvement in endogenous pathways, while preventing 
their cleavage.
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Phosphatidylinositol 4,5-bisphosphate (PIP2) is a major phosphoinositide of plasma 
membrane. In addition, it is present in nucleoplasm, where it seems to be a universal regulator 
involved in chromatin remodelling, transcription, and splicing. Since its role in RNA 
polymerase II transcription is still little understood, we studied PIP2 association with Pol II 
transcription complexes and its overall nuclear distribution. Based on the fact that NM1 is 
known as interacting partner of PIP2 in cytoplasm, we studied the interactions of PIP2 with 
NM1 and the importance of this complex for Pol II transcription. Here we demonstrate the 
involvement of nucleoplasmic PIP2 in Pol II transcription through PIP2 islets. These 
previously undescribed nucleoplasmic 40-100 nm structures are decorated by PIP2 molecules 
and composed mainly of lipids, while the periphery of PIP2 islets is covered by chromatin, 
nascent RNA transcripts, and proteins engaged in Pol II transcription, including NM1. Using 
DNase and RNase digestion, we demonstrated that PIP2 islets are chromatin-independent but 
RNA-associated structures. We showed that either the disruption of PIP2 islets or NM1 
depletion decrease Pol II transcription. We suggest that PIP2 islets provide a platform for the 
proper arrangement of the RNA polymerase II transcription complexes. 
 






Phosphoinositides are amphipathic lipids containing hydrophilic inositol head group and 
hydrophobic fatty acid tails. Phosphatidylinositol 4,5-bisphosphate (PIP2) is a 
phosphoinositide (PI) phosphorylated at 4C and 5C hydroxyl groups of the inositol ring 
(Tanaka et al. 2003; Balla 2013). PIP2 predominantly localizes to plasma membrane, where it 
participates in signalling (Balla 2013). In addition to the cytoplasm, PIP2 exists also in the 
nucleus together with the enzymes and substrates involved in its metabolism. In striking 
contrast to the cytoplasm, nuclear PIP2 is localized exclusively in the nuclear interior and is 
absent in the nuclear membrane (Cocco et al. 1987; Payrastre et al. 1992; Vann et al. 1997). 
Under extraction with high detergent concentrations, nearly half of the PIP2 amount is 
retained in the nucleus. This suggests that PIP2 is a part of the discrete intranuclear structures, 
where it interacts with the various proteins (Vann et al. 1997; Gonzales and Anderson 2006; 
Layerenza et al. 2013). Upon binding to a protein, PIP2 causes its conformational changes 
and/or affects its binding properties, which finally lead to a modulation of protein activity. In 
this manner, PIP2 participates in a regulation of a variety of nuclear processes like chromatin 
remodelling, cell proliferation, cell cycle progression, DNA transcription, and mRNA 
processing (Cocco et al. 1987; Divecha et al. 1991; Yu et al. 1998; Zhao et al. 1998; 
Anderson et al. 1999; Osborne et al. 2001; Rando et al. 2002; Jones and Divecha 2004; 
Mellman et al. 2008; Toska et al. 2012; Geeraerts et al. 2013). It was shown that PIP2 
promotes the binding of chromatin-remodelling SWI/SNF-like BAF complex to chromatin, 
which leads to T-lymphocyte activation (Zhao et al. 1998; Rando et al. 2002). Recently, we 
have found that the organization of nucleolus during cell cycle and transcription of genes 
coding ribosomal RNA (rRNA) require PIP2 (Sobol et al. 2013; Yildirim et al. 2013). We 
showed that PIP2 interacts with RNA polymerase I (Pol I), upstream binding factor (UBF), 
and fibrillarin. In such a way, PIP2 triggers conformational changes of these proteins, thus 
affecting their binding to DNA and RNA, respectively. Remarkably, PIP2 is required not only 
during rRNA synthesis and processing, but also serves as a scaffold which retains the 
components of Pol I pre-initiation complex such as UBF, PAF53, and RPA116 even during 
mitosis (Sobol et al. 2013; Yildirim et al. 2013). Even though PIP2 is a scaffold and an 
activator of Pol I transcription machinery, the effects of PIP2 on RNA polymerase II (Pol II) 
transcription are diverse. With various in vivo and in vitro biochemical approaches, Yu et al. 
(1998) identified PIP2 as a transcription activator. PIP2 binding to histone H1 results in a 
dissociation of H1 from DNA thus promoting transcription in a Drosophila embryo 
41 
 
transcription system (Yu et al. 1998). On the contrary, it was demonstrated that PIP2 
facilitates the recruitment of the transcriptional co-factor BASP1 and histone deacetylase 1 
(HDAC1) to the promoter, thus eliciting transcriptional repression (Toska et al. 2012). These 
data indicate that nuclear PIP2 might have diverse effects depending on its interactions with 
particular proteins or complexes.  
With a set of biochemical approaches, Osborne et al. (2001) showed the association of 
PIP2 with hyperphosphorylated Pol II and snRNAs, suggesting the involvement of PIP2 in 
Pol II transcription and mRNA splicing. However, the particular binding partners of PIP2 
participating in Pol II transcription are not clear. To associate with hydrophilic part of PIP2, 
many proteins contain specific motifs enriched in basic amino acids, such as pleckstrin 
homology (PH) domain (Watt et al. 2002; Mortier et al. 2005; Geeraerts et al. 2013). 
Nevertheless, some proteins are able to interact with hydrophilic and even hydrophobic parts 
of PIP2 through yet unknown moieties (Harlan et al. 1994; Ferguson et al. 1995; Lemmon et 
al. 1995; Wang et al. 2001; Zimmermann et al. 2002; Mortier et al. 2005; Gonzales and 
Anderson 2006; Irvine 2006; Sugi et al. 2008). Therefore we searched for nuclear PIP2-
interacting proteins containing known PIP2-binding motifs. One of such possible candidates 
is NM1, which possesses PH domain in the C-terminus and binds PIP2 in cytoplasm 
(Hokanson et al. 2006; Hokanson and Ostap 2006). Previously, it has been shown that NM1 
facilitates chromatin remodelling (Cavellan et al. 2006; Percipalle et al. 2006) as well as DNA 
transcription and RNA processing (Fomproix and Percipalle 2004; Philimonenko et al. 2004; 
Cisterna et al. 2006; Hofmann et al. 2006; Venit et al. 2013). The role of NM1 in rRNA 
biogenesis was revealed in detail (Ye et al. 2008; Sarshad et al. 2013). The amount of nascent 
pre-rRNA transcripts is reduced upon RNAi-mediated knockdown of NM1 gene (Sarshad et 
al. 2013). Overexpression of NM1 mutant lacking C-terminal domain decreases Pol I level at 
the rDNA promoter and transcribed region as shown by chromatin immunoprecipitation 
(ChIP) assay, suggesting a role for PIP2-binding motif in transcription (Ye et al. 2008). C-
terminus of NM1 is responsible as well for binding to rDNA and histone acetyl transferase 
PCAF (HAT PCAF) as revealed using NM1 C-terminal deletion mutant (Sarshad et al. 2013). 
In contrast, the involvement of NM1 in Pol II transcription as well as its interaction with 
nuclear PIP2 are not described in detail.  
Therefore, we investigated the association of PIP2 with Pol II transcription complexes and 
its distribution throughout the nucleus. Furthermore, we also studied the interactions of PIP2 
with NM1 and the importance of NM1-PIP2 complex for Pol II transcription.   
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In this study, we show the involvement of nucleoplasmic PIP2 in Pol II transcription 
through PIP2 islets. These previously uncharacterized nucleoplasmic 40-100 nm structures 
are decorated by PIP2 molecules and composed mainly of lipids, while the periphery of PIP2 
islets is enclosed by chromatin, nascent RNA transcripts, and proteins engaged in Pol II 
transcription, including NM1. Most importantly, disruption of PIP2 islets integrity causes a 
substantial decrease of Pol II transcription level. Altogether, our results allow us to suggest 
that PIP2 islets serve as a platform which facilitates the proper arrangement of the different 




Nucleoplasmic PIP2 appears as small roundish structures, which colocalize with 
nascent RNA and proteins involved in Pol II transcription 
Previously published data showed that PIP2 is pulled-down with Pol II (Osborne et al. 
2001) and binds to Pol I transcription machinery (Sobol et al. 2013; Yildirim et al. 2013). 
These findings prompted us to study the particular proteins associated with nucleoplasmic 
PIP2, which are the core subunits of Pol II. Using super-resolution structured illumination 
microscopy (SIM), we analyzed the colocalization between PIP2 and the components of Pol II 
transcription machinery, including BrUTP-labeled nascent RNA. We found that 
nucleoplasmic PIP2 forms small foci and colocalizes with nascent BrRNA transcripts, C-
terminal domain of Pol II, and TATA-box binding protein (TBP) of the Pol II general 
transcription factor TFIID (Figure 1a, b). The extent of colocalization between PIP2 and 
BrRNA was expressed by the high values of Manders’ (MCC) and Pearson’s (PCC) 
colocalization coefficients (Figure 1c). Another protein involved in Pol II transcription 
activation through the recruitment of chromatin remodeling proteins and histone modification 
enzymes is NM1 (Hofmann et al. 2006; Almuzzaini et al. 2015). Transmission electron 
microscopy (TEM) showed more accurately that these PIP2 foci are roundish structures of 40-
100 nm in size and revealed presence of NM1 at the periphery of these structures (Figure 1d). 
Based on their roundish shape and size, we refer to them as PIP2 islets. We show that the 
colocalization between PIP2 molecules and NM1 is significant at the distances of 25 – 75 nm 
(**p value ≤ 0.01).  
In conclusion, nucleoplasmic PIP2 appears as small roundish 40-100 nm structures - PIP2 
islets, which colocalize with some of the various components of Pol II transcription 




NM1 associates with PIP2 islets and is anchored in nucleoplasm by PIP2 
We detected NM1 on the surface of PIP2 islets. Based on the fact that NM1 contains PH 
domain which mediates its interaction with cytoplasmic PIP2 (Hokanson et al. 2006; 
Hokanson and Ostap 2006), we studied whether NM1-PIP2 interaction occurs also in the 
nucleus. First, we pulled-down NM1 from the HeLa nuclear extract using PIP2-coupled 
agarose beads (Figure 2a). To see if this interaction is direct, we prepared a recombinant wild-
type NM1 as well as NM1 mutated in the PH domain - NM1(K908A), and verified their PIP2 
binding ability using PIP2 spotted on nitrocellulose membrane. Unlike to wild-type NM1, 
NM1(K908A) showed no reaction with PIP2 (Figure 2b), so the mutation in the PH domain 
prevents binding of NM1 to PIP2 and this interaction is direct. Furthermore, NM1(K908A) 
with abolished binding to PIP2 demonstrated the increased mobility measured by 
fluorescence recovery after photobleaching (FRAP) technique as compared to wild-type NM1 
(Figure 2c), so PIP2 seems to anchor NM1 into the nuclear complexes. To confirm the 
association of NM1 with PIP2, we employed nucleus-targeted inositol 5-phosphatase or PH 
domain of phospholipase C isoform δ1 (PLCδPH) for hydrolyzing or blocking nuclear PIP2, 
respectively. Indeed, both treatments led to an increase in NM1 mobility monitored by FRAP 
(Figure 2c) upon disabling the interaction between NM1 and PIP2. To demonstrate that NM1 
is anchored to PIP2 islets, we performed a flotation of extracted HeLa nuclei on a sucrose 
density gradient in the presence of a weak non-ionic detergent Brij 98. Both NM1 and PIP2 
were present in the light fraction 1, which contains detergent-insoluble complexes composed 
of lipids and proteins, such as PIP2 islets (Figure 2d). NM1 and PIP2 were also present in the 
heavy fraction 10, which corresponds to complexes efficiently solubilized by detergent 
(Figure 2d). Hence we conclude that NM1 is anchored in nucleoplasm to PIP2 islets. 
 
PIP2-NM1 interaction and integrity of PIP2 islets are important for Pol II-dependent 
transcription 
It is known that NM1 associates with Pol II (Hofmann et al. 2006; Venit et al. 2013), 
however the details of this interaction are not clear. When we used NM1(K908A), we 
observed the loss of association with Pol II, as tested by immunoprecipitation (Figure 3a). 
Therefore we also studied the effect of this NM1 mutation on Pol II transcription. We pulse-
labelled nascent transcripts with fluorouridine (FU) in vivo and quantified the signal intensity 
by indirect immunofluorescence microscopy. The depletion of NM1 by shRNA-mediated 
knock-down (Figure 3b) significantly reduced Pol II transcription by ~25% (Figure 3c). The 
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overexpression of NM1 rescued Pol II transcription close to its original level. In contrast, the 
overexpression of NM1(K908A) did not rescue Pol II transcription, which remained at the 
knocked-down level. Thus we suggest that NM1 requires PIP2 in order to associate with Pol 
II and to participate in transcription.  
Since NM1 and the components of Pol II transcription machinery colocalized with PIP2 
islets, we investigated whether the integrity of PIP2 islets is important for DNA transcription 
on their periphery. To disintegrate PIP2 islets, we treated the cells with PLC (Supplementary 
Figure 1). Upon PIP2 hydrolysis, we quantified the level of transcription using indirect 
immunofluorescence microscopy of FU-labelled nascent RNA. For this and all following 
colocalization analyses, we considered only regions occupied by PIP2 islets, which we 
referred to as PIP2 islets area. In experiments using fluorescent microscopy, PIP2 islets area 
was identified based on the absence of labeling by a speckle-specific marker Son. We showed 
that reducing of PIP2 level to 38.2±2.9% (***p value ≤ 0.001) resulted in a decrease of 
transcription level to 42.4±0.1% (**p value ≤ 0.01) in the area of PIP2 islets (Figure 3d). 
Mutated PLC(R40A) with abolished binding to PIP2 as well as inactivated by heating PLC or 
irrelevant protein BSA did not substantially affect the level of transcription by Pol II. 
Interestingly, Pol II transcription level was directly proportional to the level of PIP2 in the 
PIP2 islets under both control and experimental conditions. In other words, cells with high 
level of PIP2 exhibited high level of Pol II transcription, while cells with low level of PIP2 
displayed low level of Pol II transcription. Altogether our results indicate that Pol II 
transcription is strictly dependent on the presence of intact PIP2 islets. In support, TEM 
clearly demonstrated that nascent BrRNA transcripts colocalize with the periphery of PIP2 
islets (Figure 3e). The colocalization between PIP2 molecules and nascent BrRNA transcripts 
was significant at 25 - 75 nm; **p value ≤ 0.01 (Figure 3f). Furthermore, the analysis of the 
relative colocalization of BrRNA and PIP2 molecules showed that almost half of nascent 
RNA transcripts is colocalized with PIP2 islets; ***p value ≤ 0.001 (Figure 3g). On the other 
hand, only a minor part of PIP2 islets – 8.8±0.3% is colocalized with BrRNA. In accordance, 
the inhibition of Pol II transcription did not significantly alter either the pattern or the quantity 
of PIP2 islets per µm2 as compared to the control (Figure 3h, i).  
In conclusion, Pol II transcription is dependent on PIP2 islets and predominantly takes 
place on their surface, while PIP2 islets seem to be independent of ongoing transcription. 
Moreover, PIP2 islets mediate the interaction of NM1 with Pol II transcription complex. 
Therefore, we suggest that PIP2 islets serve as a standard platform which facilitates the 




PIP2 islets are DNA-independent but RNA-associated structures 
Here we demonstrated the relationship between PIP2 islets and Pol II transcription. To 
further disclose the interrelation between PIP2 islets and chromatin, we studied pattern of 
PIP2 islets upon hypertony-triggered chromatin condensation (Figure 4). As shown by SIM, 
PIP2 islets overlapped with histone H1 under isotonic conditions (Figure 4a). This 
observation is supported by MCC and PCC measured for PIP2 islets area (Figure 4d, e). 
Under hypertonic conditions (final salt concentration 300 mM, 15 min), PIP2 islets minimally 
overlapped and did not significantly colocalize with histone H1 as represented by MCC and 
PCC, which decreased four- and five-fold, respectively (Figure 4b, d, e). After 3 min of 
recovery under isotonic conditions, chromatin decondensed and PIP2 islets colocalized with 
histone H1 (Figure 4c). This was documented by MCC and PCC, which regained their initial 
values (Figure 4d, e). These observations suggest that PIP2 islets do not alter their pattern, 
when chromatin dynamically changes its state. To confirm this, we calculated the relative 
volumes of PIP2 islets and chromatin in the nucleus (Figure 4f). We revealed that hypertonic 
conditions resulted in a significant decrease in the relative volume of chromatin (41.9±0.9% 
vs 27.1±0.7%). After the recovery, the relative volume of chromatin was restored to the initial 
value (40.6±0.9%). In contrast, the relative volume of PIP2 islets did not significantly change 
under hypertonic conditions as compared to the control. Therefore we conclude that PIP2 
islets do not follow the chromatin rearrangements.  
To further test if PIP2 islets are chromatin-independent structures, we studied the pattern of 
PIP2 islets upon DNase treatment. In accordance with the previous observations, PIP2 islets 
were arranged in a similar pattern in both control and DNase-treated cells (Figure 5a, b). 
Since we demonstrated that PIP2 islets colocalize with nascent RNA transcripts (Figure 1a-c, 
3e, f), we also studied the effect of RNase on the arrangement of PIP2 islets. Surprisingly, the 
treatment of cells with RNase caused disappearance of PIP2 islets labeling (Figure 5c). These 
results encouraged us to assess the overall association of RNA molecules with PIP2 islets. We 
simultaneously labeled PIP2 and total RNA with anti-PIP2 antibody and RNase conjugated to 
gold nanoparticles - RNase-gold complex (Supplementary Figure 2a, b). TEM revealed that 
RNA molecules are located on the surface of PIP2 islets (Figure 5d). For TEM colocalization 
analyses, PIP2 islets area was distinguished from nuclear speckles and nucleoli based on the 
ultrastructure and the pattern of PIP2 labeling. The colocalization of RNA and PIP2 
molecules was significant (**p value ≤ 0.01) at the distance of 25 – 75 nm. Moreover, the 
analysis of their relative colocalization showed that 73.2±7.5% of PIP2 in the area of PIP2 
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islets is colocalized with RNA molecules and vice versa, 21.8±4.2% of RNA molecules is 
colocalized with PIP2 islets (***p value ≤ 0.001).  
These data altogether clearly demonstrated that RNA is an essential part of PIP2 islets. 
Furthermore, RNA does not form the core of PIP2 islets, but associates with their surface. 
 
Morphology, composition and distribution of PIP2 islets  
We showed that nucleoplasmic PIP2 is involved in Pol II transcription through PIP2 islets. 
Previously, PIP2 was detected predominantly in nuclear speckles (Osborne et al. 2001; 
Mortier et al. 2005) as well as in nucleoli (Sobol et al. 2013; Yildirim et al. 2013). That is 
why we decided to map thoroughly nuclear PIP2 localization by anti-PIP2 antibody. Using 
SIM, we acquired z-stacks, reconstructed the nuclei in three-dimensional space and calculated 
the distribution of PIP2 labeling in the nuclear volume by the procedure described in 
Materials and Methods section (Figure 6a). We used Son as a speckle-specific marker as well 
as histone H1 and DAPI as the markers of nucleoplasm. We revealed that 68.4±4.4% of 
nuclear PIP2 localizes to speckles, while nucleolar PIP2 constitutes 3.4±1.1%. The remaining 
28.2±4.9% was dispersed throughout nucleoplasm. To visualize this pool of PIP2 more 
accurately, we inspected the nucleoplasmic PIP2 labeling by TEM (Figure 6b). We showed 
that these 28.2±4.9% of nucleoplasmic PIP2 pool were indeed located in PIP2 islets, which 
can be clearly discriminated from the nuclear speckles by size (40-100 nm) and roundish 
shape. PIP2 islets occupy up to 10.6±4.0 µm3 per nucleus, which is 1.9±0.2% of the total 
nuclear volume. Even though PIP2 is a known component of plasma membrane, 
ultrastructural analysis showed that PIP2 islets are excluded from the nuclear envelope. 
To uncover the composition of PIP2 islets, we mapped the presence of nitrogen, 
phosphorus, and carbon, which are the basic components of proteins, chromatin, and lipids. 
To achieve this, we performed electron energy loss spectroscopy (EELS) on ultrathin sections 
of U2OS cells immunolabeled with anti-PIP2 antibody (Figure 6c). We showed that PIP2 
islets are enclosed by phosphorus- and nitrogen-containing shield, while the inner space of 
PIP2 islets lacks them both (Figure 6d-f). On the contrary, the interior of PIP2 islets is mainly 
composed of carbon-rich compounds (Figure 6g). These data indicate that nucleic acids and 
proteins surround PIP2 islets, which is in agreement with the results shown in Figures 1, 3, 4, 
and 5, while lipids form the inner space of PIP2 islets. 
Since PIP2 islets are surrounded by nucleic acids and proteins, we performed a 
colocalization of PIP2 islets with histones H3K4me2 and H3K9me2, the hallmarks of active 
chromatin and heterochromatin, respectively. Using immunolabelling followed by SIM we 
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showed that PIP2 islets partially overlap with both histone marks with no preference for either 
type of chromatin (Figure 6h, i). 
We can summarize that nuclear PIP2 islets are globular structures of 40-100 nm in size 





The presence of PIP2 in a cell nucleus was shown in the early studies (Mazzotti et al. 1995; 
Osborne et al. 2001; Watt et al. 2002), but it was attributed mainly to the nuclear speckles. 
Later, the involvement of PIP2 in rDNA transcription and nucleolar organization was shown 
(Sobol et al. 2013; Yildirim et al. 2013). Besides, PIP2 was demonstrated to participate in 
chromatin remodelling and Pol II transcription (Yu et al. 1998; Zhao et al. 1998; Osborne et 
al. 2001; Rando et al. 2002; Toska et al. 2012), which occur in nucleoplasm outside nuclear 
speckles. This motivated us to study nucleoplasmic pool of PIP2 in greater detail. 
We found that nearly 30% of total nuclear PIP2 is located outside nuclear speckles and 
nucleoli. Using SIM and TEM, we revealed that this nucleoplasmic PIP2 forms 40-100 nm 
roundish structures, which we termed PIP2 islets. Recently, nuclear lipid droplets (nLDs) 
were described in rat and human liver hepatocytes (Layerenza et al. 2013). nLDs are 530-800 
nm in diameter and are composed of a hydrophobic lipid core surrounded by a hydrophilic 
outer monolayer. Among the inner part of nLDs, triacylglycerols and cholesteryl esters were 
found, while polar lipids, cholesterol, and proteins form their surface. PIP2 islets are 
organized in a similar way with a carbon-rich interior and phosphorus- and nitrogen-rich 
exterior. We suggest that the inner core of PIP2 islets is hence composed of lipids while PIP2 
molecules form outer layer with hydrophilic heads facing outwards. PIP2 islets are 
surrounded by nucleic acids and proteins. This observation is further reinforced by our pull-
down experiments, where we identified various phospholipids as PIP2-binding partners in the 
nucleus (data not shown).  
Up to now, the only known nuclear subcompartments containing PIP2 have been the 
nucleoplasmic vesicles found in the bovine adrenal chromaffin cells by Yoo et al. (2014). 
Even though similar to PIP2 islets in size (50 nm), these vesicles are enclosed by a membrane. 
nLDs and vesicles serve as storage nuclear domains for lipids and calcium, respectively. PIP2 
islets might be the storage sites for PIP2 as well, however our results indicate their 
involvement in RNA synthesis. Indeed, PIP2 islets colocalize with nascent RNA transcripts as 
48 
 
well as Pol II transcription machinery proteins, Pol II CTD and TFIID TBP. During the 
initiation phase of Pol II transcription, TFIID recognizes DNA promoter thus recruiting Pol II 
(Bieniossek et al. 2013). Phosphorylations of Poll II CTD at Ser5 and Ser2 are required for 
transcription initiation and elongation, respectively (Heidemann et al. 2013). RNA is being 
synthesized predominantly during elongation phase and remains attached until termination. 
Since these molecules are engaged in different phases of Pol II transcription, PIP2 islets serve 
as a scaffold for the arrangement of various functional subunits of Pol II transcription 
machinery. In agreement, PIP2 hydrolysis results in a significant decrease of transcription 
level in the PIP2 islets area. On the other hand, inhibition of Pol II transcription does not 
disturb PIP2 islets. Hence, PIP2 islets are stable nuclear structures independent of ongoing 
transcription. 
Next, we asked how the transcription complexes are associated with PIP2 islets surface. 
Our results document, that neither DNase treatment nor hypertony-triggered chromatin 
condensation affect PIP2 islets. Therefore, they are chromatin-independent structures and 
DNA template does not mediate the interaction between PIP2 islets and Pol II transcription 
machinery. On the contrary, RNase treatment disrupts PIP2 islets. We found that majority of 
PIP2 islets colocalizes with RNA detected by RNase-gold. Since RNase-gold complex 
recognizes total RNA, we can’t identify the type of this RNA. Our results show that PIP2 
islets however colocalize with nascent RNA transcripts, which thus contribute to the pool of 
RNA recognized by RNase-gold. However, nascent RNA does not seem to link the 
transcription complexes with PIP2 islets, because it is synthesized after the association of Pol 
II transcription machinery with PIP2 islets surface. That is why we hypothesize that other 
types of RNA and/or proteins mediate the interaction of PIP2 islets with the transcription 
complexes. It is unlikely, that RNA itself serves as a mediator, because negative charges of 
PIP2 hydrophilic heads exposed to the surface of the islets would repulse negatively charged 
RNA. Therefore, PIP2 islets and RNA molecules should have some positively charged 
interface, presumably basic protein domains. 
Here we show that PIP2 islets interact with NM1. It is known that C-terminal part of NM1 
containing PIP2-binding site is essential for NM1 to promote chromatin remodelling and Pol 
II transcription (Hofmann et al. 2006; Almuzzaini et al. 2015). We revealed that K908A 
mutation in NM1 causes loss of interaction with Pol II. Furthermore, NM1(K908A) is 
incapable to rescue drop in transcription caused by knock-down of endogenous NM1. 
Therefore we speculate that the interaction between NM1 and Pol II complex occurs via PIP2 
on the surface of PIP2 islets. In such a way, NM1 recruits chromatin remodelling complexes 
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to PIP2 islets, where they create open chromatin structure thus promoting transcription. In the 
absence of NM1-PIP2 islets association, Pol II complexes remain attached to the surface of 
PIP2 islets, but transcription cannot occur due to the lack of chromatin remodellers. 
Additionally, due to its basic nature, NM1 is able to create interface in between negatively 
charged PIP2 and RNA. 
Here we describe that PIP2 islets are required for Pol II transcription. Similarly, few 
studies demonstrated the contribution of other lipid-based structures in transcription. 
Scassellati et al. (2010) showed that sphingomyelin and nascent RNA are both located in the 
transcriptionally active chromatin regions. Yoo et al. (2014) suggested that nucleoplasmic 
vesicles containing PIP2 might be engaged in transcription via calcium-regulated chromatin 
remodelling. nLDs might indirectly participate in transcription via nuclear lipids metabolism 
(Layerenza et al. 2013). All these nuclear structures have been found in specialized cell types: 
sphingomyelin in rat and mouse liver cells, T24 human bladder carcinoma cells, and V79 
Chinese hamster cells (Scassellati et al. 2010); nLDs in rat and human liver hepatocytes 
(Layerenza et al. 2013); nucleoplasmic vesicles in bovine adrenal chromaffin cells (Yoo et al. 
2014). Nuclear granules have been described only under stress conditions (Jolly et al. 2004). 
Noteworthy, we have found PIP2 islets not only in cancer cells (HeLa, U2OS), but also in 
primary fibroblasts and mesenchymal stem cells (data not shown). This indicates that PIP2 
islets are common structures essential for nuclear processes regardless of a cell type. 
  Altogether, we suggest that PIP2 islets serve as a platform, which facilitates the spatial-
temporal arrangement of various complexes involved in Pol II transcription. These findings 
point towards existence of previously undefined nuclear structures. Future experiments are 
needed to clarify the contribution of such structures in nuclear functions and architecture. 
 
Materials and methods 
 
Cell cultures and transfections 
Human cervical carcinoma (HeLa, ATCC No. CCL2) cells, osteosarcoma (U2OS, ATCC 
No. HTB96), and H1299 (ATCC No. CRL5803) cells were grown in D-MEM with 10% fetal 
bovine serum (FBS) at 37 oC in 5% CO2 humidified atmosphere. Suspension HeLa were kept 
in S-MEM supplemented with 5% FBS at 37 °C in 5% CO2 humidified atmosphere. 
Transfections were carried out using Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s protocol. Stable cell lines were prepared by lentiviral transduction using 




NM1-EGFP and NM1(K908A)-EGFP: NM1 cDNA was ligated into pEGFP-N3 vector 
(Clontech) using HindIII and KpnI (Dzijak et al. 2012). K908A mutant was obtained by site-
directed mutagenesis. NLS-mRFP-FKBP-Inositol-5-phosphatase: SV40 NLS sequence was 
prepared by PCR from pEYFP-Nuc (Clontech). The NLS was then cloned using NheI and 
AgeI to the N-terminus of mRFP-FKBP-Inositol-5-phosphatase, which was a kind gift of Dr. 
Tamas Balla (Varnai et al. 2006). PLCPH-mCherry-NLS: SV40 NLS was released from 
pEYFP-Nuc (Clontech) vector by cutting at BsrGI and AflII restriction sites, and inserted in 
the C-terminus of PLCPH-GFP vector, which was a kind gift from Dr. Tamas Balla (Varnai 
and Balla 1998). PLCPH-GFP-NLS was then cloned to XbaI and AfeI restriction sites of 
pPSG-IBA-103 vector (Iba BioTagnology). For FRAP experiments, mCherry was exchanged 
with GFP using AgeI and BsrGI restriction sites. R40A mutant was prepared by site-directed 
mutagenesis. NM1-Flag and NM1(K908A)-Flag: cDNAs of NM1 and NM1(K908A) were C-
terminally fused with Flag tag and cloned into lentiviral expression vector pCDH-CMV-
MCS-EF1-Neo (Systems Bio) using EcorI and BamHI. Flag-HDL: cDNA fragment of NM1 
(corresponding to amino acids 712 to 1044) was amplified by PCR, fused with N-terminal 
Flag tag and ligated into pCDNA3.1 (Invitrogen) using SacI and XmaI. HIS-tagged 
phospholipase C isotype δ1 (PLC) and PIP2-binding mutant R40A in pRSETA were both 
generous gift from Dr. Hitoshi Yagisawa and Dr. Klim King (Cheng et al. 1995). NM1 
shRNA: NM1 shRNA targeting the sequence 5’-gcccgtccagtatttcaac-3’ (Open Biosystems No 
TRCN0000122925 AAO75-C-8) was ligated into pLKO.1 (Addgene, Stewart et al RNA 2003 
Apr;9). 
 
Expression and purification of recombinant proteins 
NM1-Flag and NM1(K908A)-Flag were stably expressed in H1299 cell line. Cells were 
washed with PBS and extracted with lysis buffer (50 mM HEPES pH 8, 300 mM NaCl, 4 mM 
MgCl2, 1% Triton X-100). The extract was sonicated, filtered through 0.45 μm filter, and 
incubated 2 h with pre-equilibrated anti-Flag-M2 agarose beads (Sigma-Aldrich). The beads 
were then washed three times with lysis buffer, and bound proteins were eluted five times 
with 100 μg/ml Flag peptide in elution buffer (10 mM Tris pH 8, 100 mM NaCl, 0.5% EDTA, 
20% glycerol). 
HIS-tagged PLC and PLC(R40A) were expressed in E. coli strain BL21-Gold (Agilent 





Transiently transfected U2OS cells were photobleached in nucleoplasm with a 488-nm 
laser for 20 msec. GFP fluorescence intensities were monitored every 0.175 sec on an 
Olympus microscope (IX71) with a 60x 1.42 NA objective. Approximately 15 cells were 
analyzed for each condition. All images were corrected for overall photobleaching and 
analyzed by DeltaVision software SoftWoRx 5.5 (Applied Precision). Two-dimensional 
diffusion of the fluorescent molecules is calculated according to a previously published model 
(Axelrod et al. 1976).  
 
Immunofluorescent labeling for super-resolution microscopy 
Cells grown on high performance cover glasses 18x18 mm² with restricted thickness-
related tolerance D=0.17 mm +/- 0.005 mm and refractive index = 1.5255 +/- 0.0015 were 
fixed with 3% formaldehyde and permeabilized with 0.1% Triton X-100. Unspecific targets 
were blocked with 0.25% bovine serum albumin (BSA) and 0.25% gelatine. All solutions 
were diluted in PBS. Then, cells were incubated with primary antibodies diluted in PBS, 
secondary antibodies diluted in PBS or PBST, stained with DAPI and mounted in Mowiol. 
Importantly for super-resolution microscopy technique, five extensive washes for 5 or 10 min 
in PBS or PBST were done in between all steps. 
 
Super-resolution structured illumination microscopy (SIM) 
Images were acquired using microscope ECLIPSE Ti-E equipped with Andor iXon3 897 
EMCCD camera by objective CFI SR Apochromat TIRF 100x/1.49 oil (Nikon, Tokyo, 
Japan). Software NIS-Elements AR 4.20.01 and NIS Elements AR 4.30 was used for 
capturing and analysis of the images. In each experiment, the images of all samples were 
acquired and reconstructed with the same parameters to ensure their comparability. To assess 
the distribution of PIP2 in the nucleus, z-stack was acquired, reconstructed, and analysed with 
3D Object Measurement tool. We defined the nucleus with DAPI and histone H1, and the 
nucleoli as the regions, where both markers were absent. Nuclear speckles were distinguished 
from PIP2 islets based on the co-labeling with a speckle-specific marker, Son. All markers 
were visualized with different secondary antibodies than PIP2. The respective volumes of 
nuclear speckles, PIP2 islets, and nucleolar PIP2 were calculated. To determine the proper 
threshold, MATLAB 7.7.0 (R2008b) software was used. Firstly, the maximum intensity value 
for each pixel in the projection image was computed as maximum value of the overlapping 
voxels in z-stack (PIP2 channel). Secondly, the upper quartile was applied to filter out 75% 
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non-significant pixel intensities of the projection image. The zero intensity values were 
assigned to all these pixels, which have intensity value lower than given upper quartile, so 
they are considered as a black background or noise. Consequently, the projection image in 
PIP2 channel includes 25% of the intensity values of the original projection image. The 
image was color-coded in red. Simultaneously, the same method was applied to z-stack in 
Son, H1, and DAPI channels. The ninth decile was chosen to sort out non-significant 
intensity values in projection image in Son channel. The zero values were assigned to all 
pixels with intensity values less than the 90th percentile. In the next step, we combined the 
projection images (PIP2 channel and Son channel). All overlapping pixels with non-zero 
values in both channels were classified as nuclear speckles in PIP2 channel and color-coded 
in yellow. Then, we used the information of the maximum projection images of H1 and DAPI 
channels to distinguish the nucleoli in PIP2 channel and classified pixels were color-coded in 
blue. The data on the volumes were exported and the percentage distribution of PIP2 in the 
nucleus was calculated and presented as a diagram using Microsoft Excel software. Similarly, 
the volumes of chromatin and PIP2 islets were analysed with 3D Object Measurement tool, 
exported to Microsoft Excel and related to the nuclear volume. The colocalization analysis 
was done using software ImageJ/plugin JACoP (n=10 cells). Quantitative results given in 
graphs are presented as mean ± standard deviation. The statistical significance was 
determined using the F-test two-sample for variances followed by the t-test: two-sample 
assuming (un-)equal variances. 
 
Transmission electron microscopy (TEM) 
HeLa cells and yeast cells were either fixed in 3% formaldehyde with 0.1% 
glutaraldehyde and embedded into LR White resin or Lowicryl K4M resin by a standard 
protocol (Wright 2000; Sobol et al. 2010). Alternatively, HeLa cells were high-pressure 
frozen, freeze-substituted and embedded into LR White resin or Lowicryl K4M resin 
according to a previously published procedure (Sobol et al. 2011). Ultrathin sections (70 nm) 
were immunolabeled by a conventional protocol (Stradalova et al. 2008) and examined with a 
transmission electron microscope (TEM) Morgagni 268 at 80 kV and Tecnai G2 20 LaB6 at 
200 kV (FEI, Eindhoven, The Netherlands). The images were captured with a camera Mega 
View III CCD and Gatan Model 894 UltraScan 1000. Multiple sections of at least three 
independent immunogold labeling experiments were analyzed (n=100 cells). To facilitate the 
visualization of 6 nm gold nanoparticles in images, Adobe Photoshop CS3 Version 10.0 was 
used to identify the geometrical centers of the small nanoparticles and then cover co-
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centrically with red dots. To evaluate computationally the spatial distribution and quantitative 
mutual dependence of the nanoparticles in electron microscopy images, we developed and 
used the quantitative objective approach (Pastorek et al., in preparation), based on the 
previously published one describing pair cross-correlation function (PCCF) (Philimonenko et 
al. 2000). In this study, we used new developed plugin (Pastorek et al., in preparation) on the 
ImageJ software platform. Quantitative results given in graphs are presented as mean ± 
standard deviation. The statistical significance was determined using the F-test two-sample 
for variances followed by the t-test: two-sample assuming (un-)equal variances. 
 
PIP strip 
Membranes spotted with PIs (PIP strips; Echelon) were blocked with 3% BSA in PBST 
for 1 h at 4 °C. Recombinant NM1-Flag and NM1(K908A)-Flag were diluted to 2 µg/ml with 
3% BSA in PBST and incubated with PIP strips for 4 h at 4 °C. After five washes with PBST, 
bound proteins were detected by western blotting with anti-Flag antibody. 
 
Electron energy loss spectroscopy (EELS) and elemental mapping 
Elemental mapping was performed on ultrathin sections of U2OS cells embedded in LR 
White resin. The 80-nm sections were immunolabeled with anti-PIP2 antibody and secondary 
antibody conjugated with 12 nm gold particles according to conventional protocol (Stradalova 
et al. 2008). Contrasting by uranyl acetate was omitted. EELS mapping of specific elements 
distribution was performed using a Tecnai G2 20 LaB6 TEM at 200 kV equipped with Gatan 
863 Tridiem Imaging Filter. Two pre-edge and one post-edge energy filtered images were 
collected at 100 eV, 120 eV, and 152 eV (LII, III edge) for phosphorus; at 353 eV, 383 eV, and 
416 eV (K edge) for nitrogen; at 484 eV, 514 eV, and 532 eV (K edge) for oxygen; at 130 eV, 
150 eV, and 165 eV (LII, III edge) for sulphur; at 252 eV, 272 eV, and 294 eV (K edge) for 
carbon. Drift correction was performed using an automated statistically determined spatial 
drift (SDSD) correction script for Digital Micrograph (Schaffer et al. 2004), and elemental 
maps were calculated by three-windows method using Digital Micrograph. The images were 
processed using Digital Micrograph and Adobe Photoshop CS3 Version 10.0. 
 
Hypertony-induced chromatin condensation 
U2OS cells grown under standard conditions were subjected to D-MEM adjusted with 
NaCl to the final salt concentration of 300 mM for 15 min. After this period, cells were let to 
recover under standard conditions in isotonic D-MEM for 3 min. For SIM, cells were fixed 
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with 4% formaldehyde diluted in either PBS adjusted with NaCl to the final 300 mM salt 
concentration (hypertonic samples) or in PBS (isotonic condition, initial and recovery). Then, 
cells were permeabilized with 0.1% Triton X-100 in PBS. Unspecific targets were blocked 
with 2% BSA in PBS. Then, cells were processed for SIM as described above. 
 
DNase and RNase treatments 
U2OS cells were gently fixed with 1% formaldehyde for 5 min on ice and then treated 
with either RNase A (1 mg/ml) or DNase I (250 U/ml) diluted in buffer (130 mM KCl, 10 
mM Na2HPO4, 1 mM MgCl2, 1 mM DTT, 1 mM Na2ATP, 0.1 mM PMSF; pH 7.4) for 30 
min at 32 oC. Subsequently, cells were fixed, permeabilized, and further processed for SIM as 
described above. 
 
BrUTP labeling of nascent transcripts for SIM and TEM 
HeLa cells were washed in PB buffer on ice (100 mM CH3COOK, 30 mM KCl, 10 mM 
Na2HPO4, 1 mM MgCl2, 1 mM DTT, 0.2 mM PMSF, 10 U/ml human placental RNase 
inhibitor (HPRI), 1 mM Na2ATP; pH 7.2) and permeabilized with 0.5 mg/ml saponin for 5 
min on ice. Transcription reactions were started by incubation with 100 µM BrUTP, 100 µM 
CTP, 100 µM GTP, and 300 µM MgCl2 in PB. To inhibit Pol II transcription, cells were pre-
incubated with 100 µg/ml α-amanitin for 5 min. After 15 min at 35 oC, reactions were 
stopped by rinsing in ice-cold PB. Cells were either fixed with 4% formaldehyde for 40 min 
on ice, additionally permeabilized with 0.5% Triton X-100 for 20 min, and further processed 
for SIM as described above or processed for TEM (Sobol et al. 2010). 
 
Ultrastructural detection of RNA molecules using RNase-gold  
RNase A (Thermo Fisher Scientific, Waltham, Massachusetts, USA) was conjugated 
with 10 nm gold nanoparticles (BBI Solutions, Cardiff, UK) as published previously 
(Bendayan 1981; Bendayan and Puvion 1984; Cheniclet and Bendayan 1990). HeLa cells 
were embedded into Lowicryl K4M resin and the ultrathin sections (70 nm) were sequentially 
double labeled. First, the anti-PIP2 antibody followed by the secondary antibody conjugated 
with 6 nm gold nanoparticles was applied. Next, sections were incubated with RNase-gold 
conjugates (0.08 µg/ml). The activity of RNase-gold complex was checked using in vitro 
reaction with RNA (0.5 µg of RNA for 18 ng of RNase-gold). The incubation was carried out 
for 15 min on ice. To control the labeling specificity, RNase-gold complex (3.2 ng) was pre-
blocked with RNA (5.2 µg – 20.0 µg), and these mixtures were used for labeling. 
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Quantification of transcription using 5-FU labeling of transcripts 
U2OS cells grown on the coverslips were slightly permeabilized with 0.05% Triton-X-100 
on ice for 5 min and then treated with recombinant PLC (84 µg/ml in the buffer consisting of 
50 mM HEPES pH7.4, 100 mM KCl) and 0.04 µg/ml actinomycin D (AMD) as an inhibitor 
of Pol I transcription for 1 h at RT. After 30 min of treatment, 5-fluorouridine (FU) was 
added to the final 2 mM and the cells were incubated for 30 min. Then the cells were washed, 
fixed, permeabilized and FU incorporated into the nascent RNA transcripts was detected with 
anti-BrdU antibody as described (Boisvert et al. 2000; Casafont et al. 2006; So et al. 2010; 
Kalendova et al. 2014). As the controls, buffer only or mutated PLC(R40A), or BSA, or 
inactivated by heating PLC were used. Images were acquired using IX81 high-throughput 
wide-field microscope with objective UPLSAPO 40x/0.90 oil (Olympus Corporation, Tokyo, 
Japan). SCAN-R automated image and data analysis software was used for capturing and 
analysing the images. Images were captured as 1 µm z-stacks with 200 nm z-step. For the 
analysis, DAPI channel was used to determine the nuclear area and Son channel was used to 
determine the nuclear speckles area. Total intensity of fluorescence was calculated from 
maximal projection image for each z-stack in PIP2 channel and FU channel separately. 1500 
treated cells were analyzed. Fluorescence intensity in each channel and the area of PIP2 islets 
were calculated as a result of the subtraction of the corresponding parameter for the nuclear 
speckles from this parameter for the whole nucleus. Results are presented as the intensity of 
fluorescence per unit area (mean ± standard deviation). The statistical significance was 
determined using the F-test two-sample for variances followed by the t-test: two-sample 
assuming (un-)equal variances. 
H1299 cells were treated for 1 h with 0.04 µg/ml AMD. After 30 min of treatment, cells 
were incubated for 30 min with 2 mM FU under standard conditions. After this time period, 
cells were washed, fixed, and permeabilized. FU incorporated into nascent transcripts was 
detected using anti-BrdU antibody and fluorescence intensity was measured and quantified as 
described above. 
 
Nuclear extract fractionation and dot blot analysis 
HeLa nuclear extracts were fractionated by discontinuous sucrose gradient 
ultracentrifugation method, adapted from (Marmor and Julius 2001). Nuclei from suspension 
HeLa cells were prepared as described previously (Trinkle-Mulcahy et al. 2008). Clean nuclei 
were extracted by TKM buffer (50 mM Tris pH 7.4, 25 mM KCl, 5 mM MgCl2, 1 mM 
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EDTA, 0.5% Brij 98, EDTA-free protease inhibitor), sonicated 3x10 sec on ice, and 
centrifuged for 5 min at 16 000 g. 250 μl of nuclear extract was mixed with the same amount 
of 80% sucrose in TKM buffer and placed at the bottom of the tube. Samples were 
sequentially overlaid with 4.3 ml of 36% and 0.2 ml of 5% sucrose solution to a total volume 
of 5 ml. The mixture was subjected to equilibrium density gradient centrifugation at 50000 
rpm for 18 h at 4 C in a MLS50 rotor (Beckman Coulter, Fullerton, CA). 200 μl from each of 
the collected fractions were spotted on a nitrocellulose membrane and probed for PIP2. To 
identify the protein composition, 20 µl of each fraction was resolved by SDS-PAGE, 
transferred onto a nitrocellulose membrane and immunoprobed with the respective antibody. 
 
Pull-down assay and co-immunoprecipitation 
 
Nuclei from suspension HeLa cells were prepared as described previously (Trinkle-
Mulcahy et al. 2008). Pure nuclei were extracted using RIPA buffer (50 mM Tris pH 8, 150 
mM NaCl, 0.5% NP-40, complete protease inhibitors (Roche)), sonicated and spun at 16000 g 
for 15 min. Clear lysate was incubated with pre-equilibrated PI(4,5)P2-coated agarose beads 
(Echelon Biosciences) for 2 h at 4 °C. Beads were then washed three times with RIPA. Bound 
proteins were eluted by boiling in Laemmli buffer, separated by SDS-PAGE, and detected by 
subsequent immunoblotting. 
 H1299 stable cell lines were lysed in lysis buffer (20 mM HEPES pH 8, 150 mM NaCl, 
0.5 % Triton X-100, complete protease inhibitors, PhosStop phosphatase inhibitors (both 
Roche)). Lysate was sonicated and cleared by centrifugation at 16000 g for 15 min. Clear 
lysate was incubated with pre-equilibrated anti-Flag-M2 agarose beads (Sigma-Aldrich) for 2 
h. After three washes with lysis buffer, bound proteins were processed as described above. 
 
Antibodies 
Primary antibodies: anti-PIP2 mouse monoclonal IgM antibody (Echelon Biosciences 
Inc., clone 2C11, Z-A045, 5-10 μg/ml for SIM and STED, 10 μg/ml for TEM); anti-PIP2 
mouse monoclonal IgM antibody (Abcam, clone 2C11, 2 μg/ml for dot blot); anti-H3K9me2 
rabbit polyclonal IgG antibody (Merck Millipore, 17-648, 1:300 for SIM and STED); anti-
H3K4me2 rabbit polyclonal IgG antibody (Merck Millipore, 07-030, 1:300 for SIM and 
STED); anti-bromodeoxyuridine mouse IgG1 antibody (Roche, clone BMC9318, 
11170376001, 4 µg/ml for SIM, 20 µg/ml for TEM); anti-bromodeoxyuridine (Sigma-
Aldrich, clone BU-33, B8434, 8.8 µg/ml for SCAN-R); anti-histone H1 mouse monoclonal 
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IgG2a antibody (Abcam, clone AE-4, ab71594, 10 µg/ml for SIM); anti-Son rabbit polyclonal 
IgG antibody (Abcam, ab121759, 1 µg/ml for SIM); anti-RNA Pol II CTD rabbit polyclonal 
IgG antibody (Abcam, ab26721, 6 µg/ml for SIM); anti-RNA Pol II CTD S2 rabbit polyclonal 
IgG antibody (Abcam, ab24758, 4 µg/ml for western blot); anti-TFIID (TBP) rabbit 
polyclonal IgG antibody (Santa Cruz, sc-204, 2 µg/ml for SIM); anti-His mouse monoclonal 
IgG2a antibody (Sigma, H1029, 0.4 µg/ml for western blot); anti-NM1 antibody (Sigma-
Aldrich, M3567, 1 µg/ml for western blot), anti-flag antibody (Stratagene, clone M2, 200471, 
0.4 µg/ml for western blot and 20 µg/ml for TEM). 
Secondary antibodies: goat anti-mouse IgM (μ-chain specific) antibody conjugated with 
Alexa Fluor 555 (Invitrogen, A21426, 5 μg/ml for SIM and SCAN-R); goat anti-mouse IgG 
(Fcγ fragment specific) antibody conjugated with DyLight 488 (Jackson, 115-485-008, 1:100 
for SIM and SCAN-R); goat anti-rabbit IgG (H+L) antibody conjugated with Alexa Fluor 647 
(Invitrogen, A21245, 5 μg/ml for SIM and SCAN-R); donkey anti-rabbit IgG (H+L) antibody 
conjugated with Alexa Fluor 488 (Invitrogen, A-21206, 5 μg/ml for SIM); donkey anti-human 
IgG (H+L) antibody conjugated with Cy5 (Jackson, 709-175-149, 1:50 for SIM); goat anti-
rabbit IgG (H+L) antibody conjugated with TMR (Invitrogen, T-2769, 5 μg/ml for STED); 
goat anti-mouse IgG (H+L) antibody conjugated with Alexa Fluor 532 (Invitrogen, A-11002, 
5 μg/ml for STED); IRDye 680 donkey anti-mouse IgG (H+L) antibody (LI-COR 
Biosciences; 926-68072, 1:20000 for western blotting); IRDye 800 donkey anti-rabbit IgG 
(H+L) antibody (LI-COR Biosciences; 925-32213, 1:20000 for western blotting); goat anti-
mouse IgM (μ-chain specific) antibody coupled with 12 nm colloidal gold particles (Jackson 
ImmunoResearch Laboratories Inc., 115-205-075, for TEM); goat anti-mouse IgM (μ-chain 
specific) antibody coupled with 6nm colloidal gold particles (Jackson ImmunoResearch 
Laboratories Inc., 115-195-075, for TEM); goat anti-mouse IgG (Fcγ fragment specific) 
antibody coupled with 6 nm colloidal gold particles (Jackson ImmunoResearch Laboratories 
Inc., 115-195-071, for TEM); all gold-conjugated secondary antibodies were diluted 1:30. 
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Figure 1. Nucleoplasmic PIP2 appears as small roundish structures, which colocalize 
with nascent RNA and proteins involved in Pol II transcription. (a, b) Immunofluorescent 
labeling followed by SIM demonstrates that nucleoplasmic PIP2 forms small foci and 
colocalizes with both nascent RNA transcripts (BrRNA) and C-terminal domain of Pol II (Pol 
II CTD) as well as TATA-box binding protein (TBP) of the Pol II general transcription factor 
TFIID (TFIID TBP). This colocalization is supported by intensity profiles. General view: bar 
is 5 µm; magnified view corresponds to the area outlined by white rectangle, bar is 1 µm. (c) 
Manders’ colocalization coefficients and Pearson’s correlation coefficient, presented as mean 
± standard deviation, illustrate colocalization between BrRNA and PIP2, *p value ≤ 0.05. (d) 
Cells transiently transfected with truncated form of NM1 fused to flag-tag (NM1(HDL)-flag) 
were processed for TEM and double labeled with anti-flag and anti-PIP2 antibodies. TEM 
showed more accurately that these PIP2 foci are roundish structures of 40-100 nm in size and 
revealed presence of NM1 at the periphery of these structures. Based on their roundish shape 
and size, we refer to them as PIP2 islets. Bar is 200 nm. Graph shows that PIP2 molecules and 
NM1 are colocalized at the distance of 25 – 75 nm (PCCF > 1, **p value ≤ 0.01). 
 
Figure 2. NM1 associates with PIP2 islets and is anchored in nucleoplasm by PIP2. (a) 
NM1 was pulled-down with PIP2-coupled agarose beads from the nuclear extract and 
detected by immunoblotting. (b) Direct binding of NM1 to PIP2 was confirmed by incubation 
of recombinant wild-type NM1-flag and its PIP2-binding mutant NM1(K908A)-flag with 
PIP2 spotted on a nitrocellulose membrane. Recombinant NM1-flag and NM1(K908A)-flag 
were immunodetected by anti-flag antibody. (c) Mobility of NM1-EGFP significantly 
increases after mutation in PIP2-binding site (K908A), as measured by FRAP. Mobility of 
NM1-EGFP increases when nuclear PIP2 is converted to PI4P by inositol 5-phosphatase. 
When nuclear PIP2 is hindered by the binding of PLCδPH domain, NM1-EGFP mobility 
increases. As a control, PLCδPH domain with R40A mutation, which disables its binding to 
PIP2, was used. Results are presented as mean ± standard deviation, ***p value ≤ 0.001. (d) 
Nuclei extracted by Brij98 were subjected to a flotation on a sucrose density gradient. Nuclear 
extract was placed to the bottom of the gradient. After centrifugation, fractions were subjected 
to SDS-PAGE, transferred to a nitrocellulose membrane and immunodetected for the presence 
of NM1. To detect PIP2, fractions were spotted on a nitrocellulose membrane and labeled 
with anti-PIP2 antibody. Both NM1 and PIP2 are present in the light fraction 1 containing 
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detergent-insoluble lipoprotein complexes and also in the heavy fraction 10 composing of 
soluble complexes. 
 
Figure 3. PIP2-NM1 interaction and integrity of PIP2 islets are important for Pol II-
dependent transcription. (a) Cells stably expressing NM1-flag or NM1(K908A)-flag were 
prepared, lysed and subjected to the co-immunoprecipitation by anti-flag antibody. 
Immunoprecipitates were analyzed by anti-Pol II CTD S2 and anti-flag antibodies. (b) By 
shRNA-mediated knock-down, we generated stable cell line with decreased expression of 
NM1. On top of that, we further introduced NM1-flag, or NM1(K908A)-flag. As a control, 
cell line expressing non-targeting shRNA was used. (c) We monitored Pol II transcription 
level in these cell lines by short-pulse labeling of nascent transcripts with FU. We 
immunolabeled FU with anti-BrdU antibody and quantified intensity of the signal by indirect 
high-throughput immunofluorescent microscopy. Data are related to the control value and 
presented as mean ± standard deviation. (d) For PIP2 hydrolysis, cells were slightly 
permeabilized and incubated with PLC. As a control, cells were incubated with either 
PLC(R40A), which is unable to bind PIP2, or heat-inactivated PLC, or BSA, or buffer only. 
After 30 min, FU was added to the cells. FU as well as PIP2 were visualized and quantified as 
described above in (c). Data are related to the control value and presented for PIP2 islets area 
as mean ± standard deviation, *p value ≤ 0.05, **p value ≤ 0.01, ***p value ≤ 0.001, ****p 
value ≤ 0.0001. (e) Cells were incubated with BrUTP as a labeled precursor for the RNA 
synthesis. Cells were processed for TEM and double labeled with anti-BrdU and anti-PIP2 
antibodies. We clearly showed that PIP2 molecules form the roundish islets colocalized at 
their periphery with nascent RNA transcripts. Bar is 100 nm. (f) The scheme shows PIP2 islet 
and neighbouring BrRNA over the distance, where their colocalization is significant. Graph 
represents the colocalization between PIP2 molecules and BrRNA at the distance of 25 – 75 
nm (PCCF > 2, **p value ≤ 0.01). (g) Graph shows the relative colocalization of BrRNA and 
PIP2 molecules (BrRNA/PIP2) and vice versa (PIP2/BrRNA) as mean ± standard deviation 
(***p value ≤ 0.001). (h) Upon the inhibition of Pol II transcription with α-amanitin, the 
appearance and the quantity of PIP2 islets per µm2 were not significantly changed as 
compared to the control. Bar is 100 nm. (i) Graph shows PIP2 islets quantity per µm2 in the 
nuclei of control cells and cells treated with α-amanitin as mean ± standard devaition, nsp 




Figure 4. PIP2 islets are chromatin-independent structures. Immunofluorescent 
labeling followed by SIM reveals that under isotonic conditions, PIP2 islets overlap with 
histone H1 (a). Under hypertonic conditions (final salt concentration 300 mM, 15 min), PIP2 
islets minimally overlap and do not significantly colocalize with histone H1 (b). After 3 min 
of rescue under isotonic conditions, chromatin decondenses and PIP2 islets colocalize with 
histone H1 (c). General view: bar is 5 µm; magnified view corresponds to the area outlined by 
white rectangle, bar is 200 nm. These observations are supported by the intensity profiles, 
Manders’ colocalization coefficients (d) and Pearson’s correlation coefficient (e) in PIP2 
islets area. (f) The volumes of chromatin and PIP2 islets related to the nuclear volume 
(relative volumes) under different experimental conditions. The left y-axis represents the 
percentage of histone H1, the right y-axis represents the percentage of PIP2. The values in (d-
f) are presented as mean ± standard deviation (**p value ≤ 0.01, ***p value ≤ 0.001). 
 
Figure 5. PIP2 islets are resistant to DNase treatment and are RNA-associated 
structures. Immunofluorescent labeling followed by SIM demonstrates that treatment of cells 
with 250 U/ml DNase for 30 min (b) has no significant effect on the arrangement of PIP2 
islets as compared to control (a). Cells treated with 1 mg/ml RNase for 30 min display almost 
complete disappearance of PIP2 islets labeling (c). General view: bar is 5 µm; magnified view 
corresponds to the area outlined by white rectangle, bar is 200 nm. (d) Ultrathin sections were 
first labeled with anti-PIP2 antibody followed by secondary antibody conjugated with 6 nm 
gold nanoparticles. Then sections were labeled with RNase conjugated with 10 nm gold 
nanoparticles. TEM demonstrates that RNA molecules are located on the surface of PIP2 
islets; bar is 100 nm. Graph shows the relative colocalization of RNA with PIP2 molecules 
(RNA/PIP2) and vice versa (PIP2/RNA) as mean ± standard deviation (***p value ≤ 0.001). 
 
Figure 6. Morphology, composition and distribution of PIP2 islets. (a) PIP2 was 
visualized with anti-PIP2 antibody and z-stack was acquired using SIM. Nuclear PIP2 
labeling was reconstructed in 3D and shown here as 2D maximum intensity projection image: 
N – nucleus, NS – nuclear speckles, NL – nucleolus; bar is 1 µm. Distribution of PIP2 in 
nuclear speckles, nucleoli, and nucleoplasm was calculated in 3D and color-coded using the 
software NIS-Elements and MATLAB. Color-coded original 2D image and diagram are 
shown below: nuclear speckles are in yellow, nucleoplasm is in red, nucleolar PIP2 is in blue. 
(b) TEM image of nuclear PIP2 labeling on the surface of ultrathin section. Abbreviations and 
color-coding are the same as in (a). Roundish PIP2 islets of 40-100 nm are shown below in 
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magnified view. Mapping was done using the commercially available software Ellips with the 
additionally installed software Gold plugins (Philimonenko et al. 2000; Schofer et al. 2004). 
General view: bar is 1 µm, magnified view: bar is 100 nm. (c) Ultrathin sections were first 
labeled with anti-PIP2 antibody and further subjected to elemental mapping by EELS; bar is 
100 nm. (d) Mapping of the presence of nitrogen and phosphorus in PIP2 islets. (e, f) 
Magnified view of (d) shows PIP2 islet surrounded by nitrogen (e) and phosphorus (f); bar is 
100 nm. The inner part of PIP2 islet appears to be devoid of them both. (g) Carbon mapping 
shows the inner space of PIP2 islet enriched with carbon-rich compounds; bar is 100 nm. (h, 
i) Immunofluorescent labeling followed by SIM reveals that PIP2 islets partially overlap with 
either histone H3K4me2 enriched in transcriptionally active genes (h) or histone H3K9me2 
which is a heterochromatic marker (i) as confirmed by intensity profiles. General view: bar is 
5 µm; magnified view corresponds to the area outlined by white rectangle: bar is 200 nm. 
 
Supplementary Figure 1. The purity of recombinant PLC. Expressed and purified His-
tagged PLC was detected in the eluted fraction using Coomassie staining and western blotting 
(WB) with anti-His antibody.   
 
Supplementary Figure 2. The activity of RNase-gold complex and its specificity of 
labeling. (a) The enzymatic activity of RNase after the conjugation with gold nanoparticles 
was assessed using in vitro incubation with RNA followed by agarose gel electrophoresis; 
lane 1 – input RNA, lane 2 – RNA treated with RNase before conjugation, lane 3 – RNA 
treated with unbound RNase after conjugation, lane 4 – RNA treated with RNase-gold 
complex, lane 5 – marker. Cleaved 28 S (arrow) and 18S RNA (arrowhead) proves the 
activity of the complex. (b) The labeling specificity of RNase-gold complex was tested by 
TEM. Prior to labeling, RNase-gold complex was in vitro presaturated with RNA. This 
mixture was then used for the labeling of the sections. Apparent depletion of labeling proves 
the specificity of labeling by the RNase-gold complex. General view: bar is 200 nm; 
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Abstract 
Phosphoinositides (PIs) are negatively charged glycerol-based phospholipids. Their inositol head that 
can be reversibly phosphorylated at three positions generating 7 differently phosphorylated PIs. 
Approximately 15% of PIs localize to the nucleus. Nuclear PIs are implicated in essential nuclear 
processes as DNA damage response, and pre-rRNA and pre-mRNA processing. Moreover, they 
regulate DNA transcription either by interaction with RNA polymerases and transcription factors or 
by regulation of chromatin remodelling and modifications. 
Phosphatidylinositol 4-phosphate (PI(4)P) is one of the most abundant PIs species. Although 
it can be actively metabolized within the nucleus, its nuclear functions are completely unknown. In 
this study, we show that PI(4)P is present in nuclear membrane, localizes to nuclear speckles and 
forms small nucleplasmic foci. The majority of PI(4) is associated with active chromatin. Lysine-
specific histone demethylase 1 (LSD1), which demethylates H3K4me2 and H3K4me1, binds with the 
highest affinity to PI(4)P and binds also PI(3,4)P2, PI(3,5)P2, PI(4,5)P2 and PI(3,4,5)P3. While in a 
complex with PI(4)P, the activity of LSD1 is inhibited. On the other hand, the interaction with 
PI(4,5)P2 stimulates LSD1 demethylase activity in vitro. Since PI(4,5)P2 is a precursor/product of 
PI(4)P (de)phosphorylation, a single change in phosphorylation of inositol ring could provide a rapid 









Phosphoinositides (PIs) are negatively charged glycerol-based phospholipids. They consist of 
hydrophobic acyl tail and hydrophilic inositol head that can be reversibly phosphorylated at 3’, 4’, 
and 5’ positions generating 7 differently phosphorylated PIs. Approximately 15% of PIs localize to the 
nucleus. Some PIs species associate with nuclear membrane however a large fraction of PIs occupies 
discrete nuclear domains (Vann et al. 1997), such as interchromatin and chromatin regions and 
nucleoli (Mazzotti et al. 1995; Boronenkov et al. 1998; Gillooly et al. 2000; Osborne et al. 2001; Watt 
et al. 2002; Lindsay et al. 2006; Hammond et al. 2009; Yildirim et al. 2013). 
In agreement with their diverse nuclear localization, PIs display diverse nuclear functions. 
Nuclear PIs are implicated in cell differentiation, DNA damage response, apoptosis (Bertagnolo et al. 
1999; Tanaka et al. 1999; Gozani et al. 2003; Ahn et al. 2004; Ahn et al. 2005; Jones et al. 2006; Zou 
et al. 2007; Li et al. 2012; Bua et al. 2013). They regulate pre-rRNA and pre-mRNA processing as well 
as DNA transcription (Osborne et al. 2001; Mellman et al. 2008; Okada et al. 2008; Wickramasinghe 
et al. 2013; Yildirim et al. 2013). PIs interact with both RNA Pol I and II (Osborne et al. 2001; Toska et 
al. 2012; Sobol et al. 2013; Yildirim et al. 2013) and regulate recruitment and activity of transcription 
factors (Toska et al. 2012; Blind et al. 2012; Yildirim et al. 2013; Stijf-Bultsma et al. 2015). 
In addition, PIs can regulate gene expression also at epigenetic level. PI(4,5)P2 interacts with 
transcriptional co-repressor BASP1, facilitates BASP1 interaction with histone deacetylase 1 (HDAC1) 
and target BASP1-HDAC1 complex to chromatin (Toska et al. 2012). PI(4,5)P2 also interacts with 
SWI/SNF-like BAF remodelling complex and facilitates its association with chromatin during T cell 
activation (Rando et al. 2002). PI(5)P allosterically modulates ubiquitin-like PHD and RING finger 
domain-containing protein 1 (UHFR1), which can switch between two different histone binding 
modes. In absence of PI(5)P interaction, UHFR1 binds to unmodified histone H3 and recruits histone 
methyltransferases to establish heterochromatin marks. Upon PI(5)P binding, UHFR1 recognizes 
H3K9me3 and maintains heterochromatin state (Gelato et al. 2014). 
Recently, we have detected nuclear PI(4)P by a specific anti-PI(4)P antibody (Kalasova et al. 
2016). In the nucleus, PI(4)P can be formed by two different pathways. First, phosphatidylinositol (PI) 
is phosphorylated to PI(4)P by PI4Kα and PI4Kβ kinases (de Graaf et al. 2002; Strahl et al. 2005; Szivak 
et al. 2006; Kakuk et al. 2006). Second, PI(3,4)P2 and PI(4,5)P2 are dephosphorylated to PI(4)P by 
PTEN and SHIP phosphatases, respectively (Lachyankar et al. 2000; Gimm et al. 2000; Déléris et al. 
2003; Lindsay et al. 2006; Elong Edimo et al. 2011; Nalaskowski et al. 2012; Ehm et al. 2015). These 
enzymes often localize to nuclear speckles (Boronenkov et al. 1998; Déléris et al. 2003; Szivak et al. 
2006; Mellman et al. 2008; Elong Edimo et al. 2011) and nucleoli (Kakuk et al. 2006; Kakuk et al. 
2008). Although PI(4)P is one of the most abundant nuclear PIs (Viaud et al. 2015)(Viaud et al. 2015), 
its role in the nucleus remains completely unknown. 
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In this study, we investigate localization and function of nuclear PI(4)P. We show that PI(4)P 
is present in nuclear membrane, localizes to nuclear speckles and forms small nucleoplasmic foci. 
Only a minority of nuclear PI(4)P resides in nuclear speckles. The majority localizes to other nuclear 
compartments and is associated with active chromatin. Lysine-specific histone demethylase 1 (LSD1), 
which demethylates H3K4me2 and H3K4me1 (Shi et al. 2004), interacts directly with PI(4)P, 
PI(3,4)P2, PI(3,5)P2, PI(4,5)P2 and PI(3,4,5)P3 but displays the highest affinity to PI(4)P. We 
demonstrate that the interaction with PI(4)P inhibits LSD1 in vitro. On the other hand, the interaction 
with PI(4,5)P2 stimulates LSD1 H3K4me2 demethylase activity. Since PI(4,5)P2 is a precursor/product 
of PI(4)P (de)phosphorylation, a single change in phosphorylation of inositol ring could provide rapid 
regulation of LSD1 function. 
 
Results 
PI(4)P localizes to nuclear membrane, nuclear speckles and nucleoplasm  
We have previously detected PI(4)P in nuclei of U2OS cells (Kalasova et al. 2016). Here, we 
investigate PI(4)P localization in greater detail by stimulated emission depletion (STED) super-
resolution microscopy. We show that PI(4)P is present in the nuclear membrane (Fig. 1a, insets), 
where it colocalizes with lamin A/C (Fig. 1a, arrowheads). In the nucleoplasm, PI(4)P localizes to 
nuclear speckles, where it colocalizes with Sm (Fig. 1b, upper inset) and Son (Fig. 1c, insets), nuclear 
speckles markers. Graphs show intensities of PI(4)P and Sm (Fig. 1b, right) or Son (Fig. 1c, right) 
signals along lines depicted in respective insets. The distribution of nuclear speckles-associated PI(4)P 
is not uniform, it rather forms foci inside of nuclear speckles (Figs. 2b,c, insets). Besides, bright foci of 
PI(4)P are often present at the edges of nuclear speckles (Fig. 2c, insets arrowheads), where the 
active transcription takes place (Spector and Lamond 2011). Although PI(4)P localizes to nuclear 
speckles, it does not localize to Cajal bodies, it rather forms foci around them (Fig. 1b, lower inset, 
arrowheads). 
PI(4)P forms discrete foci dispersed throughout the nucleoplasm, which do not colocalize 
with any nuclear marker tested (Fig. 1). To determine the proportion of PI(4)P in nuclear speckles 
versus other nuclear regions, we performed high throughput microscopy and quantification of PI(4)P 
and Son labelled cells (Fig. 1d). We show that only 8 % of PI(4)P resides in nuclear speckles whereas 
92 % of PI(4)P localizes outside of nuclear speckles, in other nuclear regions. Therefore, we believe 
that although PI(4)P is associated with nuclear speckles, its major roles are linked to processes 
outside of nuclear speckles.  
PI(4)P associates with active chromatin. 
To examine PI(4)P distribution, we fractionated cells into cytoplasm, soluble nuclear fraction, 
and chromatin-bound nuclear fraction (Fig. 1e). Following fractionation, an equal volume of each 
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fraction was spotted on a nitrocellulose membrane and loaded on SDS-PAGE. The purity of fractions 
was assayed by western blotting with specific cytoplasmic and nuclear markers, GAPDH and H3, 
respectively. PI(4)P was detected by a specific antibody (Fig. 3c, left). We show that approximately 
7.3 ± 1.4 % of nuclear PI(4)P is in the soluble fraction while 92.7 ±1.4 % of PI(4)P is associated with 
chromatin (Fig. 1e, right). 
To further investigate chromatin associated pool of PI(4)P, we performed colocalization with 
H3K4me2 (Fig. 2a) and H3K9me2 (Fig. 2b) markers of active and inactive chromatin, respectively. The 
values of Spearmans’ coefficients show that PI(4)P partially colocalizes with H3K4me2 but not with 
H3K9me2 (Fig. 2c). Insets with details of PI(4)P and H3K4me2 signals are provided (Fig. 2a, insets). 
Graphs display intensities of PI(4)P and H3K4me2 signal along lines depicted in respective insets and 
overlapping peaks are marked with asterisks (Fig. 2a, right). Based on these results, we conclude that 
PI(4)P preferentially associates with active chromatin. 
 
LSD1 is a general PIs interactor with the highest affinity for PI(4)P. 
Since a pool of PI(4)P colocalizes with H3K4me2 (Figs. 3a,c), we searched for PI(4)P binding 
partners among  proteins that establish, remove or bind H3K4me2. LSD1 is a histone demethylase, 
which demethylates H3K4me2 and H3K4me1 methylation marks (Shi et al. 2004) and was therefore 
one of the proteins we tested. 
First, we performed pull-down experiments with agarose beads coupled to P(4)P and 
PI(4,5)P2 from HeLa nuclear extract. This initial experiment shows that LSD1 interacts with PI(4,5)P2 
but not with PI(4)P in nuclear extracts (Fig. 3a). To test whether LSD1 interacts with PI(4,5)P2 directly, 
we incubated purified LSD1 coupled to GST (GST-LSD1) with beads coupled to all PIs, 
phosphatidylinositol (PI) and empty agarose beads as a control (C; Fig. 3b). The graph shows intensity 
of each band normalized to the signal from empty agarose beads (Fig. 3c). Surprisingly, purified GST-
LSD1 interacts mostly with PI(4)P and binds also to PI(3,4)P2, PI(3,5)P2, PI(4,5)P2 and PI(3,4,5)P3 (Fig. 
3b). Moreover, we observed that GST-LSD1 directly binds PI. Because the inositol ring of PI is not 
phosphorylated, we think that LSD1 probably contains two separate binding sites, one for 
phosphorylated PIs and another for PI. 
These results show that although LSD1 is not pulled-down by PI(4)P from nuclear extract, it is 
able to bind PI(4)P directly. Since PI(4)P and PI(4,5)P2 are the most abundant PIs species (Viaud et al. 
2015), we focused on the role of these PIs in LSD1 function. 
 
LSD1 mutated in R310 and R312 does not bind PI(4)P. 
In order to identify LSD1 PIs-binding site, we prepared 3 LSD1 truncations (Fig. 3d, top). The 
N-terminal truncation (1 - 297; LSD1-A) contains SWI3/RSC8/MOIRA (SWIRM) domain, the central 
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truncation (297 – 596; LSD1-B) contains N-terminal amino-oxidase domain (AOD), Tower domain and 
a short part of C-terminal AOD domain, and the C-terminal truncation (596 – 852; LSD1-C) contains 
the rest of the C-terminal AOD domain. We incubated these truncated forms with PI(4)P-coupled 
beads and compared the signal to the signal from empty agarose beads. We show that only GST-
LSD1-B was enriched in PI(4)P pull-down (Fig. 3d, bottom). Therefore, the PI(4)P binding site is 
probably located in the central part of LSD1. 
LSD1 does not possess any canonical PIs-binding domain or motif. In order to locate PIs-
binding site, we used crystal structure of LSD1 (pdb2dw4), which was solved at 2.3 Å resolution 
(Mimasu et al. 2008). The positions of LSD1 truncated forms within full-length LSD1 are depicted in 
the model (Fig. 3e, left). LSD1-B is shown in yellow and positively charged amino acids, which could 
bind to negatively charged PIs, are highlighted in red (Fig. 3e, left). We inspected all positively 
charged residues within LSD1-B and compared their distances using PyMol software. We identified 
three arginine residues (R310, R312 and R316) with their side chains close enough (from 4.4 to 10.7 
Å) to form a PIs binding pocket (Fig. 3e, inset). These residues are located in the N-terminal part of C-
terminal AOD domain. 
We prepared four different mutant GST-LSD1-B domains, which have positively charged 
arginine replaced by negatively charged glutamic acid residues (R310E, R310E, RR310,312EE and 
R316E). We purified these truncated forms and tested their PI(4)P binding ability in pull-down 
experiments. All four GST-LSD1-B mutants lost their binding towards PI(4)P (Fig. 3f). 
To test whether mutation of the putative binding site affects PI(4)P binding by the whole 
protein, we prepared wild-type full-length LSD1 (LSD1-WT) and full-length LSD1 bearing RR310,312EE 
mutation (LSD1-MUT). We overexpressed LSD1-WT and LSD1-MUT fused with Flag-tag (Flag-LSD1-WT 
and Flag-LSD1-MUT) in HEK293 cells. Subsequently, we immunoprecipitated Flag-LSD1-WT and Flag-
LSD1-MUT complexes (Fig. 3g, left) and assayed them for the presence of PI(4)P. We show that after 
overexpression, Flag-LSD1-WT forms a complex with PI(4)P in HEK293 cells. Moreover, double-
mutation of R310 and R312 disturbs the interaction of the full-length LSD1 with PI(4)P (Fig. 3g, right). 
 
PI(4)P and PI(4,5)P2 have opposing effects on LSD1 H3K4me2 demethylase activity. 
To test PIs role in LSD1 function, we performed in vitro demethylation reaction. We prepared 
HEK293 cells stably expressing Flag-LSD1 and used this cell line for purification of the Flag-LSD1. The 
Flag-eluate was analyzed by SDS-PAGE and western blotting with antibodies against Flag-tag and 
CoREST (Fig. 4a). Interaction with CoREST corepressor is essential for LSD1 function (Amente et al. 
2013). We show that CoREST (Fig. 4a, asterisks) is co-purified with Flag-LSD1 (Fig. 4a, arrows). 
We preincubated Flag-LSD1 complex with increasing amounts of PI(4)P or PI(4,5)P2. 
Subsequently, we used these complexes for in vitro demethylation reaction with bulk histones (Fig. 
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4b). The intensity of H3K4me2 bands normalized to H3 signal is shown in the graph as percentage of 
normalized H3K4me2 signal in the input (Fig. 4b, bottom). The incubation of mock treated Flag-LSD1 
results in a decrease of H3K4me2 to cca 80%. Pre-incubation of Flag-LSD1 with PI(4)P abolishes its 
H3K4me2 demethylase activity completely. However, pre-incubation of Flag-LSD1 with PI(4,5)P2 
stimulates LSD1 activity and decreases H3K4me2 signal to cca 60 %. These results show that the 
activity of LSD1 in a complex with PI(4)P is inhibited. On the other hand, binding of PI(4,5)P2 
stimulates LSD1H3K4me2 demethylase activity in vitro. Since the PI(4)P and PI(4,5)P2 can be easily 
interconverted by nuclear kinases or phosphatases, this mechanism could provide a very rapid 
regulation of LSD1 function and H3K4me2 level within the nucleus. 
 
Discussion 
PI(4)P is formed and metabolized in the nucleus (Vann et al. 1997; Clarke et al. 2001) by 
different nuclear kinases and phosphatases (Lachyankar et al. 2000; Gimm et al. 2000; Déléris et al. 
2003; Lindsay et al. 2006; Elong Edimo et al. 2011; Nalaskowski et al. 2012; Ehm et al. 2015). 
However, its exact nuclear localization and function was unknown. Here, we show that nuclear PI(4)P 
localizes to nuclear membrane and nuclear speckles but not to Cajal bodies and it forms small foci in 
nucleoplasm and nucleoli (Fig. 1). 
Nuclear speckles are highly dynamic structures enriched in splicing factors. They contain little 
or no DNA but they are often surrounded by actively transcribed chromatin. Electron microscopy 
revealed that nuclear speckles are composed of small granules connected by thin fibrils (Spector and 
Lamond 2011). When we closely examined PI(4)P pool in nuclear speckles, we observed that PI(4)P 
distribution is not homogenous. PI(4)P indeed forms small foci inside of nuclear speckles (Fig. 1b,c). 
Remarkably, PI(4)P also forms bright foci at the edges of nuclear speckles (Fig. 1c), where the active 
transcription takes place (Spector and Lamond 2011). PI(4,5)P2 and also enzymes, which convert 
PI(4,5)P2 to PI(4)P and vice versa, localize to nuclear speckles (Boronenkov et al. 1998; Déléris et al. 
2003; Mellman et al. 2008; Schill and Anderson 2009; Elong Edimo et al. 2011). Therefore, it is 
possible that PI(4)P serve as a precursor and enables rapid formation of PI(4,5)P2 in nuclear speckles. 
On the other hand, cytoplasmic PI(4)P alone is an important signalling molecule and displays 
functions that are independent on PI(4,5)P2(Hammond et al. 2009). It is therefore possible that also 
PI(4)P in nuclear speckles has its unique roles in DNA transcription and pre-mRNA processing.  
We show that only about 8 % of nuclear PI(4)P resides in nuclear speckles whereas 92 % 
localizes to other nuclear compartments (Fig. 1d) and that majority of nuclear PI(4)P is associated 
with chromatin (Fig. 1e). Small nucleoplasmic foci of PI(4)P partially colocalize with H3K4me2, a mark 
of active chromatin (Fig. 2a,c). Since PI(4)P localizes to active chromatin and forms foci at the edges 
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of nuclear speckles (Fig. 1c), where the active transcription takes place (Spector and Lamond 2011), 
we suggest that PI(4)P might be implicated in regulation or maintenance of active transcription. 
Further, we searched for proteins that recognize or regulate H3K4me2 level in cells. We 
focused on LSD1 histone demethylase that demethylates H3K4me2 and H3K4me1 histone 
methylation marks (Shi 2004). Although LSD1 binds PI(4,5)P2 but not PI(4)P in nuclear extract (Fig. 
3a),  it directly interacts with PI(4)P, PI(3,4)P2, PI(3,5)P2, PI(4,5)P2 and PI(3,4,5)P3. Among these PIs, 
LSD1 displays the highest affinity to PI(4)P (Fig 3b,c). Interestingly, we found that LSD1 forms a 
complex with PI(4)P after overexpression. Mutation of two positively charged residues in the C-
terminal AOD domain (R310 and R312) abolishes LDS1-PI(4)P interaction. Subsequently, we tested 
whether PI(4)P binding affects LSD1 activity. Using in vitro demethylation assay, we show that while 
LSD1 is in a complex with PI(4)P, its activity is inhibited. On the other hand, preincubation with 
PI(4,5)P2 stimulates LSD1 activity towards H3K4me2 (Fig. 4e). The mechanism how PIs regulate LSD1 
function is currently unclear. However, it has been shown that a single change in phosphorylation of 
inositol ring can regulate affinity of a PIs-interacting protein to its binding partners (Blind et al. 2012). 
AOD domain is catalytically active domain and binding of PI(4)P or PI(4,5)P2 could alter its 
conformation and regulate its affinity for the histone substrate. Another possibility is that PIs 
regulate LSD1 interaction with other proteins in LSD1 complex. Since LSD1 has neither DNA nor 
histone binding domain, LSD1 function is highly dependent on its interacting partners (Baron and 
Vellore 2012). Therefore, a single phosphorylation of PI(4)P or dephosphorylation of PI(4,5)P2  by 
particular kinases or phosphatases could provide rapid and dynamic regulation of LSD1 function also 
in vivo. 
 
Materials and methods 
Cell cultures and transfection 
U2OS, HEK293 and HeLa cells were cultured in D-MEM supplemented with 10 % FBS in 5 % 
CO2/air, 37 °C and humidified atmosphere. Suspension HeLa cells were cultured in S-MEM 
supplemented with 5 % FBS in 5 % CO2/air, 37 °C and humidified atmosphere. Plasmid transfection 
was performed using Lipofectamine 2000 (Invitrogen) according to manufacturer’s protocol. Stable 
cell lines were established using G-418 (LifeTechnologies; 500 μg/ml). 
Constructs 
GST-LSD1 construct was prepared by ligation of full-length LSD1 amplified from HeLa cDNA 
into pET42a+ vector through EcoRI restriction sites (forward 5’-
CCGGAATTCCGGATGTTATCTGGGAAGAAGGCGGC-3’, reverse 5’- 
CCGGAATTCCGGTCACATGCTTGGGGACTGCTGTG-3’). GST-LSD1-A, GST-LSD1-B and GST-LD1-C were 
prepared by amplification from GST-LSD1 construct and inserted into pET42a+ vector trough EcoRI 
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restriction sites. Flag-LSD1 construct for mammalian expression was prepared by ligation of LSD1 
cDNA into pCMV-Tag4B vector through EcoRI and XhoI restriction sites (forward 5’-
CCGGAATTCATGTTATCTGGGAA-3’, reverse 5’-AACCGCTCGAGCATGCTTGGGGA-3’). Mutated GST-
LSD1-B R310E, R313E, RR310,312EE, R316E, and full-length GST-LSD1 RR310,312EE constructs were 
prepared by site-directed mutagenesis by Q5® Site-Directed Mutagenesis Kit (New England Biolabs, 
E0552S) according to the manufacturer’s instructions. 
Antibodies 
Following primary antibodies were used: anti-PI(4)P (Echelon, Z-P004; 10 µg/ml for IF, 1 
µg/ml for dot blot), anti-Son (Abcam, ab121759; 2 µg/ml for IF, 0.2 µg/ml for WB), anti-Lamin A/C (a 
kind gift from C.J. Hutchison; diluted 10x), anti-Sm (RayBiotech, MD-16-0062; diluted 400x), anti-
H3K4me2 (Millipore, 07-030; 3 µg/ml for IF, 0.5 µg/ml for WB), anti-LSD1 (Abcam, ab17721; 8 µg/ml 
for IF, 0.8 µg/ml for WB), anti-H3 (Abcam, ab12079; 0.8 µg/ml), anti-Flag (Sigma, F1804; 1 µg/ml). For 
immunofluorescence, following secondary antibodies were used: goat anti-human IgG conjugated 
with Alexa Fluor 488, goat anti-rabbit conjugated with Alexa Fluor 488, goat anti-mouse IgG 
conjugated with DyLight 488, and goat anti-mouse IgM cojugated with Alexa Fluor 555 all purchased 
from Life Sciences. For western blotting, the following secondary antibodies were used: donkey anti-
rabbit IgG IRDye®680RD, donkey anti-rabbit IgG IRDye®800CW, donkey anti-mouse IgG 
IRDye®680RD, and goat anti-mouse IgM IRDye® 680RD (LI-COR Biosciences). 
Expression and purification of recombinant proteins 
Recombinant GST-LSD1, GST-LSD1-A, GST-LSD1-B and GST-LD1-C were expressed in E. coli 
strain BL21-Gold(DE3). Bacteria transformed with GST-LSD1, GST-LSD1-A, GST-LSD1-B and GST-LD1-C 
constructs were grown overnight in 1 l of LB medium. Expression was induced by 0.5 mM IPTG for 
48h at 4 ˚C. Cells were lysed in lysis buffer (PBS, 0.5 % Triton X-100, 1 mM DTT) containing EDTA-free 
protease inhibitor cocktail (cOmplete, Roche) and sonicated. Lysate was centrifuged at 16 000 g for 
20 min at 4 ˚C and filtered through 0.22 μm filter. Cleared lysate was loaded on a GST-trap column 
and the column was washed by 10 volumes of lysis buffer. Bound proteins were eluted (PBS, 1 mM 
DTT, 10 mM reduced glutathione, pH 8.5). 
Flag-LSD1 was stably expressed in HEK293 cell line. Cells were washed twice in PBS and lysed 
in lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1mM EDTA, 1% TRITON X-100, cOmplete) for 15 min 
at room temperature (RT) on a shaker. Cells were scraped and centrifuged at 12 000 g for 10 min at 4 
˚C. The supernatant was incubated with 50 µl of pre-equilibrated anti-Flag-M2 agarose beads (Sigma-
Aldrich) for 4 h at 4 ˚C. Beads were washed three times in wash buffer (50mM Tris pH 7.4, 150 mM 
NaCl, 0.1 % NP-40, 10% glycerol) for 15 min at 4 ˚C on an orbital shaker. LSD1-Flag complex was 
eluted by wash buffer supplemented with 3x FLAG peptide (Sigma-Aldrich; 150 ng/µl) for 30 min at 4 
˚C on an orbital shaker. 
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Nuclear extract preparation and pull-down assays 
Nuclear lysates were prepared from suspension HeLa cells as published previously (Trinkle-
Mulcahy et al. 2008). Cells were spun down, washed twice in ice-cold PBS and once in hypotonic 
buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, cOmplete).  Cells were 
resuspended in hypotonic buffer, incubated on ice for 10 min and dounced to release the nuclei. 
Nuclei were pelleted at 200 g, for 5 min at 4 ˚C. Nuclei were resuspended (0.25 mM sucrose, 10 mM 
MgCl2, cOmplete), layered over a sucrose buffer (0.88 mM sucrose, 0.5 mM MgCl2, cOmplete) and 
centrifuged at 2800 g for 10 min at 4 ˚C. Purified nuclei were resuspended in lysis buffer (50 mM Tris, 
pH 7.5, 150 mM NaCl, 1 % NP-40, cOmplete) and sonicated. Lysate was centrifuged at 16 000 g for 10 
min at 4 ˚C. PIs-coupled beads (Echelon) were pre-equilibrated in lysis buffer and blocked for 30 min 
on ice in lysis buffer supplemented with 1 % bovine serum albumin (BSA; Sigma, A-3059). Cleared 
lysate was incubated with pre-equilibrated PIs-coupled beads and incubated for 3 h at 4 ˚C on an 
orbital shaker. Beads were washed five times with lysis buffer and proteins were eluted in Laemmli 
buffer. 
Purified proteins were diluted in binding buffer (10 mM HEPES, pH 7.5, 150 mM NaCl, 0.25% 
NP-40) and incubated with pre-equilibrated and blocked PIs-coupled beads for 3 h at 4 ˚C on an 
orbital shaker. Beads were washed five times in binding buffer and proteins were eluted in Laemmli 
buffer. 
Nuclear fractionation and dot blot analysis 
Soluble and chromatin-bound fractions were prepared as described previously (Mendez 
2000). U2Os and HeLa cells were grown at 6 cm culture dish to 90 % confluence and lysed in 70 µl of 
lysis buffer (10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10 % glycerol, 1 mM 
DTT, cOmplete). Triton X-100 was added to final concentration 0.1 % and cells were incubated for 5 
min on ice. Nuclei were pelleted at 1300 g for 4 min at 4 ˚C and supernatant was kept as cytoplasmic 
fraction. Nuclei were washed in lysis buffer and resuspended in chromatin isolation buffer (3 mM 
EDTA, 0.2 mM EGTA, cOmplete). Insoluble chromatin was pelleted at 1700 g for 4 min at 4 ˚C and the 
supernatant was kept as soluble nuclear fraction. Chromatin was washed in chromatin isolation 
buffer, resuspended (50 mM Tris, pH 6.8, 2 % SDS) and sonicated. Cytoplasmic and soluble nuclear 
fractions were centrifuged at 16 000 g for 10 min at 4 ˚C and cleared supernatants were used in 
subsequent analysis. For detection of PI(4)P, 10 % of each fraction was spotted on a nitrocellulose 
membrane, blocked in 1 % BSA in PBS and incubated with anti-PI(4)P antibody. For the protein 
analysis, 10 % of each fraction was resolved by SDS-PAGE, transferred onto a nitrocellulose 
membrane, blocked with 3 % BSA and incubated with the antibodies against H3, Lamin A/C, Son and 
GAPDH. For the visualization, appropriate secondary antibodies conjugated to IRDye were used. 
Signal was detected by Odyssey Infrared Imaging System (LI-COR Biosciences).  
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Indirect immunofluorescence and fluorescence microscopy 
Cells seeded on glass coverslips were washed with PBS, fixed with 3 % paraformaldehyde in 
PBS and permeabilized with 0.1 % Triton X-100 in PBS for 20 min. Coverslips were blocked with 5 % 
normal goat serum (Life Sciences) in PBS for 30 min. For protein detection, coverslips were incubated 
with primary antibodies diluted in PBS for 1 h at room temperature (RT) and then washed with PBS. 
After washes, coverslips were incubated with corresponding secondary antibodies diluted in PBS with 
0.05% Tween 20 (PBS-T) for 1h at RT, washed with PBS-T and incubated with DAPI in PBS (1 μg/ μl). 
After final washes in PBS, coverslips were mounted in Vecta shield anti-fade reagent (Vector labs). 
Images were acquired using confocal microscopes Leica TCS SP8 and high-resolution Leica TCS SP8 
STED with 63x (NA 1.4) immersion oil objective and Leica advanced fluorescence software (LAS AF). 
High-throughput microscopy images were taken by IX81 wide-field microscope with UPLSAPO 
40x/0.90 oil objective (Olympus Corporation) and SCAN-R automated image and data analysis 
software. Images were taken as 1 μm z-stacks with 200 nm z-step. 
In vitro demethylation assay 
Purified Flag-LSD1 complex (2 μg) was pre-incubated with 0, 100 or 200 μM PI(4)P diC8 
(Echelon; P-4008) or PI(4,5)P2 diC8 (Echelon; P-4508) for 30 min at RT. Subsequently, the LSD1-Flag 
complex was incubated with 4 μg of calf thymus bulk histones (Sigma-Aldrich; H9250) in 
demethylation buffer (50 mM Tris, pH 8.5, 50 mM KCl, 5 mM MgCl2, 5 % glycerol, 1 mM DTT, 
cOmplete) in a total volume of 25 μl for 16 h at 37 ˚C. Reaction was terminated by addition of 
Laemmli buffer and the individual reactions were analyzed for protein content by SDS-PAGE and 
wetern blotting. 
Protein models 
The crystal structure of LSD1 (pdb2dw4; Mimasu et al. 2008) was downloaded from PDB 
database. LSD1 models were made using The PyMol Molecular Graphic System, Schrödinger, LLC. 
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Figure legends 
Fig. 1. PI(4)P localizes to nuclear membrane, nuclear speckles and small nucleoplasmic foci 
and is associated with chromatin. STED super-resolution microscopy shows that PI(4)P is present in 
the nuclear membrane (a). Sites of PI(4)P colocalization with lamin a/c are incicated (insets, 
arrowheads). PI(4)P colocalizes with Sm in nuclear speckles (b, upper inset) but not in the Cajal 
bodies. Arrowheads indicate foci of PI(4)P around Cajal bodies (b, lower inset). Intensity plot shows 
localization of PI(4)P and Sm along the line drawn in the inset (b). PI(4)P colocalizes with Son in 
nuclear speckles (c, insets) and forms foci at the edges of nuclear speckles (arrowheads). Intensity 
plots show localization of PI(4)P and Son along the line drawn in insets (c). The distribution of PI(4)P 
in nuclear speckles (8.3 ± 1.5 %) and other nuclear regions (91.7 ± 1.5 %). Values are results of PI(4)P 
and Son signal analysis in 614 cells (d) Proportion of PI(4)P in soluble (7.3 ± 1.4 %) and chromatin-
bound (92.7 ±1.4) fractions. Graph represents results of 4 experiments (e). Scale bar is 5 μm. 
Fig. 2. Small nucleoplasmic foci of PI(4)P colocalize with active chromatin. STED super-
resolution microscopy analysis of PI(4)P colocalization with H3K4me2, a mark of active chromatin (a). 
Details of PI(4)P and H3K4me2 colocalization are shown (insets), intensity graphs show PI(4)P and 
H3K4me2 signals along lines drawn in respective insets. Sites of intensity peak overlaps are 
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highlighted (asterisks). Colocalization of PI(4)P with H3K9me2, a mark of an inactive chromatin (b). 
Values of Spearman’s coefficient show that PI(4)P colocalizes with H3K4me2 but not with H3K9me2 
(c). Scale bar is 5 μm. 
Fig. 3. LSD1 interacts with PI(4)P and other PIs. Pull-down with PI(4)P and PI(4,5)P2 beads 
show that LSD1 binds to PI(4,5)P2 but not to PI(4)P in HeLa nuclear extract (a). Purified GST-LSD1 
binds specifically to beads coupled with PI, PI(4)P, PI(3,4)P2, PI(3,5)P2, PI(4,5)P2, and PI(3,4,5)P3 and 
displays the highest affinity to PI(4)P (b). Quantification GST-LSD1 bands intensities. Intensities are 
normalized to the signal form pull-down by control agarose beads. The level of signal in control pull-
down is indicated by red line (c). A scheme of LSD1 full-length protein and its protein domain 
composition. LSD1 truncations (LSD1-A, LSD1-B. LSD1-C) are depicted. These truncated proteins were 
used for pull-down experiments with PI(4)P coupled beads and empty agarose beads as a control. 
LSD1-B is enriched in PI(4)P pulled-down fraction (d). The crystal structure of LSD1 downloaded from 
PDB database (pdb2dw4) and visualized by PyMol software (e) Position of LSD1 truncations are color-
coded (left). LSD1-B is shown in yellow, all basic residues in LSD1-B are highlighted in red (right). 
Probable PIs-binding site formed by R310, R312 and R316 (inset). Pull-down of LSD1-B mutants by 
PI(4)P coupled beads (f).  Pull-down of full-length LSD1 (Flag-LSD1-WT) and LSD1 RR310,312EE 
mutant (Flag-LSD1-MUT) (g). HEK293 cells were transfected by Flag-tag conjugated WT and MUT 
LSD1 and an empty vector as a control. LSD1 complexes were immunoprecipitated with anti-Flag 
antibody. Purified complexes were loaded on SDS-PAGE and assayed by anti-Flag antibody (left) and 
spotted on a nitrocellulose membrane. PI(4)P was detected by anti-PI(4)P antibody (right). PI(4)P 
associates with Flag-LSD1-WT but not with Flag-LSD1-MUT or empty vector. IN – input, C – control, 
SWIRM - SWI3/RSC8/MOIRA domain, AOD – amino-oxidase domain. 
Fig. 4. PI(4)P inhibits and PI(4,5)P2 stimulates LSD1 activity. Flag-LSD1 was stably 
oveexpressed in HEK293 cells, purified and assayed on 10 % SDS-PAGE (a). Commasie stained Flag-
eluate (left) and western blot analysis (right) show Flag-LSD1 (arrows) and CoREST (asterisks) in Flag-
elution. Results of in vitro demethylation reaction (b, top) and graph representing quantification of 
H3K4me2 signal normalized to H3 signal and shown as percent of normalized input H3K4me2 signal 
(b, bottom). LSD1 was preincubated with indicated amount of PI(4)P di8 or PI(4,5)P2 di8. Incubation 
of bulk histones with Flag-LSD1 results in the decrease of H3K4me2 signal to 80 % of input signal. 
Preincubation with PI(4)P inhibits Flag-LSD1 activity. Preincubation with PI(4,5)P2 results in decrease 
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In interphase, nuclear en-actin filaments passed through 
chromatin region, but do not co-localize with either chro-
matin remodeling complexes or rna polymerases I and II. 
Surprisingly presence of en-actin filaments was connected 
with increase in the overall transcription levels in the 
S-phase by yet unknown mechanism. Taken together, en-
actin can form filaments in the nucleus which affect impor-
tant cellular processes such as transcription and mitosis.
Keywords nuclear actin · Transcription · Mitosis ·  
actin-related protein 3 · Cofilin
Introduction
actin is a highly abundant intracellular protein essential 
for maintenance of many cellular functions. It is widely 
expressed across the species and present in all eukaryotic cell 
types. In the cytoplasm, actin is present in the form of mono-
mers (globular actin, g-actin), which can polymerize to form 
filaments (F-actin) that can be specifically visualized by phal-
loidin. The formation of F-actin is driven by the availability 
of g-actin subunits—a filament grows when g-actin levels 
exceed the critical concentration required for polymerization, 
and a filament shrinks if the critical concentration was not 
reached. actin filaments are highly dynamic structures that 
can assemble or disassemble rapidly based on cell needs.
There are many actin-binding proteins available in the 
cytoplasm. Depending on their relative binding affinities, 
they can promote, block or alter the formation of actin 
filaments. In addition, various actin-binding proteins cross-
link actin filaments to form bundles or networks (reviewed 
in Winder and ayscough 2005). Such structures are impor-
tant for the maintenance of cell shape, polarity, mechanical 
resistance, adhesion and movement.
Abstract  although actin monomers polymerize into fil-
aments in the cytoplasm, the form of actin in the nucleus 
remains elusive. We searched for the form and func-
tion of β-actin fused to nuclear localization signal and to 
enhanced yellow fluorescent protein (en-actin). Our results 
reveal that en-actin is either dispersed in the nucleoplasm 
(homogenous en-actin) or forms bundled filaments in the 
nucleus (en-actin filaments). Formation of such filaments 
was not connected with increased en-actin levels. among 
numerous actin-binding proteins tested, only cofilin is 
recruited to the en-actin filaments. Overexpression of en-
actin causes increase in the nuclear levels of actin-related 
protein 3 (arp3). although arp3, a member of actin nucle-
ation complex arp2/3, is responsible for en-actin filament 
nucleation and bundling, the way cofilin affects nuclear 
en-actin filaments dynamics is not clear. While cells with 
homogenous en-actin maintained unaffected mitosis dur-
ing which en-actin re-localizes to the plasma membrane, 
generation of nuclear en-actin filaments severely decreases 
cell proliferation and interferes with mitotic progress. 
The introduction of en-actin manifests in two mitotic-
inborn defects—formation of binucleic cells and genera-
tion of micronuclei—suggesting that cells suffer aberrant 
cytokinesis and/or impaired chromosomal segregation. 
a. Kalendová · I. Kalasová · l. Uličná · P. Hozák (*) 
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actin shuttles between cytoplasm and nucleus employ-
ing importin 9 and exportin 6 (Dopie et al. 2012). In the 
nucleus, actin is present in the form of monomers (Jock-
usch et al. 2006; Kukalev et al. 2005; McDonald et al. 
2006; Obrdlik et al. 2008; Pendleton et al. 2003), yet its 
ability to form nuclear filaments has been questioned for 
a long time due to the lack of nuclear phalloidin staining. 
eventually, several conditions leading to the formation of 
nuclear actin polymers have been described. Under various 
stress conditions (e.g., heat shock, DMSO treatment, virus 
infection etc.), nuclear actin rods and paracrystals were 
observed in numerous cell types (reviewed in Hofmann 
2009). Moreover, a recent study revealed the presence of 
actin filaments in nuclei of nIH3T3 cells after overexpres-
sion of lifeact, an F-actin marker, fused to nuclear locali-
zation signal (nlS). These filaments were formed after 
serum induction in a formin-dependent manner (Baarlink 
et al. 2013). accumulation and subsequent polymerization 
of the overexpressed actin in the nucleus was also reported 
after the disruption of the actin export (Dopie et al. 2012; 
Stuven et al. 2003). additionally, Miyamoto et al. (2011) 
detected actin filaments in nuclei of somatic cells trans-
planted into oocytes of Xenopus leavis using an actin-
binding domain of utrophin fused to nlS. Interestingly, 
the same probe revealed the presence of punctate structures 
in the nuclei of U2OS cells under physiological conditions 
which were moreover susceptible to phalloidin staining 
(Belin et al. 2013). even though these polymeric structures 
do not co-localize with any actin-binding proteins, they are 
found predominantly in the interchromatin space and prob-
ably serve as a structural platform that facilitates nuclear 
organization (Belin et al. 2013).
even though the state of nuclear actin is not entirely 
clear, its functional importance has been known for 
some time. actin is together with the actin-related pro-
teins required for chromatin remodeling (Ikura et al. 2000; 
Kapoor et al. 2013; Mizuguchi et al. 2004; Shen et al. 
2000; Szerlong et al. 2008; Zhao et al. 1998). actin also 
associates with all three rna polymerases (Hofmann et al. 
2004; Hu et al. 2004; Philimonenko et al. 2004) and in 
cooperation with nuclear myosin 1 (nM1) facilitates tran-
scription initiation and recruitment of chromatin modify-
ing complexes during the elongation phase (reviewed in de 
lanerolle and Serebryannyy 2011). Furthermore, actin also 
participates in rna processing and export by interacting 
with heterogenous ribonucleoproteins (hnrnPs; Obrdlik 
et al. 2008; Percipalle et al. 2002).
From the data available, it seems that the state of nuclear 
actin engaged in chromatin remodeling complexes and in 
complex with hnrnPs (Kapoor et al. 2013; Obrdlik et al. 
2008; Percipalle et al. 2002) is rather monomeric, whereas 
in transcription both forms seem to be involved (Miyamoto 
et al. 2011; Obrdlik and Percipalle 2011; Qi et al. 2011; 
Wu et al. 2006; Ye et al. 2008; Yoo et al. 2007). Similarly, 
actin in its polymeric form is essential for the movement of 
genomic loci throughout the nucleus during transcriptional 
activation (Dundr et al. 2007; Hu et al. 2008). The presence 
of polymeric actin in the nucleus is also supported by the 
findings that various proteins known to bind F-actin in the 
cytoplasm also localize to the nucleus (reviewed in Castano 
et al. 2010)) and are implicated in nuclear processes such 
as transcription (Baarlink et al. 2013; Miyamoto et al. 
2011; Obrdlik and Percipalle 2011; Wu et al. 2006; Yoo 
et al. 2007).
Kokai et al. (2014) have previously reported that ectopi-
cally expressed β-actin fused to nlS is imported into the 
nucleus, where it forms filamentous network. Detailed 
analysis of the network revealed that distinct actin filaments 
are branched and cross-linked into parallel bundles. The 
formation of such structures alters the shape of neuronal-
like rat PC12 cells and activates serum response factor 
(SrF)-mediated transcription. In this study, we employed 
a similar fusion protein, β-actin fused to enhanced yellow 
fluorescent protein (eYFP) and to nlS (en-actin), aiming 
to explore (1) the formation of en-actin filaments in the 
nucleus, (2) contribution of actin-binding proteins to the 
en-actin filaments formation and dynamics, (3) associa-
tion of nuclear en-actin filaments with complexes where 
endogenous actin is known to localize, and (4) an effect of 
the nuclear en-actin filaments formation on cell cycle and 
transcription in human osteosarcoma cells (U2OS).
Materials and methods
Cells and transfections
U2OS, H1299, HeK293 and human skin fibroblasts were 
cultured in D-MeM supplemented with 10 % FBS in 5 % 
CO2/air, 37 °C and humidified atmosphere. Cells were 
transfected with lipofectamine 2000 (life Technologies) 
and TurboFect (Thermo Scientific) according to manufac-
turer’s protocol. 2 μg of Dna and 5 μl of lipofectamine 
or 3 μl of TurboFect was used to transfect 5 × 105 cells. 
Cells were incubated for 6 to 12 h with a transfection 
mix and additional 36 h before fixation and imaging. lin-
ear polyethylenimine (PeI), 25 kDa, was purchased from 
Polysciences. 1 mg/ml stock solution was prepared and pH 
adjusted to 7. 9 μl of this solution was mixed with 1.5 μg 
Dna in serum-free media and incubated for 15 min at 
room temperature. 5 × 105 cells were incubated with trans-
fection mix for 4 h and then grown for 48 h before imaging.
5 μg of exogenous Dna was delivered into 5 × 105 pri-
mary mouse skin fibroblasts by nucleofection using amaxa 
nucleofector (lonza), programme C005. Cells were seeded 
onto coverslips and imaged 48 h after nucleofection.
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Constructs used in this study
en-actin was generated as described previously (Hofmann 
et al. 2009). Shortly, nlS was inserted between the eYFP 
and actin into the plasmid peYFP-actin (Clontech). cDna 
of mouse nM1 was cloned into pCDna3.1-mCherry 
using nheI and HindIII by standard methods of molecular 
biology.
Indirect immunofluorescence and confocal fluorescence 
microscopy
U2OS cells seeded on glass coverslips were fixed with 
4 % paraformaldehyde in PBS for 20 min and permeabi-
lized with 0.1 % Triton X-100 in PBS for 10 min afterward. 
non-specific labeling was further blocked with 5 % BSa 
in PBS for 30 min. after washes with PBS, coverslips were 
incubated with the respective primary antibodies diluted 
in PBS for 1 h at rT in a wet chamber and washed with 
PBST (PBS supplemented with 0.05 % Tween 20). Sub-
sequently, coverslips were incubated with corresponding 
secondary antibodies for 1 h at rT in a wet chamber. after 
final washes in PBST, coverslips were mounted in Prolong 
gold anti-fade reagent with DaPI. For detection of emerin, 
cells were fixed with ice-cold methanol for 5 min without 
additional permeabilization. Images were acquired using 
confocal microscope leica TCS SP5 aOBS TanDeM 
with 63× (na 1.4) immersion oil objective lens with 405, 
512, 561 and 631 laser excitations, and laS aF software.
antibodies
Following primary antibodies were used in this study: 
lamin B (Santa Cruz cat. no. sc-6217); filamin (Santa 
Cruz cat. no. sc-28284); alpha-actinin-4 (abcam cat. no. 
ab96866); spectrin (Sigma aldrich cat. no. S1390); paxil-
lin (Millipore cat. no. 05-471); vinculin (Sigma aldrich cat. 
no. V4505); mDia1 (BD Biosciences cat. no. P66520-050); 
SUn2 (abcam cat. no. ab124916); emerin (abcam cat. no. 
ab40688); arp3 (Welch et al. 1997); cofilin (abcam cat. no. 
ab11062); P-cofilin (Cell Signaling cat. no. 3313); arp6 
(Sigma aldrich cat. no. r35554); arp5 (Kitayama et al. 
2009); arp8 (aoyama et al. 2008); Brg1 (abcam cat. no. 
ab70558); hnrnP U (Santa Cruz, clone 3g6); H3K9Me2 
(Millipore cat. no. 17-648); H3K4Me2 (Millipore cat. 
no. 07-030); CTD-phosphoS2 (abcam cat. no. ab24758); 
rPa194 (Santa Cruz, cat. no. sc-28714); and BrdU (Sigma 
aldrich, clone BU-33).
Secondary antibodies used in this study are donkey anti-
rabbit Igg conjugated with alexa Fluor 568 (a10042), goat 
anti-mouse Igg conjugated with alexa Fluor 647 (a21236) 
and donkey anti-goat Igg cojugated with alexa Fluor 647 
(a21447) all purchased from life Sciences.
5-Fluorouridine, 5-ethynyl-2′-deoxyuridine incorporation 
and en-actin fluorescence measurements
U2OS cells grown on coverslips were transfected with en-
actin using lipofectamine as described above. 48 h after the 
transfection, cells were incubated for 30 min or 1 h at 37 °C, 
5 % CO2/air with 2 mM 5-fluorouridine (FU) or 5-ethynyl-
2′-deoxyuridine (edU), respectively. after this time period, 
cells were washed, fixed and permeabilized as mentioned 
above. FU incorporated into nascent transcripts was 
detected using anti-BrdU antibody as described above. edU 
was directly labeled in a click reaction using ClickiT edU 
alexa Fluor 647 Flow Cytometry assay kit (life Technolo-
gies). Images were acquired as four 200-nm optical stacks 
of a total thickness of 2 μm using the above mentioned fluo-
rescence confocal microscope. Total intensity of FU/edU 
fluorescence in the nucleus was integrated from 3D recon-
struction (maximal projection) of all four optical stacks 
in laS aF, background subtracted and normalized to the 
nuclear area. The measurement was repeated three times, 
and fluorescence intensities of the cells expressing en-actin 
were in each replicate normalized to the controls to prevent 
variations caused by antibodies dilutions, etc. results are 
presented as a mean of three experiments ± standard devia-
tion (SD) and were plotted using Prism graphPad. T test 
was used to determine the statistical significance. each cell 
imaged was manually classified according to the en-actin 
expression pattern as g-actin (homogenous signal), F-actin 
(nuclear filaments) or control (no expression of en-actin). 
Fluorescence of en-actin was quantified in the same way.
Results
en-actin forms filaments in the nucleus
We studied the behavior of exogenous β-actin in the nucleus. 
In order to achieve its nuclear localization, we fused β-actin 
with nlS and eYFP (en-actin). It has been observed pre-
viously that the overexpression of nlS-β-actin leads to the 
formation of filamentous structures inside of the nucleus 
in various cell lines (Kokai et al. 2014). When we overex-
pressed en-actin in human osteosarcoma cell line (U2OS), 
majority of cells (95 to 99 %) exhibited homogenously dis-
persed nuclear signal, apparently corresponding to the free 
g-actin or short actin polymers (Fig. 1a). However, in 1–5 % 
of cells, en-actin assembled into filamentous structures 
which stretched through the whole nuclear volume with the 
exception of nucleoli (Fig. 1b, c). The en-actin filaments 
adopt various shapes from straight long (Fig. 8h) to curved 
(Fig. 1b), or they form a dense meshwork (Fig. 1c). These 
nuclear actin filaments are phalloidin-positive structures 
(Fig. 2a) which in some cases run at the nuclear periphery 
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along the nuclear lamina (Fig. 2b, white arrows), occasion-
ally even reaching the nuclear lamina (Fig. 2c, d). The thick-
ness of and the length of the filaments range from 50 to 
100 nm and 1 to 15 μm, respectively, which corresponds to 
actin bundles rather than single filaments, as has been con-
cluded previously (Kokai et al. 2014).
In parallel to its nuclear localization, en-actin was also 
incorporated into canonical cytoplasmic filaments in both 
cells with homogenous nuclear pattern (Fig. 1a), as well 
as in the cells that contained nuclear en-actin filaments 
(Fig. 1c). This suggests that the presence of cytoplasmic 
en-actin filaments does not restrict nuclear en-actin fila-
ments formation, and vice versa.
Since nuclear en-actin filaments are present only in a 
small fraction of cells, this raises the question which stimu-
lus triggers their formation. One could predict that when 
the critical concentration of actin monomers inside a com-
partment is reached, the polymerization process starts. To 
find out whether there is a difference in the amount of en-
actin in the nucleus between the cells forming filaments 
and those having homogenous dispersion of en-actin, 
we measured the total fluorescence intensity of en-actin 
in the nuclei of those cells. Because there is a variability 
in size of the nuclei among the cells, we normalized total 
fluorescence intensity to the nuclear area after background 
subtraction. We found that there is no significant difference 
in normalized fluorescence intensity between nuclei with 
homogenously dispersed en-actin (g-actin) and filaments-
forming nuclei (F-actin; Fig. 2e).
In addition, we tested the impact of transfection method 
on the filament formation. For this purpose, we used lipo-
fectamine 2000 (life Technologies), TurboFect (Thermo 
Scientific) and linear polyethylenimine (Polysciences) 
according to the manufacturers’ protocols (see Materials and 
methods). even though the efficiencies of the transfections 
varied, the percentage of transfected cells containing nuclear 
actin filaments did not change significantly (data not shown).
Taken together, after overexpression of en-actin, 1–5 % 
of cells contain nuclear en-actin filaments assembled into 
bundles. Formation of these filaments is dependent neither 
on the intranuclear concentration of en-actin nor on the 
transfection method.
Formation of nuclear en-actin filaments varies among cell 
types
We analyzed the formation of nuclear en-actin filaments in 
various cell types. The pattern of overexpressed en-actin 
Fig. 1  Overexpressed en-actin 
forms filaments in the nucleus 
of U2OS cells. In vast majority 
of cells (95–99 %), en-actin 
was imported into the nucleus, 
where it was homogenously dis-
persed throughout the nucleo-
plasm (a). Minority of cells 
(1–5 %) displayed en-actin 
assembled into thick nuclear 
filaments (b). at the same time, 
en-actin was also incorporated 
into cytoplasmic filaments (a, 
c). Single focal plane in the 
equatorial position (b) and 3D 
reconstructions of the entire 
cells (a, c) are shown. Scale 
bars 5 μm
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was inspected in immortalized human embryonic kidney 
cell line (HeK293), human cervical carcinoma cell line 
(Hela), human non-small cell lung carcinoma cell line 
(H1299) and primary mouse skin fibroblasts. Formation 
of nuclear actin filaments was noticed in all immortalized 
human cell lines (HeK293, Hela, H1299; Fig. 3c–e); how-
ever, no nuclear filaments were found in primary mouse 
fibroblasts (Fig. 3a, b). In mouse fibroblasts, en-actin was 
preferentially incorporated into cytoplasmic fibers (Fig. 3a, 
optical section focused to the cytoplasmic fibers), while 
only a small portion was imported into the nucleus, where 
it stayed homogenously dispersed in the monomeric form 
(Fig. 3b, the same cell—optical section in the equatorial 
position).
However, we noticed some differences between the 
immortalized cell lines. HeK293 cells (Fig. 3e) formed 
nuclear actin filaments more readily than U20S cells, reach-
ing up to 10–20 % of cells with filaments. On the other 
hand, the proportion of H1299 cells forming nuclear actin 
filaments was only around 0.5 % (Fig. 3d). even though 
we found nuclear en-actin filaments in some H1299 cells, 
en-actin was not imported into the nucleus efficiently; it 
rather stayed in the cytoplasmic filaments in majority of 
cells (not shown).
altogether, we conclude that the ability to translocate 
en-actin into the nucleus and form nuclear en-actin fila-
ments is cell-type specific and reflects diverse nuclear envi-
ronment and/or nucleocytoplasmic transport properties.
Cells with nuclear en-actin filaments undergo a mitotic 
block
In order to investigate the behavior of nuclear en-actin 
during cell cycle, we observed localization of homog-
enously dispersed en-actin and en-actin incorporated 
into the filaments at various stages of mitosis by light 
Fig. 2  Properties of nuclear 
en-actin filaments formed in 
U2OS cells. nuclear en-actin 
filaments are susceptible to 
phalloidin staining (a), run 
along the nuclear lamina (b 
white arrows) and occasionally 
join the nuclear lamina (c–d). 
no significant difference in the 
total nuclear fluorescence inten-
sity of en-actin normalized 
to the nuclear area was found 
between the cells forming en-
actin filaments (F-actin; e) and 
cells containing homogenously 
dispersed en-actin (g-actin; 
e). as a control, cells having 
no expression of en-actin 
but present within the same 
coverslip were used. results 
are presented as mean ± SD of 
three independent experiments, 
whiskers indicate minimal and 
maximal values. In total, 30 
cells for F-actin, 69 cells for 
g-actin and 130 control cells 
were analyzed (e). Scale bars 
5 μm (a–e), 1.25 μm (f–g),  
n. s. p>0.05
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microscopy (Fig. 4a–f). We revealed that homogenously 
dispersed en-actin is at the onset of mitosis exported from 
the nucleus (Fig. 4b). In later phases of mitosis, en-actin 
is not associated with chromosomes; it is enriched at the 
plasma membrane and in plasma membrane protrusions 
instead (Fig. 4c–e). en-actin is imported into the nucleus 
after the re-assembly of the nuclear envelope during cytoki-
nesis (Fig. 4f).
Interestingly, when we monitored cells by a long-term 
live-cell observations, we did not observe any cells contain-
ing en-actin filaments to progress through mitosis. at the 
same time, other cells in the field of view which contained 
cytoplasmic en-actin filaments or homogenous nuclear 
en-actin divided normally (data not shown). This sug-
gests a block in mitosis caused by the presence of en-actin 
filaments in the nucleus. Indeed, when we measured pro-
liferation rate by edU incorporation, 53 % of the control 
or homogenous nuclear en-actin containing cells incorpo-
rated edU (Fig. 5c, control and g-actin, respectively). after 
the formation of nuclear en-actin filaments, the edU incor-
poration decreased by a half, to 24 % (Fig. 5c, F-actin). We 
furthermore noticed that many cells carrying nuclear actin 
filaments exhibited two types of morphological abnormali-
ties: in the first case, additional micronuclei was formed. 
This micronuclei contained DaPI-stainable chromatin and 
also a homogenous or filamentous en-actin (Fig. 5a). Sec-
ond, some cells did not complete cytokinesis resulting in 
retention of both daughter nuclei within one cell (Fig. 5b). 
Of the binucleic cells, 90 % contained nuclear en-actin fil-
aments in both nuclei, while only 10 % of cells had homog-
enous en-actin. The other way around, of all the nuclear 
en-actin filament-containing cells, 10 % were binucleic, 
while only 1 % of cells with homogenous nuclear en-actin 
were binucleic. In the binucleic cells, both nuclei always 
contained the same pattern of en-actin—either filamentous 
or homogenous.
Based on the results, we propose that the presence of 
the en-actin filaments in the cell nucleus may disturb pro-
gress into mitotic phase of a cell cycle. In case the cell still 
undergoes mitosis, irregularities in structure of daughter 
cells or aberrant cytokinesis appear as a consequence.
Cofilin co-localizes with nuclear en-actin filaments, 
and arp3 is enriched in cells with en-actin
The initial experiment (Fig. 2e) showed that the concen-
tration of en-actin is not the only factor which triggers 
assembly of nuclear en-actin filaments. To see whether 
actin-binding proteins participate in the regulation of en-
actin filaments formation in the nucleus, we observed their 
localization in respect of the nuclear en-actin filaments 
by confocal light microscopy (Fig. 6). We considered par-
ticular protein as co-localizing when it was accumulated or 
enriched at the en-actin filaments or in their close vicinity.
as we have established that en-actin does not form indi-
vidual filaments but bundles instead, we explored the local-
ization of F-actin cross-linking proteins filamin, α-actinin 
and spectrin (Fig. 6a–c) which are known to localize to the 
nucleus (Bedolla et al. 2009; Dingova et al. 2009). none 
of these actin cross-linkers, however, showed preferential 
co-localization with nuclear en-actin filaments; therefore, 
it remains unclear by which mechanism nuclear en-actin 
filaments become bundled.
next, we explored the localization of the F-actin-bind-
ing proteins paxillin and vinculin (Fig. 6d, e). These two 
proteins typically associate with focal adhesions, where 
Fig. 3  Formation of nuclear en-actin filaments varies among cell 
types. In primary mouse skin fibroblasts, en-actin (delivered by 
nucleofection) incorporates preferentially into cytoplasmic fibers (a 
optical section focused on the cytoplasmic fibers) and does not form 
filaments in the nucleus (b optical section of the same cell in the 
equatorial position). en-actin, delivered by transfection, assembled 
into filaments in the nuclei of Hela (c), H1299 (d) and HeK293 (e) 
cells. Scale bars 10 μm (a–c), 5 μm (d–e)
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vinculin mediates the association between integrin and 
F-actin and binds also paxillin (Turner et al. 1990). Despite 
the fact that both vinculin and paxillin were previously 
reported to localize in the nucleus (Dingova et al. 2009; 
Dong et al. 2009; Kano et al. 1996), we detected only a 
negligible amount of nuclear paxillin. Yet, neither of them 
co-localized with the nuclear filaments formed after the 
overexpression of en-actin (Fig. 6d, e). Therefore, we 
speculate that nuclear-specific isoforms of actin-bundling 
proteins assist in cross-linking of en-actin filaments.
In a recent study, Baarlink et al. (2013) showed that for-
mation of the actin filaments in the nucleus is dependent on 
the presence of nuclear formins. Since we observed neither 
co-localization of formin mDia1 with the en-actin fila-
ments nor any change in pattern of mDia upon en-actin fil-
aments formation (Fig. 6f), we concluded that mDia1 does 
not assist in en-actin polymerization.
Our results show that nuclear en-actin filaments join 
nuclear lamina occasionally (Fig. 2b–d). Therefore, we also 
tested their association with two other nuclear envelope-
associated proteins—SUn2, a member of linker of nucle-
oskeleton and cytoskeleton complex (lInC; Fig. 6g); and 
emerin, an inner nuclear membrane protein, which binds 
lamin a/C (Fig. 7a, b). Of these proteins, nuclear en-actin 
filaments join in some cases emerin (Fig. 7a, b) in a similar 
manner as lamin B (Fig. 2b–d).
next, we investigated the localization of proteins which 
affect F-actin assembly. First of them, cofilin binds to the 
pointed end of F-actin filaments and causes their disassem-
bly. Surprisingly, cofilin co-localized with the nuclear en-
actin filaments (Fig. 7c, arrowheads) not only at the ends, 
but along the entire length of the filament (Fig. 7d, arrow-
heads). On the contrary, phosphorylated form of cofilin 
(P-cofilin), which becomes incapable of F-actin binding, 
did not co-localize with en-actin filaments (Fig. 7e), even 
though it was present in the nucleus.
Since the previous study suggested that nlS-actin fila-
ments are branched (Kokai et al. 2014), we explored also 
localization of branching proteins which area able to bind 
to the existing filaments in order to trigger nucleation and 
growth of new branches of the actin filaments. We found 
that levels of arp3, a member of arp2/3 nucleation com-
plex (Pantaloni et al. 2000), are increased upon expression 
of en-actin (Fig. 7f, g). It is therefore plausible that arp3 
re-localizes to the nucleus after elevation of en-actin to 
assist in the growth of new filaments.
among the actin-binding proteins analyzed, only arp3 
and cofilin seem to be in relation with the nuclear en-
actin filaments. Such limited co-localization indicates that 
assembly and bundling of nuclear en-filaments are con-
trolled by nuclear-specific regulators or nuclear-specific 
isoforms of actin-associated proteins.
Fig. 4  en-actin is enriched at the plasma membrane during mito-
sis. localization of overexpressed en-actin was observed at various 
stages of mitosis in U2OS cells (a–f). at the onset of mitosis, en-
actin is exported from the nucleus to the plasma membrane (b–e). 
When the nuclear envelope re-assembles, en-actin is imported back 
into the nucleus (f). Maximal projections of five optical sections are 
shown. Scale bars 10 μm
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nuclear en-actin filaments formation enhances 
transcription in the S-phase
It is known that actin is found in chromatin remodeling com-
plexes (Szerlong et al. 2008; Zhao et al. 1998). To test the 
functional involvement of the en-actin filaments in chroma-
tin remodeling, we performed co-localization studies with 
protein hallmarks of chromatin remodeling using confocal 
microscopy. However, no significant co-localization was 
observed with the actin-related proteins (arp5, arp8 and 
arp6), brahma-related gene 1 (Brg1) or hnrnP U (Fig. 8a–e).
Fig. 5  Cells with en-actin filaments exhibit irregularities in the 
interphase. U2OS cells with en-actin filaments exhibit two phenom-
ena originated in mitosis—presence of DaPI-stainable micronuclei 
(a) and retention of both daughter nuclei within a single cell (b). Cell 
proliferation was measured by edU incorporation. after labeling, 
fluorescence of edU was measured and percentage of edU-positive 
cells is shown for cells containing en-actin filaments (F-actin, c), 
homogenous en-actin (g-actin, c) and control. results are pre-
sented as mean ± SD of three independent experiments. More than 
50 cells were analyzed in each experiment (c). Scale bars 10 μm, 
***p < 0.001
Fig. 6  nuclear en-actin filaments do not co-localize with the actin-
binding proteins tested. Co-localization of the nuclear en-actin 
filaments with various actin-binding proteins was tested by indirect 
immunofluorescence microscopy in the U2OS cells (a–g). a protein 
was considered as co-localizing when it predominantly accumulated 
at the nuclear en-filaments or was enriched in their close vicinity. 
nucleus of cell with no en-actin expression is labelled by a dashed 
line. Scale bars 5 μm
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numerous studies have repeatedly emphasized the 
importance of actin in transcription (Hofmann et al. 2004; 
Hu et al. 2004; Philimonenko et al. 2004). nM1 is a tran-
scription factor, which exerts its function in cooperation 
with actin (Ye et al. 2008). even though one would expect 
nM1, which requires oligo- or polymeric actin for its func-
tion, to be predominantly found on the en-actin filaments, 
it is not the case (Fig. 8f). Overexpressed nM1-mCherry is 
in the nucleoplasm present in the vicinity of the en-actin 
filaments, but no evidence points toward their association.
Fig. 7  nuclear en-actin filaments recruit arp3 and cofilin. Co-local-
ization of the nuclear en-actin filaments with various actin-binding 
proteins was tested by indirect immunofluorescence microscopy in 
the U2OS cells (a–g). en-actin filaments occasionally come into con-
tact with emerin (a and b inset). en-actin filaments co-localize with 
cofilin in the nucleus (c and d, arrowheads). Inset of the en-actin 
filaments (d). en-actin filaments do not co-localize with P-cofilin (e), 
but recruit arp3 into the nucleus (f). nucleus of cell with no expres-
sion of en-actin is labeled by dashed line (f). Inset of the cell with 
increased arp3 levels and en-actin filaments (g). Scale bars 2.5 μm
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Fig. 8  nuclear en-actin filaments enhance Dna transcription. Co-
localization of overexpressed nuclear en-actin and hallmarks of 
various nuclear functional complexes was observed in U2OS cells 
by indirect immunofluorescence microscopy. a protein was con-
sidered as co-localizing when it predominantly accumulated at the 
nuclear en-filaments or was enriched in their close vicinity. nuclear 
en-actin filaments do not co-localize with components of chromatin 
remodeling complexes (a–f), but passed through both transcription-
ally inactive (g) and active chromatin (h). Formation of en-actin 
filaments does not affect either localization of C-terminal domain of 
rna polymerase II phosporylated on serine 2 (CTD-PS2, i) or the 
catalytic subunit of rna polymerase I (rPa194, j). generation of 
nuclear en-actin filaments causes increase in the overall transcrip-
tion levels in the S-phase (k). In this experiment, transcription lev-
els of cells containing en-actin filaments (k F-actin) were compared 
to cells with homogenous en-actin (k g-actin) and to cells with no 
expression of en-actin, which resided within the same coverslips (k 
control). nascent transcripts were labeled by FU in the U2OS cells 
and their amounts were then quantified by indirect immunofluores-
cence using anti-BrdU antibody. Total fluorescence intensity in the 
nucleus was normalized to the nuclear area. The experiment was 
repeated three times and the values in each replicate were further 
normalized to the control. normalized mean values ± SD of three 
independent experiments are shown in the graph where whiskers rep-
resent the minimum and maximum values. More than 20 cells were 
analyzed in each experiment. S and g1/g2 phases of the cell cycle 
were analyzed separately. no significant changes (p < 0.05) were 
observed unless indicated by asterisks. **p = 0.01-0.001. Scale bars 
5 μm
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We then proceeded with the study of participation of 
en-actin in transcription and observed its occurrence in 
transcriptionally inactive and active chromatin regions, 
marked by H3K9Me2 and H3K4Me2 histone modifica-
tion, respectively. nuclear en-actin filaments did not 
show any preferential enrichment in either type of chro-
matin, neither did homogenously dispersed en-actin 
(Fig. 8g, h). On the other hand, en-actin filaments did 
not avoid either type of chromatin; they passed through 
both chromatin regions instead. Therefore, we asked 
whether en-actin filaments or free en-actin do indeed 
affect transcription as has been previously published 
(Miyamoto et al. 2011; Wu et al. 2006; Ye et al. 2008). 
To answer this question, we explored the presence of the 
catalytic subunit of rna polymerase I (rPa194) as well 
as the active form of rna polymerase II phosphorylated 
on serine 2 (CTD-PS2), as these would indicate active 
transcription. Both CTD-PS2 and rPa194 were pre-
sent in the cells containing nuclear en-actin filaments 
(Fig. 8i, j), and no obvious changes in their localiza-
tion were noticed in comparison with non-transfected 
cells. In order to assess the impact of homogenous and 
filamentous en-actin on transcription, we compared 
transcription levels of those cells with cells having no 
overexpression of actin (control). as it is known that 
transcription is inactivated during mitosis, gradually 
activated during g1 and its levels are maximal in S and 
g2 phases (Klein and grummt 1999; Oelgeschlager 
2002; White et al. 1995), we measured the transcription 
levels in different stages of the cell cycle based on the 
proliferating cell-nuclear antigen (PCna) pattern. nas-
cent transcripts were labeled with fluorouridine (FU) 
in vivo, which was then detected by indirect immuno-
fluorescence microscopy. Total fluorescence intensity 
of FU in the nucleus was quantified and normalized to 
the nuclear area. Transcription levels of cells expressing 
either homogenous en-actin (Fig. 8k, g-actin) or en-
actin filaments (Fig. 8k, F-actin) did not significantly 
differ from the control (Fig. 8k, control) cells in the g1 
and g2 phases of the cell cycle. However, we detected 
changes in transcription in the S-phase when cells form-
ing nuclear en-actin filaments significantly increased 
their transcription levels by 30 % (Fig. 8k) in compari-
son with control cells. On the other hand, S-phase tran-
scription of cells having homogenous nuclear en-actin 
did not significantly differ either from control cells or 
from the cells with en-actin filaments.
In conclusion, nuclear en-actin filaments do not par-
ticipate in chromatin remodeling, do not preferentially 
associate with transcriptionally active or inactive chro-
matin, but their presence causes increase in general tran-
scription levels in the S-phase in comparison with control 
cells.
Discussion
The fundamental ability of actin is to form polymers. 
although polymeric structures are long known to exist 
in the cytoplasm, their presence and form in the nucleus 
remains unclear.
We showed that the overexpression of en-actin trig-
gers formation of bundled filaments in the nucleus bearing 
various shapes from straight long (Figs. 7e, 8h) to curved 
(Fig. 7a) and dense meshwork (Figs. 1c, 6e). This observa-
tion is in agreement with a previous work by Kokai et al. 
(2014), which moreover proposed that some of the fila-
ments are even branched. even though we did not study 
this feature in greater detail, we support the notion that 
some of the filaments are indeed branched, not only cross-
ing each other (Fig. 2b–c).
In U2OS cells, en-actin localizes not only to the 
nucleus, but is also incorporated into cytoplasmic fila-
ments (Fig. 1a and c). The incorporation of en-actin into 
the cytoplasmic fibers affected neither formation of en-
actin nuclear filaments nor its nuclear translocation, which 
was indeed favored (Fig. 1c). The distribution of en-actin 
within a cell seems to be cell-type specific, because cyto-
plasmic retention was not observed in rat PC12 cells (Kokai 
et al. 2014), whereas in primary mouse skin fibroblasts 
(Fig. 3a, b) en-actin resided preferentially in the cytoplasm 
and did not form nuclear filaments. at the same time, en-
actin was readily imported into the nucleus of HeK293 
cells (Fig. 3e). This may reflect differential requirements of 
actin in the nuclear processes in various cell types.
The formation of nuclear filaments after expression of 
exogenous en-actin is relatively rare in U2OS cells, since 
only 1–5 % of cells show such phenomenon. Such a low 
incidence of en-actin filament formation suggests that 
specific conditions are required to trigger polymeriza-
tion. It is known that actin begins to polymerize when the 
critical concentration of free actin monomers is achieved. 
However, we did not observe such concentration depend-
ency, since the expression levels of en-actin normalized 
to nuclear area did not differ significantly in cells with 
homogenous en-actin versus cells containing en-actin fil-
aments (Fig. 2e). This indicates that the amount of actin in 
the nucleus is not the only factor determining the filament 
formation, but seems to be a prerequisite. In agreement, 
blocking the actin export has been reported to cause actin 
polymerization inside of the nucleus (Dopie et al. 2012; 
Stuven et al. 2003).
While we observed that cells containing homogenous 
en-actin progressed through mitosis (Fig. 4), during which 
en-actin mimicked localization of the endogenous actin 
(Yang et al. 2004), the presence of nuclear en-actin fila-
ments decreased cell proliferation rate by a half (Fig. 5c). 
Moreover, we observed two abnormalities in the interphase 
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cells which seem to originate in mitosis—formation of 
additional micronuclei or retention of both daughter nuclei 
within one cell (Fig. 5a, b). These two irregularities were 
previously observed by Moulding et al. (2007) as a conse-
quence of increase in cytoplasmic F-actin assembly, which 
caused its mislocalization and led to delay in mitosis and 
defects in cytokinesis. Besides, both micronuclei forma-
tion and bridging the two daughter nuclei together are 
also results of improper chromosome segregation, which 
is caused by aberrant centromeric incidence (reviewed in 
Fenech et al. 2011). Because F-actin is as well required 
for the anchoring of mitotic spindle to the cell cortex and 
moreover to establish the direction of spindle movement 
(Woolner and Bement 2009), it is plausible that the exces-
sive amount of overexpressed en-actin (which may form 
filaments during mitosis) prevents correct spindle posi-
tioning and manifests in chromosome segregation errors. 
Since 90 % of the binucleic cells contained nuclear en-
actin filaments, whereas only 10 % of the cells contained 
homogenous nuclear en-actin, we speculate that the effect 
is reinforced with increasing filamentous en-actin levels. 
In conclusion, multiple aspects seem to contribute to the 
defects in mitosis; however, the severity is related to the 
amount of en-actin which is available for polymerization 
into nuclear filaments.
It has been shown that the increase in cofilin expression 
causes arrest in g1 phase of a cell cycle by a mechanism 
which involves cyclin-dependent kinase inhibitor p27Kip1 
(Tsai et al. 2009). although we did not observe elevated 
levels of cofilin, we showed a co-localization between cofi-
lin and the nuclear en-actin filaments (Fig. 7c, d). There-
fore, we speculate that cofilin might trigger the nuclear 
p27Kip1 leading to g1 arrest. In conclusion, the defective 
mitosis is probably a result of more than one aspect and 
additional experiments need to be performed to understand 
this issue clearly.
numerous actin-binding proteins localize and exert their 
functions in the nucleus (reviewed in Castano et al. 2010). 
among those tested in this study, cofilin co-localized with 
the nuclear en-actin filaments (Fig. 7c, d,), whereas its 
phosphorylated form (P-cofilin) did not (Fig. 7e). Besides 
its involvement in cell cycle progression, cofilin employs 
multiple modes of action—upon increase in g-actin 
amount, cofilin maintains actin import into the nucleus 
(Pendleton et al. 2003) and, at the same time, regulates 
actin dynamics. Cofilin severs actin filaments at low actin 
concentrations and nucleates actin filaments at high actin 
concentrations (andrianantoandro and Pollard 2006). 
When filaments are bundled, they become more resistant to 
cofilin severing (Michelot et al. 2007). Therefore, we sug-
gest that cofilin promotes en-actin filament formation.
We also found arp3 upregulated upon en-actin overex-
pression (Fig. 7f, g). arp3 is a member of arp2/3 complex, 
which triggers nucleation of the new or branching of the 
existing actin filaments (Pantaloni et al. 2000). although 
we did not study branching of the en-actin filaments, anal-
ysis of nuclear nlS-actin filaments performed by Kokai 
et al. (2014) revealed that the filaments are most likely 
branched. Hence, we propose that arp3 might assist in en-
actin filament nucleation and branching.
Besides cofilin and arp3, we did not identify any other 
actin-associated protein to co-localize with the en-actin 
filaments, despite testing many potential candidates. How-
ever, as recent studies identified nuclear actin filament for-
mation being dependent on nuclear formin (Baarlink et al. 
2013), Toca-1, (Miyamoto et al. 2011), n-WaSP (Wu et al. 
2006) and JMY (Zuchero et al. 2009), we assume that other 
nuclear-specific actin-binding proteins assist in en-actin 
dynamics too.
We showed here that both homogenous and filamen-
tous forms of en-actin are preferentially neither enriched 
nor excluded from the chromatin regardless of its tran-
scriptional state (Fig. 8g, h). noteworthy, we observed 
that en-actin filaments seem to avoid only densely packed 
heterochromatin (Figs. 1c, 3c–e, 7g), which indeed occurs 
rarely in the U2OS cells as revealed by the electron micros-
copy (not shown). Based on the absence of co-localization 
between nuclear en-actin filaments and chromatin remod-
eling complexes (Fig. 8a–f), we support the notion that the 
actin in chromatin remodeling complexes and in complex 
with hnrnPs is monomeric (Obrdlik et al. 2008; Percipalle 
et al. 2002) and nuclear en-actin filaments do not seem to 
affect chromatin state.
Similarly, formation of nuclear en-actin filaments did 
not affect the gross localization of active forms of rna 
polymerases I and II (Fig. 8i, j), which were concentrated 
in discrete foci throughout the nucleolus and nucleo-
plasm, respectively. The pattern of transcription foci 
was identical to the control cells, and all the cells were 
transcriptionally active. after we quantified transcription 
levels, we found that there is an elevation in the S-phase 
of the cell cycle in the presence of nuclear en-actin fila-
ments by 30 % in comparison with control, whereas the 
presence of homogenous en-actin did not affect tran-
scription significantly (Fig. 8k). In g1 and g2 phases, the 
transcription levels did not differ significantly from con-
trol. It is plausible that recruitment of en-actin filaments 
to the transcription complexes in the S-phase is enabled 
by a more permissive state of chromatin in the S-phase. 
This finding also points toward the possibility that poly-
meric state of actin is required for transcription as has 
been suggested previously (Miyamoto et al. 2011; Obrd-
lik and Percipalle 2011; Wu et al. 2006; Ye et al. 2008; 
Yoo et al. 2007). Up to date, numerous studies focused on 
the involvement of actin in transcription of SrF-regulated 
genes. To trigger transcription, SrF requires its cofactor 
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Mal which is only imported into the nucleus when free 
of g-actin (Miralles et al. 2003; Vartiainen et al. 2007). 
Collectively, these studies revealed that formation of 
F-actin in the nucleus or in the cytoplasm depletes lev-
els of g-actin, which cannot sequester Mal. Mal is in 
turn imported into the nucleus leading to upregulation of 
SrF-mediated transcription (Baarlink et al. 2013; Kokai 
et al. 2014; Stern et al. 2009; Vartiainen et al. 2007). It 
is therefore reasonable to speculate that the elevation of 
transcription upon en-actin filaments formation that we 
observed occurs via exhaustion of free g-actin mono-
mers. However, to answer this clearly, more experiments 
need to be performed.
To sum up, our study documents a potential for en-actin 
to form filaments in the nucleus closely resembling actin 
filaments in the cytoplasm. generation of nuclear en-actin 
filaments recruits cofilin and arp3 into the nucleus and 
affects cellular processes. Since our observations of the 
en-actin polymerization, its behavior during cell cycle, co-
localization with actin-binding proteins and transcriptional 
activity are in agreement with previous studies, we suggest 
that en-actin fusion protein mimics the endogenous actin 
and may be used as a tool for future challenging research 
focusing on actin functions in the nucleus.
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5.  DISCUSSION 
5.1 Phosphoinositides and their localization in the nucleus 
Nuclear PIs are important regulators of various nuclear processes (reviewed in Shah 
et al. 2013). To better understand their role in the nucleus, tools for nuclear PIs visualization 
both in vivo and in vitro are needed. 
In order to detect nuclear PIs, we tested several antibodies and PIs-binding protein 
domains. Overexpressed PIs-binding domains conjugated with GFP are widely used for 
detection of PIs in cellular membranes. They often localize also to the nucleus however their 
nuclear localization is probably a result of unspecific accumulation after overexpression 
(Hammond and Balla 2015). Indeed, most of PIs-binding domains we tested display the same 
nuclear pattern as their mutant forms, which are not able to bind PIs. Only EEA1-FYVE 
domain specifically detected PI(3)P foci in nucleoli of U2OS cells. In support of our data, 
PI(3)P has been previously detected in nucleoli of human fibroblasts and baby hamster 
kidney cells (Gillooly et al. 2000). The function of nucleolar PI(3)P is completely unknown and 
will be a subject of our future research.  
As most of the overexpressed PIs-binding domains are not suitable for PIs detection 
in the nucleus, we prepared purified PLCδ1-PH, Tubby and OSH1-PH domains fused with 
eGFP, which recognize PI(4,5)P2 and PI(4)P, respectively. We compared a nuclear pattern of 
these domains with patterns of anti-PI(4,5)P2 and anti-PI(4)P antibodies. 
Using OSH1-PH and anti-PI(4)P, we demonstrate for the first time that nuclear PI(4)P 
can be visualized in the cell nucleus.  PI(4)P is present in the nuclear membrane, it localizes 
to the nuclear speckles and forms small nucleoplasmic foci. The pattern of PI(4)P in nuclear 
speckles is not homogenous, it forms small foci inside and at the edges of nuclear speckles, 
where the active transcription takes place (reviewed in Spector and Lamond 2011). Only a 
minority of nuclear PI(4)P resides in nuclear speckles. The majority of nuclear PI(4)P localizes 
to other nuclear compartments and most of nuclear PI(4)P is associated with chromatin. 
Moreover, small nucleoplasmic foci of PI(4)P partially colocalize with H3K4me2, the mark of 
active chromatin (Wang et al. 2014).  
PI(4)P localization to the active chromatin and to the edges of nuclear speckles 
indicates that PI(4)P might play a role in the regulation of DNA transcription. In addition, 
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PI(4)P in the nuclear speckles could be implicated in splicing of newly transcribed pre-mRNA. 
The other possibility is that PI(4)P in nuclear speckles serves as a precursor for PI(4,5)P2. 
Enzymes, which convert PI(4,5)P2 to PI(4)P and vice versa, localize to the nuclear speckles 
(Boronenkov et al. 1998; Déléris et al. 2003; Mellman et al. 2008; Schill and Anderson 2009; 
Elong Edimo et al. 2011) and therefore it is highly probable that an active metabolism of 
these PIs in nuclear speckles indeed occurs. 
Using PLCδ1-PH and Tubby domains and anti-PI(4,5)P2 antibody we detected 
PI(4,5)P2 in nucleoli, nuclear speckles and nucleoplasm. In agreement, localization of 
PI(4,5)P2 in nuclear speckles and nucleoli has been described (Osborne et al. 2001; Yildirim 
et al. 2013; Sobol et al. 2016). Moreover, we show that nearly 30 % of total nuclear PI(4,5)P2 
detected by anti-PI(4,5)P2 antibody is located in foci outside of these structures. This 
nucleoplasmic PI(4,5)P2 forms 40-100 nm roundish structures, which we termed PI(4,5)P2 
islets. They have carbon-rich interior and phosphorus- and nitrogen-rich exterior. Therefore, 
we suggest that the inner core of PI(4,5)P2 islets is composed of lipids while their outer 
surface is surrounded by proteins and nucleic acids. 
Recently, nuclear lipid droplets (nLDs) have been described in rat and human liver 
hepatocytes (Layerenza et al. 2013). Their hydrophobic lipid core is formed by 
triacylglycerols and cholesterol and is surrounded by a hydrophilic outer monolayer from 
polar lipids and proteins. Yoo et al. (2014) showed that PI(4,5)P2 can form membrane 
enclosed nucleoplasmic vesicles in the bovine adrenal chromaffin cells (Yoo et al. 2014).  
However, PI(4,5)P2 islets are approximately 10-times smaller than nLDs and are not 
surrounded by a membrane. These results suggest that PI(4,5)P2 islets are a novel type of 
phospholipid-containing foci in the nucleus. 
We show that the active form of RNA Pol II and transcription machinery proteins as 
well as nascent RNA are associated with PI(4,5)P2 islets. PI(4,5)P2 islets are RNA but not DNA 
dependent structures. The majority of PI(4,5)P2 islets colocalizes with RNA and can be 
disturbed by RNase treatment. Therefore, PI(4,5)P2 islets might serve as a scaffold for the 
arrangement of RNA Pol II transcription machinery. In agreement, PI(4,5)P2 hydrolysis 
results in a significant decrease of transcription level. Similarly, several studies demonstrated 
a contribution of other lipid-based structures in transcription (Scassellati et al. 2010; 




 We show that the inhibition of RNA Pol II transcription does not disturb PI(4,5)P2 
islets. Hence, PI(4,5)P2 islets are stable nuclear structures independent of ongoing 
transcription. Therefore, we suggest that PI(4,5)P2 islets facilitate spatial-temporal 
arrangement of transcription complexes assembly. 
5.2 Binding partners of phosphoinositides in the nucleus and their functions 
Nuclear phosphoinositides associate with histones and other chromosomal proteins 
to regulate chromatin remodelling, DNA modifications and transcription (reviewed in Viiri et 
al. 2012). However, their functions in the nucleus are still poorly understood. Here, we 
describe two novel PIs interacting proteins - nuclear myosin 1 (NM1) and lysine-specific 
histone demethylase 1 (LSD1). 
NM1 contains C-terminal PH domain that specifically binds PI(4,5)P2 and tethers 
NM1 to the plasma membrane (Hokanson and Ostap 2006; Hokanson et al. 2006). In the 
nucleus, NM1 is involved in chromatin remodelling and RNA Pol II transcription. The C-
terminal part of NM1 containing PI(4,5)P2-binding site is essential for these functions 
(Hofmann et al. 2006; Almuzzaini et al. 2015). 
We show that NM1 interacts with PI(4,5)P2 also in the cell nucleus and this 
interaction anchors NM1 to bigger nuclear complexes. The mutation of PI(4,5)P2 binding site 
results in a loss of interaction with RNA Pol II and downregulation of transcription. We show 
that NM1 localizes to the surface of PI(4,5)P2 islets. Therefore we hypothesize that NM1 is 
sequestered to PI(4,5)P2 islets through the interactions with PI(4,5)P2. In such way, NM1 
could recruit chromatin remodelling complexes to PI(4,5)P2 islets to create an open 
chromatin structure and promote transcription. We speculate that after disruption of NM1 
association with PI(4,5)P2 islets, RNA Pol II complexes remain attached to the surface of 
PI(4,5)P2 islets. However, transcription cannot occur probably due to the lack of chromatin 
remodelling factors.  
We found that PI(4)P associates with chromatin and colocalizes with H3K4me2. We 
show that PI(4)P interacts with LSD1, which demethylates H3K4me2 and H3K4me1 histone 
methylation marks and therefore represses transcription of its target genes (Shi et al. 2004). 
By direct binding assay, we show that LSD1 interacts directly with PI, PI(4)P, PI(3,4)P2, 
PI(3,5)P2, PI(4,5)P2 and PI(3,4,5)P3 but displays the highest affinity towards PI(4)P. As PI(4)P 
and PI(4,5)P2 are the most abundant PIs species (reviewed in Viaud et al. 2015), we studied 
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how these two PIs regulate LSD1 activity. We demonstrate that PI(4)P binding inhibits LSD1 
activity in vitro whereas PI(4,5)P2 binding has a stimulatory effect. Interestingly, LSD1 binds 
PI(4,5)P2 but not PI(4)P in nuclear lysates. Since LSD1 interacts with PI(4)P after 
overexpression, we hypothesize that PI(4)P binds to LSD1 only when downregulation of 
H3K4me2 demethylase activity is necessary. 
It has been shown that a single change in phosphorylation of inositol ring can 
regulate the affinity of a PIs-interacting protein to its binding partners (Blind et al. 2012). 
Since LSD1 has neither DNA nor histone binding domain, its function is highly dependent on 
its interacting partners in transcriptional repression complexes (reviewed in Amente et al. 
2013). Therefore, a single phosphorylation of PI(4)P or dephosphorylation of PI(4,5)P2  by 
particular kinases or phosphatases could provide a rapid and dynamic regulation of LSD1 
function also in vivo. Such regulation could provide a fine adjustment of LSD1 functions and 
expression of its target genes. 
5.3 Actin in the nucleus 
In the cytoplasm, actin is present in two different forms - as monomeric globular 
actin (G-actin), which can polymerize and form actin filaments (F-actin). In the nucleus, actin 
is present in monomeric form (reviewed in Jockusch et al. 2006). Initially, it was uncertain 
whether actin polymerization can occur in the nucleus. Eventually, several studies reported 
F-actin formation in the nucleus (Miyamoto et al. 2011; Belin et al. 2013; Baarlink et al. 2013; 
Kokai et al. 2014). We investigated whether nuclear actin filaments recruit actin-binding 
proteins and affect the nuclear processes. After over-expression of EYEP-NLS-actin (EN-
actin), 1 to 5 % of cells formed long thick nuclear filaments, which in their length and 
thickness resembled cytoplasmic F-actin. The rest of the cells displayed diffused nuclear 
actin signal. We show that cofilin, actin-depolymerizing factor, and Arp3, a component of 
actin nucleation complex Arp2/3 colocalizes with nuclear actin filaments. EN-filaments do 
not preferentially localize to either active or inactive chromatin. Although EN-actin does not 
colocalize with RNA polymerases, the level of transcription increases in S-phase in the 
presence of EN-actin filaments. In support of this finding, earlier studies reported an 
increased transcription in the presence of polymeric actin in the nucleus (Ye et al. 2008; 
Baarlink et al. 2013; Kokai et al. 2014). 
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The formation of EN-actin filaments decreases the cell proliferation rate and 
increases incidence of formation of additional micronuclei or retention of both daughter 
nuclei within one cell. Similar results were reported previously as a consequence of 
cytoplasmic F-actin assembly (Moulding et al. 2007). However, it could be also a result of 
aberrant chromosome segregation (reviewed in Fenech et al. 2011). Since EN-actin 
polymerization, its behaviour during the cell cycle, colocalization with actin-binding protein, 
and transcriptional activity are in agreement with previous studies, we suggest that EN-actin 
could be used as a tool in future research regarding actin functions in the nucleus.  
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6. SUMMARY AND CONCLUSIONS 
6.1 PI(4,5)P2 islets are associated with active transcription 
PI(4,5)P2 forms 40-100 nm large structures in the nucleoplasm, which we call PI(4,5)P2 islets. 
Their interior is composed of carbon rich structures, probably lipids. They are surrounded by 
proteins and nucleic acids. PI(4,5)P2 islets surface is associated with active form of RNA 
polymerase II,  transcription machinery proteins and nascent RNA. 
6.2 NM1 interacts with PI(4,5)P2 in the nucleus 
NM1 interacts with PI(4,5)P2 in the nucleus through its PH domain. PI(4,5)P2 anchors NM1 
to PI(4,5)P2 islets and is essential for NM1 interaction with transcription machinery. The 
mutation of PI(4,5)P2 binding site results in loss of interaction with RNA Pol II and decreased 
transcription. 
6.3 PI(4)P localizes to the nucleus and  is associated with chromatin 
In the nucleus, PI(4)P is present in the nuclear membrane, nuclear speckles and small 
nucleoplasmic foci. The majority of nuclear PI(4)P is associated with chromatin and 
colocalizes with H3K4me2, a mark of active chromatin. 
6.4 LSD1 is regulated by nuclear phosphoinositides 
LSD1 binds directly to both PI(4)P and PI(4,5)P2. While the interaction with PI(4)P leads to 
the inhibition of LSD1, the interaction with PI(4,5)P2 stimulates LSD1 H3K4me2 demethylase 
activity. 
6.5 Nuclear actin filaments alter cellular behaviour 
After overexpression of nuclear targeted EN-actin, 1-5 % of cells display formation of nuclear 
actin filaments. These filaments resemble cytoplasmic F-actin and recruit cofilin and Arp3 
actin binding proteins. A formation of actin filaments in the nucleus results in an increased 




7. FUTURE PROSPECTS 
Our results demonstrate that nuclear phosphoinositides can regulate DNA transcription 
directly by interaction with RNA polymerase and transcription factors or indirectly by the 
alteration of epigenetic regulation. Further, we would like to answer the following questions: 
7.1 What is the composition of PI(4,5)P2 lipid islets? Which genes are transcribed 
at their surface? 
The core of PI(4,5)P2 islets is enriched in carbon and probably contains lipids. We would like 
to investigate the composition of PI(4,5)P2 islets core in greater detail. Moreover, the 
surface of PI(4,5)P2 islets is associated with actively transcribing RNA Pol II. However, it 
remains unknown whether certain genes are transcribed in the vicinity of PI(4,5)P2 islets. 
We would like to identify genes which are associated with nuclear PI(4,5)P2 and whose 
transcription is connected to PI(4,5)P2 islets. 
7.2 What are the other binding partners of nuclear PI(4)P? 
Although it is known that PI(4)P is metabolized in the nucleus, its localization, binding 
partners and functions were unknown. We showed for the first time that PI(4)P localizes to 
nuclear membrane, nuclear speckles and forms small nucleoplasmic foci that partially 
colocalize with H3K4me2. Moreover, we demonstrated that PI(4)P interacts with LSD1. In 
our future research, we would like to analyse other possible binding partners and identify 
PI(4)P role in their function. 
7.3 How do PIs regulate LSD1 activity? 
PIs regulate nuclear processes by two different mechanisms. First, PIs target their binding 
partners to the sites of their action. Second, PIs bind proteins partners and allosterically 
regulate their functions. We showed that H3K4me2 demethylase activity of LSD1 can be 
donwregulated or upregulated by PI(4)P or PI(4,5)P2, respectively. However, how this 
regulation is achieved is unclear. We would like to elucidate the mechanism of LSD1 
regulation. Moreover, LSD1 can bind also other PIs as PI(3,4)P2, PI(3,5)P2 and PI(3,4,5)P3. 
Although these PIs are present in minor amounts in the cell, we would like to investigate 
whether and to which extend they can regulate LSD1 function. 
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7.4 What is the role of PI(3)P in nucleolus? 
Previously, we have shown that PI(4,5)P2 is synthesized at rDNA promoter and regulates 
RNA Pol I transcription (Yildirim et al. 2013). Here, we have detected PI(3)P in nucleoli of 
U2Os cells by specific EEA1-FYVE domain. Since PI(3)P is not a direct product of PI(4,5)P2 
(de)phosphorylation, it has probably its own unique roles in the nucleolus. We would like to 
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